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Detection, imaging and quantification of gene expression in living cells can 
provide essential information on basic biological issues and disease processes.  To 
establish this technology, we need to develop molecular probes and cellular delivery 
methods to detect specific RNAs in live cells with potential for in vivo applications.  In 
this thesis work, the major focus is placed on the development of molecular beacons and 
biochemical approaches (peptides etc.) to deliver such probes to different cellular 
compartments. These approaches are then employed to study the expression and 
localization of mRNAs, co-localization of mRNAs with cytoplasmic organelles and 
cytoskeleton, and co-localization of RNA molecules in the nuclei of living cells.  
Further along this direction, we were interested in developing a better 
understanding of the functional states of mRNAs and the fluorescent signal observed in 
optical imaging experiments. To acheive this goal, we altered the translational process 
and studied its effect on the detection of mRNAs in living cells. The results of these 
studies indicate that the translational state of mRNAs favors the hybridization of 
molecular beacon with its target sequence. This study has also provided the evidence 
that molecular beacons are reversibly bound to target mRNAs and the repression of the 
translational process can prevent molecular beacon from binding to its target mRNA. 
Further, using these approaches in combination with FRAP based biophysical analysis, 
the dynamics of endogenous RNA in living cells are studied. These studies revealed the 
possible subcellular organization of RNA molecules and their dynamics in living cells. 
The results also demonstrated the role of cytoskeleton and ATP in the mobility of 
specific mRNAs in the cytoplasm.   
 xvii
In addition to optical probes, studies have been carried out to develop an MRI 
contrast agent using iron-oxide nanoparticles for deep tissue molecular imaging. 
Specifically, we have functionalized magnetic nanoparticles that are water-soluble, 
mono-dispersed, biocompatible, and easily adaptable for multifunctional bioconjugation 
of probes and ligands.  We have successfully delivered magnetic nanoparticle 
bioconjugates into live cells and demonstrated their effect on relaxivity. We have further 
studied the role of coating thickness for optimization of contrast and further enhance the 










Various technologies and methodologies have been developed to study 
intracellular RNA biology by creating tagged full length RNAs or using RNA targeting 
probes.  In most cases these tags are fluorescent, chemical (such as digoxigenin), or 
radioactive.  For example, tagged full length RNA has been introduced into living cells 
using microinjection ([3]; [4]; [5]) to monitor the localization of a specific mRNA or 
nuclear RNA.   
Labeled linear oligonucleotide (ODN) probes of 20-50 bases have been used to 
study intracellular mRNA (e.g. [6]; [7]; [8]; [9]) via in situ hybridization (ISH) in which cells 
are fixed and permeabilized to increase the probe delivery efficiency and unbound 
probes are removed by washing, therefore reducing background and achieving 
specificity.  To enhance the signal level, multiple probes targeting the same mRNA can 
used (e.g. [10]).  However, fixation agents and other supporting chemicals can have 
considerable effect on signal ([11]) and possibly on the integrity of certain organelles 
such as mitochondria.  Therefore, fixation of cells, by either cross-linking or denaturing 
agents, combined with the use of proteases in ISH may not provide an accurate 
description of intracellular mRNA localization.  Labeled linear ODN probes are not very 
useful in detecting mRNA in live cells since it is impossible to remove unbound probes 
by washing and thus difficult to distinguish between signal and background.  
In addition to oligonucleotide probes, tagged RNA-binding proteins such as those 
with GFP tags have been used to detect mRNA in live cells ([12]).  One limitation is that 
it requires the identification of a unique protein, which only binds to the specific mRNA of 
interest.  To address this issue, recently a transgene with a binding site for the phage 
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MS2 protein was synthesized ([13]).  Generation of a GFP tagged phage MS2 protein in 
Drosophila eggs allowed the specific targeting of the nanos mRNA in a living egg 
system.  However, there is still a significant challenge in generating transgenes with the 
same functionality as endogenous mRNA.   
To detect endogenous gene expression in living cells, we need to develop a probe, 
which can be delivered specifically to cytoplasm of living cells and on binding its target m 
RNA it can provide a signal different from its unbound state. One such design of probe, 
which has been mainly developed, for PCR applications are molecular beacons. These 
molecular beacons are hairpin probes. In the following section, we discuss in more 
details the design of hairpin probes for gene detection in living cells. 
 
Molecular Beacons (hairpin probes) 
 
 The detection and quantification of specific mRNAs require probes to have high 
sensitivity and specificity, especially for low abundance genes and with a small number 
of diseased cells in clinical samples.  Further, for detecting genetic alterations such as 
mutations and deletions, the ability to recognize single nucleotide polymorphisms 
(SNPs) is essential.  When designed properly, hairpin nucleic acid probes have the 
potential to be highly sensitive and specific, with fast probe-target hybridization kinetics.  
As shown in Figure 1a, one class of such probes is known as molecular beacons, which 
are dual-labeled oligonucleotide probes with a fluorophore at one end and a quencher at 
the other end ([14]).  They are designed to form a stem-loop structure in the absence of 
a complementary target so that fluorescence of the fluorophore is quenched.  
Hybridization with target nucleic acid in solution or in a living cell opens the hairpin and 
physically separates the fluorophore form quencher, allowing a fluorescence signal to be 
emitted upon excitation.  Thus, molecular beacons enable a homogenous assay format 
where background is low, without the need to wash away unbound probes.  The design 
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of the hairpin structure provides an independently adjustable energy penalty for hairpin 
opening which improves probe specificity ([15]; [16]).  The ability to transduce target 
recognition directly into a fluorescence signal with high signal-to-background ratio, 
coupled with an improved specificity has allowed molecular beacons to enjoy a wide 
range of biological and biomedical applications.  
 There are three major design issues of nanostructured molecular probes for gene 
detection in living cells: specificity, melting temperature, and secondary structure of 
target mRNA.  First, to endure specificity, for each gene to target, one can use BLAST or 
a similar software to select 16-20 base target sequences that are unique for the target 
mRNA.  Secondly, since the melting temperature of molecular beacons affects both the 
signal-to-background ratio and detection specificity, especially for mutation detection, 
one has to systematically adjust the G-C content of the target sequence, the loop and 
stem lengths and the stem sequence of the molecular beacon to realize the optimal 
melting temperature.  In particular, it is necessary to understand the effect of molecular 
beacon design on melting temperature so that, at 37oC, single-base mismatch in target 
mRNAs can be differentiated.  Finally, since mRNA molecules often have secondary 
(folded) structures, it is important to avoid targeting sequences that are buried (i.e., 
where double stranded RNA was formed).  One difficulty in the molecular beacon design 
is that, although predictions of mRNA secondary structure can be made using software 
such as mfold, they may not be accurate due to limitations of the biophysical models 
used.  Therefore, for each gene to target, it is often necessary to select multiple target 
sequences, and have corresponding molecular beacons designed, synthesized and 
tested in living cells ([17]).  
A conventional molecular beacon has four essential components: loop, stem, 
fluorophore and quencher, as illustrated in Figure 1.1 A. The loop usually consists of 15-
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25 nucleotides and is selected based on target sequence, melting temperature, and the 
secondary structure of the target mRNA. The stem, formed by two complementary short-
arm sequences, is typically 4-6 bases long and is usually chosen to be independent of 
the target sequence (Figure 1.1 B).  Molecular beacons, however, can also be designed 
such that one arm of the stem participates in both stem formation and target 
hybridization (shared-stem molecular beacons), as illustrated schematically in Figures 
1.1 C.  Although a molecular beacon can be labeled with any desired reporter-quencher 
pair, proper selection of the reporter and quencher could improve the signal-to-

























Figure 1.1: Illustrations of molecular beacons. (A) Molecular beacons are stem-loop 
hairpin oligonucleotide probes labeled with a reporter fluorophore at one end and a 
quencher molecule at the other end.  (B) Conventional molecular beacons are 
designed such that the short complementary arms of the stem are independent of the 
target sequence.  (C) Shared-stem molecular beacons are designed such that one arm 




The loop, stem lengths and sequences are the critical design parameters for 
molecular beacons, since at any given temperature they largely control the fraction of 
molecular beacons in each of three different conformational states: bound-to-target, 
stem-loop, and random-coil ([15]).  The adapted representation of three states of 
molecular beacons is shown in Figure 1.2.  In many applications, the choices of the 
probe sequence are limited by target-specific considerations, such as the sequence 
surrounding a single nucleotide polymorphism (SNP) of interest.  Figure 1.3 represents 
the melting curve analysis of molecular beacons in presence of perfect complementary 
and single base mismatched targets. This study indicates the selection of SNP’s vs. 
perfect complementary sequences in a homogeneous assay.  However, the probe and 
stem lengths, and stem sequence, can be adjusted to optimize the performance (i.e. 
specificity, hybridization rate and signal-to-background ratio) of a molecular beacon for a 
specific application ([18];[16]).  Figure 1.4 illustrates the role of length of stem in 
controlling the melting point of molecular beacons.  It is interesting to note, however, that 
stem-less molecular beacons, which lack the short complementary arms and rely solely 
on the random-coiled nature and interactions between the dye and quencher to maintain 









Figure 1.2: Three thermodynamic phases of molecular beacons in presence of 
target 
Phase (1) - Target hybridized with molecular beacon which provides signal due to 
opening of hairpin. 
Phase (2) - Molecular beacon in hairpin shape (unhybridized to target) 
Phase (3) - Randomly opened beacon which will contribute to background signal 















Figure 1.3: Thermal denaturation profiles of solutions containing molecular 
beacons. 
Curve a: Absence of targets; 
Curve b: Presence of a 6-fold excess of perfectly complementary targets 
Curve c: Presence of a 6-fold excess of single-base mismatched targets 




Figure 1.4: Structure-function relations of molecular beacons 
(a) Melting temperatures for molecular beacons with different structures in 
 the presence of target. 
(b) The rate constant of hybridization k1 (on-rate constant) for molecular beacons 
with various probe and stem lengths hybridized to their complementary targets 
(Adapted from Ref. 16) 
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            In the previous section, we have discussed the design of molecular beacons to 
detect mRNA. All the discussions regarding design of molecular beacons/hairpin probes 
is based on homogeneous assays such as solution studies with short oligonucleotides or 
PCR with mRNA /c-DNA strands but at elevated temperatures.  This implies that there is 
no significant constraint of secondary structure of mRNA, or RNA-protein complex during 
detection. This constraint of both secondary/tertiary mRNA structure and RNA-protein 
complexes becomes a major challenge in designing probes for detection of mRNA in 
living cells.  
When in situ hybridization (ISH) techniques are applied for detection of mRNA in 
fixed cells, the challenge of mRNA secondary structure is overcome by using fixative 
agents (precipitation of proteins/removal of agents) in combination with permeablizing 
agents, proteases to cleave proteins, and high temperature for hybridization.  The 
specificity of ISH assays is realized by extensive washing.  None of these can be 
realized for live cell assays.  Although the use of longer linear probes can provide some 
signal even with partial hybridization, it can also lead to false-positive signals.  
Therefore, there are many challenges in living cell mRNA detection both due to the 
possible difficulties in target accessibility and the lack of predictive models, as discussed 




 RNA Secondary Structure 
RNA secondary and tertiary structures play an important role in the accessibility 
of nanostructured probes in living cell gene detection.  This structural aspect provides a 
significant challenge in designing nanostructured probes as secondary structure of RNA 
can inhibit binding of the hairpin oligonucleotide probe to complementary sequences on 
the target.  However, no existing model or software can give accurate prediction of 
mRNA secondary or tertiary structure in living cells is mainly due to the limited 
understanding of RNA-protein interactions and RNA intra-sequence interactions. Thus, 
most investigators have relied on empirical approaches where multiple targeting 
sequences are selected by “walking” along the length of the target RNA and the optimal 
binding sites are predicted based on the RNase H assay or gel shift assays. 
A number of computational programs have been developed to predict the 
secondary structure of mRNA based on the sequence of mRNA and salt concentration 
but without considering RNA-protein interactions.  The existing algorithms can be 
classified into two groups: (1) predictions based on minimizing free energy (e.g. Mfold, 
RNAsoft, Vienna RNA package); (2) probabilistic or stochastic prediction based on the 
alignment and phylogenetic trees of the sequences and the evolutionary conservation of 
critical structural components of mRNA (e.g. Pfold).  For example, the algorithms initially 
developed by [20] based on minimizing free energy and later modified by [21] to include 
base pairing probabilities (Vienna RNA Secondary Structure Prediction) have been 
widely used as a structural prediction tool in the nucleic acids research community.  One 
of the major limitations of the minimum-energy based models (e.g., Mfold) is the inability 
to predict pseudoknots in the secondary structure of mRNA.  Although a significant 
progress has been made in predicting the secondary structure of a naked mRNA, it is 
still far from making accurate predictions of mRNA structure taking into account the 
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interactions between proteins and target mRNA in an intracellular environment.  This is 
very problematic in the design of nanostructure oligonucleotide probes for living cell 
mRNA detection. 
Understanding the structural changes in target mRNA upon binding of probes 
([22]) is also important, since alterations in native structure of a target mRNA due to the 
binding of short oligonucleotides may drastically change its functionality. It has been 
suggested that the binding of DNA probes may prevent translation by either blocking the 
process or by RNase H activation. To study probe/RNA interactions, tools such as 
OligoWalk ([23]) and PairFold ([24]) have been developed.  For example, OligoWalk 
predicts the interaction of oligonucleotide probes (both DNA/RNA) with target RNA 
structure based on equilibrium affinity at 37°C, and allows the user to study the effects of 
probe length, concentration, and to some extent backbone chemistry (RNA or DNA) on 
the local and global structure of target RNA.   
After a probe is designed based on BLAST searches for unique target sequences 
and secondary structure prediction using mFold, we typically perform solution studies to 
measure the signal-to-background ratio of the molecular beacons synthesized.  Here the 
probe synthesis also plays a crucial role, since a well designed probe could have a low 
signal-to-background ratio if a large fraction of beacons do not have a quencher 
attached to it.  The ultimate test is to deliver the molecular beacons to living cells with 
high efficiency and measure the signal level.  It is also necessary to use negative control 
beacons to measure the background signal.  Figure 1.5 is a schematic representation of 
molecular beacon based detection of cellular mRNA in cells. 
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Figure 1.5: Schematic representation of Molecular Beacon based detection and 
imaging of mRNA in live cell 
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Modified Oligonucleotide Chemistry 
How does the oligonucleotide backbone chemistry affect a hairpin probe’s 
behavior within the cellular environment? The backbone chemistry of a hairpin probe has 
profound implications for the behavior of the probe within the environment of a cell.  
Modified oligonucleotide backbones affect probe affinity, melting temperatures, and 
nuclease resistance.  The antisense field of research has put considerable effort into 
backbone modification to confer nuclease resistance while maintaining RNase H-
mediated mRNA degradation, so much learned from this research can be applied to the 
design of hairpin probes. 
The most commonly used modification in the antisense field uses a 
phosphorothioate bond instead of the phosphodiester bond within the oligonucleotide.  In 
phosphorothioate oligonucleotides (PS-ONs), a sulfur atom replaces one of the non-
bridging oxygen atoms in the phosphate backbone.  This modification has been shown 
to have greater resistance to nuclease degradation than phosphodiesters while 
maintaining RNase H-mediated mRNA degradation ([25]).  The melting temperature of 
the PS-ON-target RNA duplex is slightly lower than the comparable phosphodiester 
oligonucleotide duplex and PS-ONs have lower affinities than the natural DNA 
oligonucleotides for the RNA target ([25]).  A major drawback to this backbone 
modification, as described by ( [25]) is its polyanionic backbone, which can lead to 
elevated protein binding and immune problems.  Excess protein binding would certainly 
negatively impact the ability of a hairpin probe to bind to its target mRNA.  It also 
activates RNase H activity, which is desirable for antisense therapy, but not when the 
goal is a minimally invasive probe of cellular activity. 
Modification of the sugar portion of oligonucleotides forms the basis for another 
class of modified oligonucleotides.  A number of modifications have been made at the 2’ 
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position of the sugar ring ([26]).  Adding a 2’-O-methyl group at this position significantly 
increases binding affinity and confers nuclease resistance.  An increase in melting 
temperature in the sequence has been shown to be on the order of 1°C per modified 
oligonucleotide ([27]).  This modification is not ideal for antisense work because it is 
RNase H-resistant (the duplex looks more like an RNA:RNA duplex than a DNA:RNA 
duplex that RNase H recognizes); however, when designing a hairpin probe, it is 
desirable to avoid inducing RNase H-mediated RNA degradation. 
Another nucleic acid analog in which the sugar ring has been modified has been 
described as “locked nucleic acid” (LNA) ([28]).  In this backbone modification, the 2’O 
and 4’C are linked by a methylene linker.  This “locks” the sugar into the conformation 
(C3’-endo sugar) that is supposedly ideal for recognition of RNA.  This modification gives 
significant increases in melting temperatures (ranging from 1° to 8° C against DNA) and 
has higher selectivity than native DNA oligonucleotides.  LNAs have higher affinity for 
targets primarily due to slower dissociation, as shown by stopped-flow kinetics 
experiments ([28]).  LNAs have also been shown to be stable in the presence of a 
number of nucleases ([29]).   
Peptide nucleic acids (PNAs) are nucleotide analogs that also offer advantages 
for the design of hairpin probes.  PNA is a DNA mimic where the phosphodiester-linked 
backbone has been replaced with an N-(2-aminoethyl)glycine backbone ([30],[31]) and 
behaves according to traditional Watson-Crick base-pairing rules.  PNAs have very high 
binding affinity for single-stranded DNA and RNA; the melting temperature is increased 
by 1.45° per monomeric PNA unit ([32]).  The rate of hybridization is at least as fast as 
DNA:DNA duplex formation.  PNA:RNA duplexes are also more stable at lower salt 
concentrations due to the neutral character of the PNA backbone.  PNA oligonucleotides 
exhibit both high affinity and high specificity ([33]).  PNA oligonucleotides are completely 
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nuclease-resistant.  Also, they have the unique ability to “invade” a DNA duplex, 
although this strand displacement occurs only at salt concentrations much lower than 
physiologically relevant ([32]).  A careful study of the ability of PNA probes to bind to 
structured targets (i.e. those with hairpin structural motifs) showed that the higher affinity 
conferred by the PNA backbone enhances probe binding over a natural DNA probe 
([31]), suggesting that PNA hairpin probes will have a distinct advantage when targeting 
a sequence suspected of significant secondary and tertiary structure.   
Optimization of probe design will require much empirical determination, as there are 
innumerable variations to be examined.  The antisense field has shown that partial 
backbone modifications (modifying only a few of the oligonucleotide units) often confers 
desired properties while minimizing undesirable ones.  Some combination of any of the 
above described modifications may lead to the ideal probe for a given situation; each 
target sequence, however, may offer unique challenges.  One target sequence, for 
example, may exhibit significant secondary structure, while another may be occluded by 
a number of bound proteins.  Hybridization to either of these sequences may require a 
specific set of backbone modifications. In this study, we have used regular DNA 
chemistry, Phosphothiorate chemistry and 2’ o methyl chemistry in design of our probes. 
 
Intracellular RNA Targets 
 
 One of the most exciting and promising applications of nanostructured molecular 
probes such as molecular beacons is their potential use for real-time visualization of 
RNA expression in vivo (i.e., in living cells and tissues).  For example, the ability to 
monitor the level of mRNA expression in vivo will provide important information 
concerning the temporal and spatial processing, localization, and transport of specific 
mRNA under various conditions.  Further, detecting pathogenic markers will provide a 
 17
means of locating and identifying diseased cells, allowing rapid diagnosis and prognosis 
of a disease.  
To have sensitive detection and quantification of mRNA in live cells, it is 
extremely important to understand the form, distribution, dynamics and lifetime of target 
mRNA in vivo in order to optimize the probe design and measurement.  Further, it is 
important to understand the impact of the probe on the cell, including its delivery, 
chemistry, possible toxicity, and non-specific interactions.  In the following sections, we 
describe the basic features of mRNA in living cells, aiming to set a stage for 
understanding the challenges for intracellular mRNA detection and quantification.   
Cytoplasmic and nuclear RNA 
 
In a living cell, the functional forms of pre-mRNA/mRNA exist as ribonucleoprotein 
complexes (RNPs) in which numerous heterogeneous nuclear ribonucleoproteins 
(hnRNPs) bind to the transcript ([34]).  The association of these proteins begins during 
transcription, and there is evidence to show that some of these proteins remain bound to 
the mRNA all the way to the ribosome.  The distribution of these proteins along the 
transcript, as well as the dynamic nature of the protein/RNA association, has a 
significant impact on the accessibility of pre-mRNA/mRNA to hairpin probes. 
Transcription and polyadenylation mRNA is transcribed by a protein transcription 
complex containing RNA polymerase II which, especially the carboxy-terminal domain, 
couples transcription with mRNA processing ([35]).  All pre-mRNA processing is a co-
transcriptional event, including addition of the poly(A) tail and splicing.  Even as the 
nascent transcript (20-25 nucleotides in length) is emerging from the transcription 
complex, a capping enzyme binds the 5’ end, attaching the 5’-7-methylguanosine cap 
([36]).  This cap is then methylated in order to stabilize the transcript against 5’ 
exonucleolytic attack ([36]).  The methylated end is also a signal for nuclear cap binding 
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proteins that facilitate the interaction between the 5’ splice site of a pre-mRNA containing 
introns and a protein complex called the spliceosome.  Depending upon a functional 
poly(A) signal and the terminal splice acceptor site of the terminal intron ([37]), the 
termination of transcription occurs far downstream of the poly(A) . Figure 1.6 illustrates 
the overview of the protein-RNA interactions involved in the export of mRNAs from the 





















Figure 1.6: HnRNP proteins and mRNP proteins along the pathway of mRNA 
biogenesis.  Overview of the interaction and dynamics of the myriad of RNA-binding 
proteins with pre-mRNA and mRNA.  EJC, exon-exon junction complex; NMD, 
nonsense-mediated mRNA decay; RNA pol II, RNA polymerase II; hnRNP, 
heterogeneous nuclear ribonucleoprotein; nRNP, small nuclear ribonucleoprotein; 
mRNP, mRNA-protein complex; PABP, poly(A)-binding protein; m7G, methylguanosine 
cap.  Adapted from Ref. ([34]) 
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site ([35]), either before or at the same time as poly(A) is cleaved due to cleavage 
factors ([38]).  The addition of the 3’ poly(A) tail of a pre-mRNA requires more than a 
dozen polypeptides to be present ([36]).  The pre-mRNA first undergoes endonucleolytic 
cleavage by an endonuclease at the poly(A) synthesis initiation site, followed by 
processive poly(A) synthesis by a poly(A) polymerase.  The poly(A) tail (ranging in 
length from 20 to 250 nucleotides) is then bound by poly(A) binding proteins ([34]). 
Splicing.  During pre-mRNA processing, introns are removed from pre-mRNA by a 
ribonucleoprotein (RNP) machine (spliceosome) that contains at least 50 proteins and 5 
small nuclear RNAs ([39]).  This spliceosome is assembled at each intron, excising the 
intron and then releasing it in a branched “lariat” form along with the spliced pre-mRNA.  
Many of the splicing proteins remain bound to mRNA after splicing ([40]; [41]), 
generating a specific nucleoprotein complex that facilitates mRNA export ([42]).  
Specifically, some of the bound proteins are members of the SR (serine-arginine) protein 
family of splicing factors ([42]), a number of which have been shown to shuttle between 
the nucleus and cytoplasm ([40]).  Proteins within this complex (such as Y14 and Mago) 
can target an mRNA for nonsense-mediated mRNA decay or recruit proteins such as 
TAP/p15 to assist in nuclear export.  
Nuclear export and localization.  Trans-acting factors (proteins that bind to cis elements or 
“zipcode” sequences within RNA) for mRNA localization are often present in granules 
(ribonuclear protein–RNP–complexes) that contain all components necessary for RNA 
processing, transport, localization, anchoring, and translation ([43]).  In other words, 
mRNA localization is a process initiated in the nucleus, based on the proteins that are 
bound during processing and accompany the mature mRNA from the nucleus to the 
cytoplasm.  The hnRNP (heterogeneous nuclear ribonuclear protein) A/B family is one 
group of proteins that play a significant role in mRNA localization.  Both hnRNP A1 and 
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A2 leave the nucleus with mRNAs and then dissociate from the mRNA in the cytoplasm.  
Specifically, hnRNP A2 has been shown to help localize myelin basic protein (MBP) 
mRNA in oligodendrocytes ([43]).  In addition, it has roles in splicing, nuclear export, 
translational regulation, and RNA stabilization. hnRNP A2 binds to a 21-nucleotide 
element in the 3’ untranslated region (UTR) of mRNA ([44] ; [45]).  A second example of 
a nuclear-bound trans-acting factor is zipcode-binding protein 2 (ZBP2), which binds to 
the 3’ UTR of β-actin mRNA ([46]). 
Tap protein is another protein that plays a significant role in nuclear RNA export 
([47]).  This protein contains an RNA binding domain, a nuclear export signal, and a 
binding domain for nucleoporins (proteins that make up the nuclear pore) ([48]).  The 
recruitment of this protein to spliced mRNA has been proposed to be the final step 
required before nuclear pore binding ([48]).   
 
 
Table 1.1: Summary of proteins bound to pre-mRNA 
Type of Protein Comments 
RNA polymerase II  
Capping enzyme  
Cap binding proteins May stay attached all the way through 
export from nucleus ([36]) 
Polyadenylation machinery At least 12 proteins including an as-of-yet 
unidentified endonuclease and Poly(A) 
polymerase, along with many other 
required protein factors. 
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Poly(A) binding proteins  
Spliceosome A ribonucleoprotein (RNP) machine that 
contains at least 50 proteins and 5 small 
nuclear RNAs.  Some of these proteins 
remain bound after splicing and are 
required for nuclear export ([49]). 
Exon-exon junction complex Multi-protein complex 20-24 nucleotides 
upstream of an exon-exon junction ([50]; 
[34]).  This complex binds to as little as 
eight nucleotides 
hnRNP proteins An assortment of at least 20 proteins that 
associate with nascent pre-mRNA; has 
roles in localization, processing and 
nuclear transport. The binding sites of 
some of these proteins has been identified 
as being in the 3’ UTR of mRNAs.  Others 
(of the hnRNP C family) associate 
preferentially with introns. 
 
Distribution of RNA between nucleus and cytoplasm.  An important issue pertaining to the 
measurement of mRNA levels using hairpin probes is the relative levels of RNA in the 
nucleus and cytoplasm.  It has been reported that a large fraction of RNA (>95%) 
synthesized by RNA polymerase II never leaves the nucleus as mature mRNA ([51]).  
Further, over 1/3 of the RNAs never reaches the cytoplasm due to mRNA processing 
events (removal of introns, transcription termination).  There is also a population of 
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primary transcripts that are not polyadenylated or transported from the nucleus (termed 
“nonproductive hnRNAs”), and therefore never destined to produce mRNA ([51]).  It is 
therefore possible for probes to bind to mRNAs in the nucleus that may never be 
translated.   
Transport and localization of mRNP.  Following export from the nucleus, an mRNP is often 
transported to specific regions within cells.  It is believed that the specific localization of 
mRNPs has a key role in the compartmentalization of protein synthesis in the cytoplasm 
([52];[53]; [54]).  Key questions remain open in this area include: (1) Are mRNPs 
localized in cells? If so, is there a general cell structure where most of the mRNPs are 
localized? (2) What is the intracellular system along which they are being transported to 
their destination? (3) What factors decide specific localization of mRNPs? (4) What is the 
biological significance of mRNP localization in cells? 
Most mRNPs are believed to be associated with the cytoskeleton, which may be 
used to transport and localize the mRNP to specific sites within a cell.  Although the 
details of this process remain elusive, there is growing evidence suggesting the 
importance of the cytoskeleton in mRNA localization.  The key evidence is that there 
exists a close association of polyribosomes (also referred to as polysomes) with the 
cytoskeleton ([10]; [54]; [55]; [2]).  In addition, studies have shown that microtubules are 
involved in the assembly of membrane-bound polyribosomes ([56];[57]). Using drug 
treatment to depolymerize microtubules, membrane-bound ribosomes were prevented 
from initiating protein synthesis and showed a decreased level of total poly(A) mRNP 
and fibronectin mRNP.  Although these studies did not identify the nature of the 
interaction between membrane (ER) bound polysomes and microtubules, they did show 
a close relationship between the cytoskeleton, ER bound polysomes, mRNP transport 
and protein synthesis.   Further, using both in vitro reconstitution and biochemical 
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fractionation provided EM evidence that a fraction of polyribosomes/mRNPs was bound 
to microtubules ([57, 58]). Figure 1.7 illustrates the proposed models for transport of 





Figure1.7:A:Representation of cytoskeletal elements (microtubule and 
microfilaments) involved in localization and transport of mRNA (Adopted from 
Ref. ([1]) 
B: Transport of specific mRNA along microtubule in an axon of a neuron 




Localization of mRNPs and mRNAs.  At present, there is no clear consensus as to what 
fraction of mRNPs are localized with the cytoskeleton.  Biochemical evidence provided 
by ([59]) suggests that 70-80% of mRNPs in a cell are co-localized with the cytoskeleton.  
Due to the lack of fluorescent or chemical tags, the verification of the biochemical results 
in intact cells has been limited to one or two specific mRNPs.  For example, using in situ 
hybridization and biochemical fractionation, [60, 61] and [62] have demonstrated co-
localization of mRNPs of the myosin heavy chain with cytoskeletal elements.  The 
studies by [2, 6, 63] have shown the association of actin and poly(A) mRNAs with 
cytoskeletal elements, especially microtubules.  Using a similar in situ approach, a study 
by ([55]) have implicated cytoskeletal localization of metallothionein I.  There is a clear 
need to better understand the localization of mRNPs, their association with specific 
elements in a cell and the biological significance of co-localization.   
It has been shown ([9, 64]) that the 3’ UTR plays a significant role in specific 
localization of certain mRNA’s in cells.  Specifically, using genetic engineering to perturb 
mRNA in the 3’ UTR region, it has been shown that the 3’ UTR regions of heavy chain 
myosin, actin, c-myc, metallothionein-I are critical for the localization of these specific 
mRNPs.  Although the localization signal in the mRNA sequence has been identified, the 
structural basis of the 3’ UTR, the associated binding proteins and, perhaps more 
importantly, the processes involved in specific localization and transport are still poorly 
understood.  To date, proteins responsible for the specific localization of mRNA have 
been identified only for oskar and nanos mRNA in Drosophila oocytes ([65]; [13]) and for 
actin mRNA in chicken fibroblasts ([66, 67]).  In both cases, cytoskeletal elements have 
been shown to be involved in transport and localization of the mRNAs.   
As mentioned earlier, it is mRNP rather than mRNA alone that provides the 
functional unit for localized protein synthesis.   In order to understand the intracellular 
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transport and localization of mRNA, extensive studies need to be performed to track the 
movement of mRNP complexes.  Possible approaches for doing so include labeling 
proteins with GFP ([12]), generating transgenes with high affinity binding sites for a GFP 
tagged proteins ([13]), site-specific protein labeling using FLAsH ([68]), and targeting 
mRNAs using molecular beacons ([69]).  These approaches in combination with high-
resolution microscopy ([70]) or EM may reveal the detailed structural organization of 
mRNP transport and localization in living cells.   
Degradation of mRNA.  One of major pathways of regulating posttranscriptional gene 
expression is the degradation of mRNA.  Considerable focus has been placed on 
understanding the transcriptional controls of mRNA synthesis, but there is very limited 
understanding of the mechanisms responsible for controlling the rate of mRNA 
degradation, which affects the intracellular mRNA level.  It has been suggested that a 
variety of physiological signals such as hormones ([70-72]), iron binding proteins and cell 
cycle regulators ([73]) may have significant effects on the decay rates of specific 
mRNAs, and the half-life of different mRNA’s is closely related to its biological role.  It 
has been found that specific cis acting elements rich in AU sequences, designated as 
the AU rich element (ARE) in the 3’ UTR determine the stability of mRNA.  Sequence 
analysis of various mRNAs with short half-lives has confirmed the presence of 
consensus ARE sequences.  Further comparisons across species (C. elegans and 
humans) have indicated the evolutionary conservation of ARE domains ([74]).  ARE 
sequences are homologous across different mRNAs but their copy number and their 
clustering pattern (groups of pentamers etc.) is different. This may account for 
differences in mRNA lifetimes. 
Association of ARE binding proteins with ARE rich domains have been proposed 
as the key regulatory step in controlling the turnover of RNA.  Currently, we do not have 
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a rigorous understanding of this class of proteins.  Do regulatory protein-complexes such 
as exosomes directly bind to ARE regions?  What are the structural requirements for 
such recognition and what is the key recognition domain? Is it structural such as hairpin 
loops or a combination of structural and sequence dependence? Answering these 
questions requires fundamental understanding of the structural features of protein-RNA 
complexes, as well as the dynamics of protein-RNA interactions in the cytoplasm.  
The hypothesis of ARE binding protein mediated regulation is based on 
remodeling of local RNA structure, which leads to recruitment of additional trans acting 
elements such as ribonucleases or helicases to degrade and unfold RNP complexes.  
mRNA molecules may be stabilized by the binding of signaling proteins or competing 
proteins, which may disrupt or interfere with the proteins involved in mRNA degradation.  
This model has been proposed for the self-stabilization of Bcl-2 mRNA since the Bcl-2 
protein binds to the ARE rich domain of its own mRNA. 
In addition to the above ARE model of mRNA degradation, several theories have 
been proposed to explain the decay pathways of mRNA using a yeast-based model 
system.  For example, ([75]) has proposed a relationship between mRNA stability and 
the length of mRNA.  However, studies by [76] using microarray analysis of mRNA 
stability in yeast have failed to correlate stability with the length of mRNA.  Their data 
suggest that mRNA decay is closely related to specific functions of a given mRNA and is 
controlled by interactions of mRNA with specific signaling proteins.  In addition, a 
nonsense-mediated decay pathway both in the nucleus and the cytoplasm but 
independent of the 3’ UTR region has been described as a control mechanism for mRNA 
degradation ([77]; [78]).  
Much remains to be elucidated regarding the processes of mRNA production, 
transport, localization and degradation.  It is obvious, however, that at each step, from 
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transcription to nuclear export of a mature mRNA, to mRNA decay, proteins are always 
associated with pre-mRNA and mRNA.  These associations are dynamic in nature with 
regard to both protein type and binding sites.  An mRNA molecule that gets exported to 
the cytoplasm is more precisely an mRNP (ribonucleoprotein complex) ([34]).  The 
proteins bound to the mRNA not only play a crucial role in the processing of pre-mRNA 
but also are ([79]; [49]; [80]) involved in the export, transport, localization, and stability of 
mRNA in the cytoplasm.  Although we are still in the early stages of identifying proteins 
that are associated with mRNPs, some specific protein–RNA associations have been 
uncovered using both biochemical and genetic methods (e.g. [81], [41]; [82]).  
Specifically, proteins have been shown to be associated at exon-exon junctions, the 
3’UTR region, and the 5’ cap regions of mRNA.  This is a critical issue in mRNA 
detection in that probes cannot hybridize to the target regions occupied by RNA-binding 
proteins.  It is necessary to identify the mechanisms for mRNA transport and 
degradation as controlled by the RNA/protein interactions.  As the steps of mRNA 
production, transport and localization are further clarified, it will become easier to design 
nanostructured hairpin probes to target regions of pre-mRNA that are least likely to be 
occluded by bound proteins.  Probe design should therefore take into account what is 
already known about proteins bound to pre-mRNA; specifically, probes should not be 
designed to target the 3’ UTR, the exon-exon junction, or introns due to the proven 




Cellular delivery of probes 
 
One of the most critical aspects of measuring the intracellular level of mRNA using 
synthetic probes is the ability to deliver these probes into cells through the plasma 
membrane. In what follows we discuss the existing methods for delivering hairpin probes 
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into live cells and the possible effects of delivery on intracellular distribution, dynamics, 
binding and lifetime of the probes.  
The plasma membrane is quite lipophilic and restricts the transport of large and 
charged molecules.  Therefore, it is a very robust barrier to polyanionic molecules such 
as hairpin oligonucleotides.  Further, even if the probes enter the cells successfully, the 
efficiency of this process must be defined not by how many probes can enter the cell or 
how many cells have probes internalized, but how many probes remain functional inside 
cells and hybridize to their targets with high specificity.  This is very different from both 
antisense and gene delivery applications where the level of protein expression or 
reduction is the final metric used to define efficiency or success.  It is also important to 
examine how the delivery technique might impact the fate of the probes inside a cell.  
Since a significant amount of RNA molecules (including mRNA and rRNA) are in the 
cytoplasm, any delivery method aimed at measuring intracellular RNA should result in a 
large amount of probes in the cytoplasm.   
Existing cellular delivery techniques can be divided into two categories: endocytic 
and non-endocytic methods.  Endocytic delivery typically employs cationic and 
polycationic molecules such as liposomes and dendrimers, while non-endocytic methods 
include microinjection, and the use of cell-penetrating peptides (CPP) or steptolysin O 
(SLO).  Here we focus on the applications of these methods to delivering oligonucleotide 
(ODN) probes into live cells and how delivery would impact the functionality of the 
probes.   
Endocytic Methods.  ODN probes can be transported into live cells by simply incubating 
them in solution with cells for ~ 2 h.  The delivery is mediated by the endocytic pathway 
is by specific membrane surface receptors and studies have shown the existence of at 
least 5 major cell surface receptors that bind specifically to ODNs ([83]).  Fluorescently 
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labeled ODN probes usually exhibit a punctate fluorescence pattern indicating 
endocytosis.  Electrostatic complexes of anionic ODNs with cationic liposomes or 
polymeric dendrimers (such as polyamidoamine or polyethyleneimine) have been shown 
to enhance ODN uptake; they are designed to provide some level of nuclease protection 
and have in many cases incorporated pH sensitive molecules that enhance their ability 
to escape from endosomes.  However, even with all these, the efficiency of cytoplasmic 
delivery of functional probes was estimated to be only 0.01-10 percent ([83]) due to the 
fact that once internalized via endocytosis, the ODN probes are predominately trapped 
inside endosomes and often lysosomes, and being degraded there.   
During endocytosis, the receptors on the cell surface are activated by the ODN 
probes, which are then being enclosed in a small portion of the plasma membrane that 
pinches off to form an endocytic vesicle called early endosomes.  The environment 
within early endosomes is fairly acidic, with a pH of approximately 6.  As they proceed to 
become late endosomes, the pH continues to decrease and the newly synthesized acid 
hydrolases are accumulated within them.  Unless escaped from the endosomes, the 
ODN probes will be trapped in lysosomes, which are membrane-enclosed vesicles filled 
with hydrolytic enzymes for intracellular digestion.  Most of the active cytoplasmic 
nucleases are in the lysosomes, not in the cytosol itself.  Clearly, inside a lysosome the 
environment is extremely bad for ODN probes and therefore it is imperative that the 
ODN probes are released from the early endosomes as soon as possible.  For example, 
viruses, both enveloped and non-enveloped, have specific mechanisms to enable their 
genetic material to escape from the endosomes/lysosomes and be efficiently delivered 
to the cytosol.   
To overcome this difficulty, polyamidoamine dendrimers were designed to 
escape from endosomes by polymer swelling and osmotic-induced swelling, as 
theorized by ([84]).  At neutral pH, electrostatic repulsion between protonated primary 
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amines causes the fractured dendrimer to be fully extended which, after binding 
electrostatically with DNA, collapse into a more compact form.  Once the pH decreases 
within the endosome, tertiary amines become protonated and the excess polymer is 
released from the complex, resulting in endosomal swelling and subsequent rupture.  A 
large excess of dendrimer is usually required to promote high delivery efficiency, 
possibly because the excess non-complexed dendrimers swell and help burst the 
endosomes.   
Even with this mechanism for endosomal exit of probes, it is still unclear how 
nucleic acids are released from cationic molecules.  For liposomes it has been 
suggested ([85]) that once inside a vesicle, anionic lipids from the cytoplasmic-facing 
monolayer diffuse into the complex, fusing with the cationic liposome and therefore 
releasing the oligonucleotide.  Dissociation of nucleic acids from cationic molecules may 
occur in endosomes, cytosol or the nucleus, but in most cases the mechanisms are 
unknown. 
Many issues remain to be addressed in endocytic delivery of ODN probes, for 
example, how to protect ODN probes from nucleases in the endosomes, and why 
endocytic delivery often results in internalization of nucleic acids into the nucleus.  
Various studies have shown that, when internalized through the endocytic pathway, a 
large portion of ODN probes are trapped within intracellular vesicles such as endosomes 
and lysosomes, degraded by nucleases, and prevented from reaching their target ([83]).   
Cell permeable Peptides 
 
 As mentioned above, intracellular delivery can be very challenging as the plasma 
membrane forms a formidable barrier for biomolecules.  The discovery of cell permeable 
peptides has made it possible to transduce a broad range of agents into living cells ([86], 
[87]). These peptides have been used to deliver range of biomolecules such a proteins 
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[88], peptides (including phosphopeptides [89]), PNA [90], liposomes [91] into live cells. 
Figure 1.8 outlines some of the potential application of CPP mediated delivery of 
macromolecules. Even though at present there is very limited understanding of 
transduction mechanism, this technology is emerging as a useful tool for targeting 
heterologous cargos in living cells.  Among the host of peptides with membrane 
translocating activity are antennapedia, HSV-1 VP22, and the HIV-1 tat peptide (Tat48-60).  
The HIV-1 tat peptide and its derivatives have received the most attention because they 
are short and very efficient in delivery (can deliver huge macromolecules across cell 
membrane in less than 30 mins).  The Tat protein from HIV-1 is an 86 amino acid 
transactivation protein that is involved in promoting transcription of the HIV-1 virus.  The 
Tat peptide is rich in cationic amino acids and especially arginines (Amino acids 49-60 of 
the Tat protein).  Arginines are very common in many of the cell permeable peptides 
(CPP), yet there seems to be little homology among them.  The exact mechanism for 
membrane translocation is currently unknown. It has been shown to be very effective 
method to deliver proteins etc in living cells as well as for in-vivo applications ([92]; [87]). 
This makes this peptide based delivery an interesting candidate for our study, as we are 
interested in developing probes for live cells measurement using optical detection as 
well as MR contrast agents for in-vivo applications. Thus we can extend our learning 
from development of peptide- MB constructs to deliver probes in living cells to in-vivo 
applications. With this motivation, we have decided to pursue peptide-based delivery in 
living cells as a first step towards achieving our long-term research goals for in-vivo 
imaging.  
 In addition, CPP’s are of interest to wide range of researchers due to their 
efficient translocation of macromolecules across cell membrane. This poses an 
interesting question regarding mechanism of translocation across cell membrane. 
Answer to this question, may help us develop better drug delivery strategies and also 
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understand the basic cellular physiology involved in translocation of CPP’s across cell 
membrane. Although, in present research our major focus is to develop approaches for 
imaging of cellular process using molecular probes, we plan to use some of the imaging 
tools to address the possible nature of interaction of CPP’s to the cell surface. In this 
study, we have selected to use HIV-1 Tat peptide (49-60 amino acids) and poly Arg 









Figure 1.8: Illustration of the Tat mediated delivery of various cargos across the plasma 
membrane of living cells 
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Challenges in Imaging of mRNA using Molecular Beacons 
 
Based on our discussion in previous sections, it is clear that the major challenges 
in measuring endogenous gene expression in living cells and tissue is the design of 
highly sensitive and selective reporter probes with a wide dynamic range. For 
oligonucleotide-based probes, in addition to challenges of delivery and maintaining 
integrity of probe in cell cytoplasm, the biggest challenge is to find a segment of mRNA, 
which can be targeted by the probe. This segment of mRNA has to be unique, such that 
it does not have significant sequence homology with other RNA sequences and also it 
should not have a structural constraint that may prevent hyrbridization of the probe. As 
discussed in previous sections, proteins play a significant role in controlling the tertiary 
structure of mRNP’s. Although at present the theoretical prediction of the tertiary 
structure of RNPs is not feasible, yet using secondary structure predictions of RNAs may 
provide a first order approximation towards rational design of MB probes.  
Further in cellular imaging, a significant challenge is the sensitivity of our 
detection system. In this study, we have used confocal microscopy for most of the 
studies. We have also validated our confocal measurements using epifluoresence 
microscopy. Both these methods of imaging have their relative advantages and 
disadvantages. Confocal microscopy uses a narrow source of light (laser of fixed 
wavelength) to excite the sample, further the detection system (confocal pin hole) is 
designed with a pinhole to allow for detection of light only from a focus area using PMT 
(Photomultiplier Tube). This system allows us to take thin slices in a living cell sample, 
without significant background and out of focus fluorescence. The ability to optically 
section the cells can be extremely useful in understanding the distribution of the mRNAs 
in living samples. Further PMTs are highly sensitive in detection of the fluorescent signal 
as the signal is amplified within the PMT detector. The limitation of using PMT can be 
the higher level of noise in the detector especially if the PMT’s is not cooled. Further 
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challenge in using PMT as a detector is the non-uniform response of the PMT to the 
wavelength range of interest. PMTs have a peak in their detection efficiency around 540-
570 nm, but a detection efficiency decays rapidly for near-IR wavelength range (680 nm 
or higher wavelength range).  Some of these challenges can be overcome by using 
APD’s as they have much flat response in their detection efficiency over a wide range of 
wavelengths. The other major advantage of confocal imaging is the ability to 
simultaneously detect multi-color labeling which can be extremely useful for co-
localization experiments. 
The epi-fluoresence microscopy has a distinct advantage of providing a 
comprehensive intensity over a thick slice in a cell, which can be useful especially if the 
signal intensity is particularly low. The epi-fluoresence microscopy can be further 
improved by combining de-convolution of the fluorescence images to remove out of 
focus blur, which is a major limitation of this imaging method. Further using automated 
stage we can improve the ability to optically section living cells and also take z slices 
similar to a confocal imaging set up.  
Further the challenge in sensitivity also comes from the lack of ability to detect 
single molecules or few molecules of fluorescent dyes. This limitation is inherent in this 
study, as neither of our set-ups have the ability to detect signal with this sensitivity. This 
implies if mRNAs are not localized in the cells, our imaging system may not be able to 
detect them. Thus with our system, our results in imaging are biased towards areas with 
high intensity of fluorescent signal. This is the inherent limitation of most of the imaging 
methods. Thus localized RNAs can lead to significant enhancement of our signal to 
noise ratio in the cells, in addition to inherent signal to noise of a molecular beacons.  
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Organization of the Thesis 
 
With this background information, the part-1 of this study is focused on 
developing a probe -based approach to image RNAs in living cells. In this area, my focus 
is in developing MB probes as a potential probe for imaging of RNAs in living cells. In the 
early part of this study, my objective was to develop a delivery approach, which can 
allow for effectively delivery of MB probes in living cells. Further we wanted to develop a 
method, which is not only limited to cell culture but also has a potential for in–vivo 
imaging in a small animal models. With this focus, I have chosen to adapt a cell 
permeable peptide as a carrier for MB probes (Chapter 2).  Using this approach we 
have demonstrated effective delivery of MB probes to the cytoplasm of living cells and 
spepcific detection of mRNAs in living cells. In nest stage, I have studied the co-
localization of specific mRNAs with the sub cellular structures using previously 
developed peptide linked MB probes in living cells (Chapter 3). This part provides us 
insight into specific organization of mRNAs in living cells. This addresses a key 
biological question, regarding sub-cellular localization and co-localization of specific 
mRNAs in the cytoplasm of living cells. 
 In a next step in this direction, my research has been aimed at understanding at 
what stage our probes hybridize with mRNAs (Chapter 4). This is a central question, 
which address the issues related to understanding if the probes have a preferred 
accessibility to hybridize to mRNAs during a specific stage in its life cycle in the 
cytoplasm. This also provides us insight into issues related to RNA secondary structure 
and sub-cellular localization. This understanding is also critical for relating the 
fluorescence intensity from the MB probe signal with gene expression. For this study we 
have combined chemical perturbations with the MB probes to study this question.  I have 
also explored the role of backbone chemistry in this direction. 
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Further in next part of this study, I have combined a FRAP (Fluorescence 
recovery after photo bleaching) based biophysical imaging approach with the MB probes 
to understand the dynamics of the target mRNAs (Chapter 5).  This part has focused on 
understanding the role of various cellular structures and biochemical activities which 
regulate the transport/ dynamics of the target mRNAs. This study has provided further 
insight into the structure- function relationship in sub-cellular organization of mRNAs. 
To expand the potential of MB probes for study of mRNA biology, we have 
extended the previously developed peptide based delivery approach to target MBs to the 
nucleus of living cell. This approach in combination with the earlier developed method for 
imaging of RNA in the cytoplasm can allow us to image the integrated distribution of 
mRNAs from the nucleus to the cytoplasm. In this direction I have focused on detection 
and imaging of small nuclear RNAs in nuclei of living cells (Chapter 6).  
In second part of this thesis, I have focused on development of magnetic 
nanoparticles based probes for MR based imaging. In this area, the first study was 
focused on development of biocompatible functionalized particles with a very narrow 
size distribution (Chapter 7). In (Chapter 8), I have extending this research towards 
further development and optimization of contrast of these magnetic nanoparticles. In this 
study, we have evaluated the role of coatings thickness in optimization of MR contrast. 
The major motivation for this effort has been to develop a magnetic nanoparticles based 
probes, which can allow for deep tissue imaging. This initial study has identified and in 
certain cases addressed various challenges in adapting inorganic nanoscale particles to 
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Quantitative methods to measure gene expression in vitro, such as real-time PCR 
and microarray analysis, have revolutionized molecular biology and drug development 
([[1]-[4]]).  These approaches, however, are generally used with purified DNA or RNA 
from cell lysates.  The ability to detect and quantify the expression of specific 
endogenous mRNA in living cells and tissues in real time will offer tremendous 
opportunities for biological and disease studies, and will significantly impact drug 
discovery and medical diagnostics.  However, currently available technologies for gene 
detection in intact cells such as in-situ hybridization (ISH) cannot be used in vivo, since 
ISH studies rely on washing away unbound probes to reduce background signal 
([[5],[6]]).  To perform gene detection in living cells, the probes must be able to recognize 
the target with high specificity, convert target recognition directly into a measurable 
signal with high signal-to-background ratio, and allow for differentiation between true and 
false-positive events ([[7]]).  Probes must also be delivered into living cells with high 
efficiencies. 
Among the technologies currently under development for living cell gene detection 
and quantification, the most promising one is perhaps molecular beacons.  Molecular 
beacons are dual-labeled antisense oligonucleotide (ODN) probes with a fluorophore at 
one end and a quencher at the other end ([[8],[9]]).  In contrast to fluorescently labeled 
linear ODN probes, molecular beacons are designed to form a stem-loop (hairpin) 
structure in the absence of complementary target so that fluorescence of the fluorophore 
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is quenched.  Hybridization with target mRNA opens the hairpin and physically 
separates the reporter form quencher, allowing a fluorescence signal to be emitted upon 
excitation.  Thus, molecular beacons enable a homogenous assay format where 
background is low without the need to wash away free probes.  However, to detect 
mRNA in vivo, one needs to deliver molecular beacons into living cells with high 
efficiencies and fast kinetics.  Conventional delivery approaches are based on DNA 
transfection techniques, such as those employing liposomes or dendrimers.  These 
approaches are inefficient (<80%) ([[10]]), slow (delivery times ~4 h), and can potentially 
trap molecular beacons in the endosomes and degrade them in the lysosomes, 
significantly increasing the background signal ([[11]]).  The long delivery time also gives 
rise to significant degradation of cytoplasmic molecular beacons by nuclease, further 
increasing false positive detection ([[12]]).  Although the reversible membrane 
permeabilization method using streptolysin O (SLO) is faster (~ 2 h) and not based on 
endocytosis ([[13]]), it can only be used in ex-vivo cellular assays.  Other delivery 
methods, such as microinjection ([[14]]) and electroporation ([[15]]) are invasive and may 
cause severe damage to cells.  Further, microinjection is labor-intensive and only 
practical for studying a small number of cells. 
To overcome these difficulties, we have developed novel peptide-linked molecular 
beacons that can quickly and efficiently enter living cells without the need of any other 
delivery reagent.  Recent research has identified several small regions (9-16 amino 
acids) of proteins called protein transduction domains (PTDs) or cell penetrating 
peptides (CPPs) that confer the ability to traverse biological membranes efficiently ([[16]-
[18]]).  Here we show that conjugating one such peptide (TAT-1) to molecular beacons 
yields a multifunctional probe that can enter into living cells with nearly 100% 
efficiencies, fast (~30 min) delivery kinetics, and the ability to localize in cell cytoplasm.  
Further, these peptide-linked molecular beacons function well for mRNA detection in 
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living cells as compared with the results of in situ hybridization.  This novel molecular 
beacon design can thus provide a powerful means for rapid detection of gene 
expression in living cells and tissues in real time, with high specificity and sensitivity. 
Materials and Methods 
 
Design of peptide-linked molecular beacons 
 
 We designed and synthesized peptide-linked molecular beacons targeting the 
human GAPDH (glyceraldehyde 3-phosphate dehydrogenase) and survivin mRNAs, as 
well as molecular beacons with a ‘random’ probe sequence.  The specific design of 
these molecular beacons, and the sequence of the 11 amino-acid TAT-1 peptide used in 
the study are shown in Table 2.1.  GAPDH is a glycolytic protein that has a diverse 
range of activities in mammalian cells including membrane fusion, microtubule bundling, 
nuclear RNA export, DNA replication and repair ([[20]]).  These activities suggest that 
GAPDH is involved in apoptosis, age-related neurodegenerative disease, prostate 
cancer and viral pathogenesis.  Survivin is a member of the inhibitor of apoptosis protein 
(IAP) family and also regulates cell division ([[21]]).  The GAPDH beacon is comprised of 
a 19-base probe domain targeting the Exon 6 region of GAPDH gene flanked by 
complementary 5-base sequences that hybridize to form the stem.  The survivin beacon 
has a 16-base target sequence with a similar design of the stem.   
 The ‘random’ beacon was designed as a negative control, with a 17-base probe 
sequence that does not have any match in the entire human genome.  To ensure good 
target accessibility, we typically design and test molecular beacons complementary to 
different segments of the same mRNA molecule to avoid targeting sequences that are 














Table 2.1: Design of peptide-linked molecular beacons 
 
 Peptide  











Three conjugation strategies were developed in attaching the delivery peptide to 
molecular beacons, as illustrated in Figure 2.1.  In the first approach (Figure 2.1 A), 
peptides were linked to a molecular beacon through a streptavidin-biotin bridge by 
introducing a modified oligonucleotide, biotin-dT, to the quencher arm of the stem 
through a carbon-12 spacer.  The peptide-linked molecular beacon consisted the biotin-
modified molecular beacon, a streptavidin molecule, and biotin-modified TAT-1 peptides.  
Since each streptavidin molecule has four biotin-binding sites, we were able to link 
biotin-modified molecular beacons and delivery peptides on the same streptavidin 
molecule.  The stoichiometry was controlled so that the probability of having more than 
one molecular beacons linked to the same streptavidin is small.  In the second design 
(Fig. 1b), we placed a thiol group to the quencher-arm of the molecular beacon stem 
through a carbon linker; the thiol group then reacted with a maleimide group added to 
the C terminus of the peptide to form a thiol-maleimide linkage (Figure 2.1 B).  Both the 
streptavidin-biotin bridge and the thiol-maleimide linkage are stable in the cell cytoplasm.  
We and others have demonstrated that, for certain cell types, CPPs including TAT-
1 peptide tend to carry cargos into cell nucleus ([[18],[22]]).  While this may be useful in 
detecting nuclear RNA targets such as polyadenylated nuclear RNA (PAN), in most 
applications however, the target mRNAs are in the cytoplasm, so should be the 





Figure 2.1: A schematic illustration of three different conjugation schemes for 
linking the  delivery peptide to molecular beacons 
(A) The streptavidin-biotin linkage in which a molecular beacon is modified by  
introducing a biotin-dT to the quencher arm of the stem through a carbon-12 
spacer.   
(B) The thiol-maleimide linkage in which the quencher-arm of the molecular 
beacon stem is modified by adding a thiol group which can react with a 
maleimide group placed to the C terminus of the peptide to form a direct, stable 
linkage.  
(C) The cleavable disulfide bridge in which the peptide is modified by adding a 
      cysteine residue at the C terminus which forms a disulfide bridge with the 
thiol- modified molecular beacon.   
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  Thus, as the third approach, we functionalized the TAT-1 peptide by adding a 
cysteine residue at the C terminus which forms a disulfide bridge with the thiol-modified 
molecular beacon as shown in Figure 2.1 C.  This cleavable design was based on the 
rationale that the reducing environment of the cytoplasm will cleave the disulfide bond 
once the construct enters the cell, thereby separating peptide from probe.  This has 
been demonstrated by Hallbrink et al using a TAT-peptide linked cargo-quencher 
construct ([[23]]).  Specifically, a peptide-conjugated, fluorescently-labeled cargo was 
linked to a fluorescence quencher through a disulfide bond, resulting in a reduction-
sensitive construct.  Upon internalization into Bowes human melanoma cells, the 
disulfide bond was quickly reduced, as indicated by the increased fluorescence intensity.  
Since fast cleavage of disulfide bridge inside living cells is well documented ([[24]]), we 
believe that, once the cleavable, peptide-linked molecular beacons (Figure 2.1 C) are 
inside the cell, the disulfide bridge will be reduced, leaving the molecular beacons in the 
cytoplasm.  
Further the affinity of the MB probes for mRNA target in the cytoplasm may limit 
their delivery only to the cytoplasm of living cells. The delivery to the nuclei has been 
observed for cases when the cargo molecules/ beads etc. did not have any target in the 




 In the design shown in Figure 2.1 A, streptavidin was chosen as a linker molecule 
because of its high affinity for biotin and availability of multiple biotin-binding sites. The 
modified nucleotide (dT) at the third base from the 3’ end on the quencher-arm of the 
stem was linked to biotin through a 12-carbon spacer, and the biotin-modified peptides 
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were conjugated to the biotin-modified molecular beacon through binding between biotin 
and streptavidin.  The peptide-linked molecular beacon complex was dialyzed with PBS 
(1X) overnight using a Slide-A-Lyzer Dialysis Unit, 10K MWCO (Pierce Biotech Inc., 
Rockford, IL) to exchange the buffer and to remove the unconjugated peptide.  The 
modified molecular beacons were synthesized at Integrated DNA Technologies, Inc 
(Coralville, IA) and MWG Biotech, Inc (High Point, NC), and the modified peptides were 
synthesized by Invitrogen Inc (Carlsbad, CA) and Synpep Corporation (Dublin, CA). 
In the direct linkage approaches shown in Figures 2.1 B and 2.1 C, the same 
position on the quencher-arm of the stem bore a modified nucleotide dT-amine group 
with a 6-carbon spacer.  To generate a direct, stable linkage between the peptide and 
molecular beacon, the peptide was modified with a maleimide group at its C terminus.  
Amine-modified molecular beacons were reacted in PBS buffer with a twofold molar 
excess of the heterobifunctional crosslinker SPDP, N-Succinimidyl 3-(2-
pyridyldithio)propionate (Sigma-Aldrich) for 2 h, followed by reduction with a twentyfold 
molar excess of TCEP, 3,3,3-Phosphinidyne-tripropionic acid hydrochloride (Sigma-
Aldrich), to create a free thiol (-SH) functional group.  This thiolated beacon was then 
reacted with maleimide-modified peptide to form a stable chemical bridge between the 
beacon and the peptide.  The peptide-linked molecular beacon complex was dialyzed 
overnight using Slide-A-Lyzer Dialysis Unit, 10K MWCO (Pierce Biotech Inc., Rockford, 
IL) to remove the unconjugated peptide.  A similar approach was used in forming a 
cleavable disulfide bridge between the cysteine-modified peptide and the amine-
modified molecular beacon.  To reduce the probability of forming beacon-beacon 
conjugates, a higher (1.5x) concentration of peptides was used compared with that of 




Solution assays of hybridization kinetics and signal-to-background ratio 
 
Measurement of hybridization kinetics and signal-to-background ratio of peptide 
linked molecular beacons was carried out using a SAFIRE microplate monochromator 
reader (TECAN, Austria). For kinetic studies, 200 nM peptide-linked molecular beacons 
were mixed with 1 M complementary oligonucleotide target at 37oC and the 
fluorescence intensity was recorded as a function of time for conventional molecular 
beacons, direct linked (stable and cleavable) peptide-molecular beacon complexes, and 
streptavidin-linked peptide-molecular beacon complex.  To determine the signal-to-
background ratios, 200 nM conventional and peptide-linked molecular beacons were 
mixed with 200 nM of complementary target respectively in the microplate reader, and 
the fluorescence intensity at equilibrium was recorded.  The fluorescence signal of each 
molecular beacon type (conventional and peptide-linked) in the absence of target was 




Cellular delivery of peptide-linked molecular beacons 
 
Primary human dermal fibroblast (HDF) cells (Cambrex, NJ) and a pancreatic 
cancer cell line MiaPaca-2 (ATCC, VA) were used for this study.  These cells were 
cultured in an 8-well Nalge Nunc culture plate with a glass coverslip bottom in their 
respective cell culture media for 24 h prior to experiments.  Delivery assays were 
performed by incubating cells at 37oC with the media containing peptide-linked molecular 
beacons.  For molecular beacons targeting GAPDH, peptide-linked molecular beacons 
with three different concentrations (0.25 M, 0.5 M and 1.0 M) were incubated with 
HDF cells for 30, 60 and 90 min.  For molecular beacons targeting survivin, 0.5 M of 
peptide-linked molecular beacons were incubated with HDF and MiaPaca-2 cells for 30 
min.  For all assays, the cells were washed twice with PBS to remove the incubation 
medium and placed in fresh medium for fluorescence imaging, which was carried out 
using a confocal microscope (Axiovert LSM-100, Zeiss).  
 
Fluorescence in-situ hybridization 
 
Normal human dermal fibroblast cells were cultured in 8-well chambered 
coverslides for 24 hours in normal growth medium (FGM-2 Cambrex Co.) and then 
washing with 1x PBS (without Ca or Mg).  The slide was fixed in 100% methanol at –20 
oC for 10 minutes.  After removing the methanol, the slides were allowed to air dry and 
stored overnight at –80 oC.  In-situ hybridization assays were then performed by first 
washing the slides for 5 minutes in 1x PBS and hybridizing them overnight at 37 oC in 1x 
PBS (no Ca or Mg) containing 200 nM of unmodified GAPDH-targeting molecular 
beacons.  After removing the hybridization solution with washing and adding 1x PBS, the 





Delivery of molecular beacons using commercial transfection reagents 
 
To compare the efficiency and functionality of different delivery methods, we 
used three commercially available transfection reagents:Effectine (Qiagen), Superfect 
(Qiagen), and Oligofectimine (Invitrogen).  Transfection assays were carried out 
according to the procedure recommended by respective suppliers; both primary HDF 
cells and MiaPaca-2 pancreatic cancer cells were incubated with conventional 
(unmodified) molecular beacons for 0.5, 2 and 3.5 h.  
 
Results and Discussion 
Hybridization kinetics of peptide-linked molecular beacons 
 
To determine the effect of peptide conjugation on molecular beacon function, in-
solution hybridization assays were carried out for the binding kinetics of peptide-linked 
molecular beacons with different conjugation methods.  One concern was that, when the 
positively charged TAT-1 peptide is conjugated to a molecular beacon, it might interact 
with the negatively charged hairpin oligonucleotide, thus interfering with proper probe-
target binding.  Shown in Figure 2.2 A are normalized fluorescence intensity verses time 
curves as a result of probe-target hybridization for unmodified GAPDH-targeting 
molecular beacons and peptide-linked molecular beacons with the streptavidin-biotin 
linkage, the stable thiol-maleimide linkage, and the cleavable disulfide bridge.  Peptide-
linked molecular beacons with the thiol-maleimide linkage had almost exactly the same 
probe-target hybridization kinetics as unmodified molecular beacons (black and green 
curves respectively in Figure 2.2 A), indicating that the conjugation of peptide using the 
thiol-maleimide linkage has essentially no effect on the functionality of molecular 
 64
beacons.  Molecular beacons with the cleavable disulfide bridge also behaved similarly 
to the unmodified ones.  With streptavidin-biotin linkage, the hybridization kinetics of 
peptide-linked molecular beacons was slightly slower, but it did not affect the signal 
level, as can be seen from Figure 2.2 A.  It is possible that the streptavidin molecule, 
whose size is comparable to that of the molecule beacon, may have sterically hindered 
binding between the target and the hairpin probe, leading to a slightly reduced 
hybridization kinetic rate. The effect of different conjugation methods on signal-to-
background ratio (S/B) is relatively small (Figure 2.2 B), although the S/B for peptide-
linked molecular beacons was slightly lower than that of the unmodified ones.  Taken 
together, the results shown in Figure 2.2 clearly indicate that conjugation of peptide to 





Figure 2.2: Probe-target hybridization kinetics of unmodified and peptide-linked 
molecular beacons 
 (A) Normalized fluorescence intensity as a function of time for unmodified 
molecular beacons, and for the three types of peptide-linked molecular beacons. 
Note that the probe-target hybridization kinetic curves of peptide-linked molecular 
beacons with the thiol-maleimide linkage (black curve) and unmodified molecular 
beacons (green curve) are almost identical. 
 (B) Signal-to-background ratios (red) of probe-target hybridization for peptide-
linked molecular beacons with different conjugation methods. The signal-to-
background ratios for thiol-modified and biotin-modified molecular beacons (blue) 
without peptide are also shown for comparison.   
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Detection of GAPDH mRNA using peptide-linked molecular beacons 
 
To demonstrate the delivery and mRNA targeting functions of peptide-linked 
molecular beacons, we first detected mRNA of a housekeeping gene human GAPDH in 
normal human dermal fibroblast (HDF) cells.  After just 30 min of incubation with TAT-
peptide conjugated GAPDH-targeting molecular beacons, we observed clear and 
localized fluorescence signal in HDF cells as a result of molecular beacon-target mRNA 
hybridization for all three conjugation schemes, i.e., thiol-maleimide (Figure 2.3 A), 
disulfide bridge (Figure 2.3 B) and streptavidin-biotin (Figure 2.3 C).  In contrast, 
peptide-linked random-sequence molecular beacons with streptavidin-biotin conjugation 
gave essentially no signal 30 min after delivery (Figure 2.3 D).  Similar results were 
obtained using random-sequence molecular beacons with thiol-maleimide and disulfide 
linkages for peptide (data not shown).  This demonstrates that peptide-linked molecular 
beacons remained highly specific in living cells after internalization.  Further, we found 
that GAPDH mRNAs displayed a very intriguing filament-like localization pattern in HDF 
cells, with a clear tendency of surrounding the cell nucleus and following the cell 
morphology.  Interestingly, molecular beacons with the cleavable (thiol-cysteine disulfide 
bridge) design seemed to give better localization patterns than those with the thiol-
maleimide linkage, and the latter seemed to perform better than molecular beacons with 
the streptavidin-biotin linkage.  Cleavage of the delivery peptide from the construct may 
have provided molecular beacons a better access to target mRNA molecules, although 
more studies of this phenomenon are required to validate this assumption.  It is likely 
that a molecular beacon with a relatively bulky streptavidin molecule is less able to 
penetrate into the secondary structure of the GAPDH mRNA, thus reducing its ability to 
seek out its targets.  Almost all the HDF cells exposed to GAPDH peptide-linked 
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molecular beacons showed strong fluorescence signal, implying a near 100% delivery 
efficiency (data not shown). 
 Similar results were obtained after 60 min of incubation (Figure 2.3 E-H).  About the 
same level of fluorescence was observed for GAPDH-targeting molecular beacons with 
different linkages for peptide, whereas the random-sequence molecular beacons did not 
give much signal.  Even after 90 min, there was essentially no increase in the signal 
level (data not shown), indicating that most of the peptide-linked molecular beacons 
entered the HDF cells within the first 30 min.  Further, fluorescence signal levels and 
mRNA localization patterns in HDF cells were similar for experiments at three different 
nominal molecular beacon concentrations (0.25 M, 0.5 M and 1.0 M).  Due to the 
peptide conjugation process, it was estimated that, with 0.25 M nominal molecular 
beacon concentration, the actual concentration of peptide-linked molecular beacons 








Figure 2.3: Detection of GAPDH mRNA in HDF cells using 0.5 µM of peptide-
linked molecular beacons 
(A-C), fluorescence images of HDF cells after 30 min of incubation with TAT-
peptide conjugated, GAPDH-targeting molecular beacons, with (A) thiol-
maleimide, (B) disulfide bridge and (C) streptavidin-biotin linkages.  (D) With 
peptide-linked random-sequence molecular beacons, essentially no detectable 
signal 30 min after delivery.   
(E-G) fluorescence images of HDF cells after 60 min of incubation of the 
peptide-linked, GAPDH-targeting molecular beacons with (E) thiol-maleimide, 
(F) disulfide bridge and (G) streptavidin-biotin linkages.  The signal level of 
peptide-linked random-sequence molecular beacons after 60 min is shown in 
(H).  Clearly, the fluorescence signal level did not increase when incubation time 
was doubled, indicating that most of the molecular beacons internalized within 
the first 30 min.  Note the intriguing GAPDH mRNA localization patterns shown 




Comparison with in-situ hybridization 
 
To correlate the results of present method with a traditional method, we 
performed fluorescence in situ hybridization (FISH) assays targeting GAPDH mRNA in 
fixed HDF cells.  The probes used in the FISH assays were fluorescently labeled linear 
probes (5'-Cy5-GAGTCCTTCCACGATACCA-3') that have the same probe sequence as 
the GAPDH-targeting molecular beacon.  As demonstrated in Figure 2.4 A, the 
fluorescence image obtained in FISH assays of GAPDH mRNA in HDF cells gave a 
filamentous localization pattern similar to that shown in Figure 2.3, confirming that the 
mRNA localization revealed in this study is not an artifact.  However, the fluorescence 
signal as a result of FISH was not as sharp as that in living cell assays.  Since the 
probes entered into both the cell cytoplasm and nucleus during FISH, a diffused 
fluorescence signal appeared in the fixed HDF cell nuclei (Figure 2.4 A).  This is in 
contrast to the living cell images shown in Fig. 3 where very low signal can be observed 
in cell nucleus.  We believe that this diffused signal may reflect the high abundance as 
well as a rather uniform distribution of GAPDH mRNA in cell nucleus.  As a negative 
control, we performed a FISH assay with fluorescently labeled linear Poly-A probes (5'-
Cy5-AAAAAAAAAAAAAAAAAA-3') and the resulting background signal was very low, as 
can be seen from Figure 2.4 B.  This further confirmed that the fluorescence signal 
observed in our live cell and fixed cell studies of specific mRNA detection was truly due 







Figure 2.4: Control studies using fluorescence in situ hybridization (FISH). 
 
(A) Detection of GAPDH mRNA in Fixed HDF cells. The filamentous localization 
pattern of GAPDH mRNA was similar to that revealed in living cell 
assays, although the signal was not as sharp. Note the diffused fluorescence 
signal in cell nuclei. 
 
(B) A negative control study of the FISH assay using fluorescently labeled linear Poly-A 
probes resulted in very low background. 
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Detection of survivin mRNA 
 
 After successful study of the delivery of the MB linked probes to the cells and 
detection of the specific mRNAs in the cytoplasm of living cells, our next goal was to 
demonstrate the feasibility to detect differential levels of mRNA in living cells. The ability 
to detect differential levels of the mRNA holds a key opportunity for this method to be 
useful for the disease detection studies. To demonstrate this using the MB probes, we 
decided to study Survivin mRNA as a candidate gene of interest.   
We and others have demonstrated that the Survivin expression level is very low 
in HDF cells, whereas in MiaPaCa-2 cells the level is relatively high.  After 60 min of 
incubation with peptide-linked molecular beacons, the fluorescence signal in MiaPaca-2 
cells was quite high, as shown in Figure 2.5 A, but in HDF cells, only very low 
fluorescence signal can be observed (Figure 2.5 C).  In addition, Survivin mRNAs 
shown an intriguing localization pattern, i.e., the Survivin mRNA molecules in MiaPaCa-2 
cells seemed to be concentrated near one side of the cell nucleus (Figure 2.5 B).  
Although with very low expression level, Survivin mRNA localized in HDF in a similar 
fashion (Figure 2.5 C).  Previous research suggested that the expression level and 
localization of Survivin may be an important indicator for cancer progression or 












Figure 2.5: Detection of Survivin mRNA in live HDF and MiaPaca-2 cells.   
(A) Strong fluorescence signal was observed in MiaPaca-2 cells after 60 min of 
incubation with peptide-linked molecular beacons.  Note that essentially all cells shown 
fluorescence.  
(B) Survivin mRNA molecules in MiaPaca-2 cells seemed to be concentrated near one 
side of the cell nucleus HDF cells.  (C) Only very low fluorescence signal can be 
observed in HDF cells, but with a survivin mRNA localization pattern. 
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Comparison with conventional transfection methods 
 
 As mentioned above, cellular delivery of molecular beacons using conventional 
transfection methods, either liposome based or dendrimer based, typically requires 3-4 
hours of incubation during which a high level of background signal is generated.  To 
compare the efficiency of delivery and the stability of molecular beacons during 
internalization, we performed delivery studies of unmodified GAPDH-targeting molecular 
beacons with three commercially available transfection reagents: Superfect (dendrimer-
based), Oligofectamine (liposome-based), and Effectene (liposome based), and followed 
all the manufacturers’ instructions.  When fluorescence in HDF cells was observed after 
30 min of GAPDH beacon delivery using Superfect, Oligofectamine or Effectene, there 
was essentially no signal (data not shown).  We found that, after 3.5 h of transfection 
with Superfect, the molecular beacons gave strong signal in HDF cells.  However, the 
fluorescence image had different characteristics from that of peptide-linked molecular 
beacons.  Specifically, the fluorescence signals were concentrated in random ‘bright 
spots’ in both cytoplasm and nucleus (Figure 2.6 A), suggesting that molecular beacons 
were trapped and degraded by endosomes, lysosomes and nucleus.  Even more 
disturbing is that the random-sequence molecular beacons showed similar fluorescence 
signal levels and ‘bright spots’ in HDF cells (Figure 2.6 D), indicating that the signals in 
both cases were largely due to molecular beacon degradation.  With Oligofectamine 
transfection, the results after 3.5 h incubation were even worse: only highly concentrated 
bright spots were present in the HDF cells, with a similar signal level generated by 
GAPDH-targeting and random-sequence molecular beacons (Figure 2.6 B and E).  
Using Effectene for molecular beacon delivery gave fluorescence images (GAPDH-
targeting and random-sequence molecular beacons, respectively) that resembled the 
corresponding images shown in Figures 2.6 A and 2.6 E.  Clearly, caution must be 
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taken in using these transfection methods in delivering molecular beacons for living cell 










Figure 2.6: Cellular delivery using conventional transfection methods 
 (A-C) Fluorescence signal in HDF cells after 3.5 h transfection of unmodified 
GAPDH-targeting molecular beacons with (A) Superfect, (B) Oligofectamine 
and (C) Effectene.  Note the concentrated ‘bright spots’ in both cytoplasm 
and nucleus.   
 
(D-F) Similar fluorescenc signal level was observed after 3.5 h delivery of 
random-sequence molecular beacons with (D) Superfect, (E) 
Oligofectamine and (F) Effectene.  The resulting ‘bright spots’ in HDF cells 
indicate that the fluorescence signals in (A-F) were largely due to 




We have clearly demonstrated that cellular delivery of molecular beacons using 
the peptide-based approach has far better performance compared with conventional 
transfection methods.  This opens new opportunities that become possible only with 
peptide-linked molecular beacons.  For example, the fast delivery kinetics (~30 min) and 
high efficiency in probe internalization, combined with the high specificity and signal-to-
background ratio of molecular beacon makes the peptide-linked molecular beacon 
probes a unique and novel system for studying gene expression in living cells in real 
time.  We and other have shown that when delivered through the endocytic pathway 
(e.g., liposome-based transfection), antisense oligonucleiotide probes tend to be trapped 
inside endocytic vesicles and degraded in the endosomes and lysosomes by nucleases 
([26]).  Peptide-based internalization has the potential to avoid the endocytic pathway, 
therefore reducing false-positive signals due to nuclease degradation.  Consequently, 
ODN backbone modifications of the probe such as the use of 2’-O-methyl modified 
molecular beacons may not be necessary.  As demonstrated in our study, combining 
fast probe delivery with prompt optical imaging, a high signal-to-background can be 
realized in live cell mRNA detection.  The peptide-linked molecular beacons approach, is 
a faster (~30 min) and simpler, which may be more suitable for certain applications, 
including basic biological studies of mRNA expression level in living cells in response to 
drug molecules, toxin and external stimuli, the knock-down effect of RNAi, and disease 
detection and diagnosis.  Using NIR fluorophores as the reporter, peptide-linked 
molecular beacons have the potential to become a powerful tool for shallow tissue 
molecular imaging with high sensitivity and spatial resolution.   
 Although our results demonstrated the high efficiency of peptide-based probe 
delivery, the underlying mechanism of cell membrane penetration remains largely 
unknown.  Some studies suggest that cell entry is independent of the endosomal 
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pathway ([[28]]) with the notion that the internalization is much faster than known 
endocytotic processes ([[29]]), whereas others suggest that the CPP-induced cargo 
internalization is due to classical endocytosis ([[30],[31]]).  One possibility is that the 
initial interaction between the peptide and cell surface is due to electrostatic forces, but 
subsequent cell membrane penetration is mediated by glycosaminoglycans ([[32]]).  
However, many questions still remain open.  For example, for certain cell lines the TAT-
1 and other peptides have the ability to deliver cargos into cell nuclei, suggesting a 
directed motion in the cytoplasm.  It is still unclear whether different CPPs follow a 
common mechanism or have different pathways.  More biochemical and biophysical 
studies of the CPP-based delivery mechanism are clearly warranted. 
 There are many challenges in quantifying mRNA expression in living cells, 
including the need to create an internal control for fluorescence intensity of the reporter 
fluorophore in the intracellular environment, and determine the fraction of mRNA 
molecules hybridized with probes.  The detection sensitivity is also affected by the 
properties of fluorophore, fluorescence detection method, the optical imaging 
instrumentation used and background signal.  It has been suggested that the molecular 
beacon based approach could detect as low as 10 mRNA molecules in a single cell 
([[14]]).  Alternatively, the average mRNA expression over a large number of cells can 
be obtained using FACS (Fluorescence Activated Cell Sorter) to yield more reproducible 




[1] Karge, W.H. 3rd, Schaefer, E.J., Ordovas, J.M. (1998) Quantification of mRNA 
by polymerase chain reaction (PCR) using an internal standard and a 
nonradioactive detection method. Methods Mol. Biol. 110, 43-61. 
 
 
[2] Jung, R., Soondrum, K., Neumaier, M. (2000) Quantitative PCR. Clin. Chem. 
Lab. Med. 38, 833-836. 
 
 
[3] Brown, P.O., Botstein, D. (1999) Exploring the new world of the genome with 
DNA microarrays. Nat. Genet. 21, 33-37. 
 
 
[4] DeRisi, J.L., Iyer, V.R. (1999) Genomics and array technology. Curr. Opin. 
Oncol. 11, 76-79. 
 
 
[5] Femino, A.M, Fay, F.S., Fogarty, K. & Singer, R.H. (1998) Visualization of single 
RNA transcripts in situ. Science 280, 585-590. 
 
 
[6] Levsky, J.M., Shenoy, S.M., Pezo, R.C., Singer, R.H. (2002) Single-cell gene 
expression profiling. Science 297, 836-840.  
 
 
[7] Molenaar, C., Marras, S.A., Slats, J.C., Truffert, J.C., Lemaitre, M., Raap, A.K., 
Dirks, R.W., Tanke, H.J. (2001) Linear 2' O-Methyl RNA probes for the 
visualization of RNA in living cells. Nucleic Acids Res. 29, E89-9. 
 
 
[8] Tyagi, S., Kramer, F.R. (1996) Molecular beacons: probes that fluoresce upon 
hybridization. Nat. Biotechnol. 14, 303-308. 
 
 
[9] Tyagi, S., Bratu, S.P., Kramer, F.R. (1998) Multicolor molecular beacons for 
allele discrimination. Nat. Biotechnol. 16, 49-53. 
 
 
[10] Barton, G.M., Medzhitov, R. (2002) Retroviral delivery of small interfering RNA 
into primary cells. Proc. Natl. Acad. Sci. U.S.A. 99, 14943-14945. 
 
 
[11] Cheung, C.Y., Murthy, N., Stayton, P.S., Hoffman, A.S. (2001) . A pH-sensitive 









[13] Faria, M., Spiller, D.G., Dubertret, C., Nelson, J.S., White, M.R., Scherman, D., 
Helene, C., Giovannangeli, C. (2001) Phosphoramidate oligonucleotides as 
potent antisense molecules in cells and in vivo. Nat. Biotechnol. 19, 40-44. 
 
 
[14] Sokol, D.L., Zhang, X., Lu, P., Gewirtz, A.M. (1998) Real time detection of 




[15] Yin, D., Tang, J.G. (2001) Gene therapy for streptozotocin-induced diabetic mice 
by electroporational transfer of naked human insulin precursor DNA into skeletal 
muscle in vivo. FEBS Lett. 495, 16-20. 
 
 
[16] Wadia, J.S., Dowdy, S.F. (2002) Protein transduction technology. Curr. Opin. 
Biotechnol. 13, 52-56. 
 
 
[17] Becker-Hapak, M., McAllister, S.S., Dowdy, S.F. (2001) TAT-mediated protein 
transduction into mammalian cells. Methods 24, 247-256. 
 
 
[18] Snyder, E.L. and Dowdy, S.F. (2001) Protein/peptide transduction domains: 




[19] Tsourkas, A., Behlke, M.A., Xu, Y. & Bao, G. (2003) Spectroscopic features of 
dual fluorescence/luminescence resonance energy transfer molecular beacons. 
Analytic. Chemistry 75, 3697-3703.  
 
 
[20] Sirover, M.A. (1999) New insights into an old protein: the functional diversity of 
mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim. Biophys. 
Acta 1432, 159-84. 
 
 
[21] Chiou, S.K., Jones, M.K., Tarnawski, A.S. (2003) Survivin - an anti-apoptosis 
protein: its biological roles and implications for cancer and beyond. Med. Sci. 
Monit. 9, PI25-29.  
 
[22]  Nori, A., Jensen, K.D., Tijerina, M., Kopeckova, P., Kopecek, J. (2003) Tat-
conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to 




[23] Hallbrink, M., Floren, A., Elmquist, A., Pooga, M., Bartfai, T., Langel, U. (2001) 




[24] Feener, E.P., Shen, W.C., Ryser, H.J. (1990) Cleavage of disulfide bonds in 
endocytosed macromolecules. A processing not associated with lysosomes or 
endosomes. J. Biol. Chem. 265, 18780-18785. 
 
 
[25] Okada, E., Murai, Y., Matsui, K., Isizawa, S., Cheng, C., Masuda, M., Takano, Y. 
(2001) Survivin expression in tumor cell nuclei is predictive of a favorable 
prognosis in gastric cancer patients. Cancer Lett. 163, 109-116. 
 
 
[26] Dokka, S., Rojanasakul, Y. (2000) Novel non-endocytic delivery of antisense 
oligonucleotides. Adv. Drug Deliv. Rev. 44, 35-49. 
 
 
[27] Santangelo, P. J., Nix, B., Tsourkas, A. and Bao, G. (2004) Dual FRET 




[28] Simeoni, F., Morris, M.C., Heitz, F., abd Divita, G. (2003) Insight into the 
mechanism of the peptide-based gene delivery system MPG: implications for the 
delivery of siRNA into mammalian cells. Nucleic Acids Res. 31, 2717-2724. 
 
 
[29] Vives, E., Richard, J.P., Rispal, C. and Lebleu, B. (2003) TAT peptide 




[30] Lundberg, M., Wikstrom, S.and Johansson, M. (2001) Cell surface adherence 
and endocytosis of protein transduction domain. Mol. Ther. 8, 143-150. 
 
 
[31] Console, S., Marty, C., Garcia-Echeverria, C., Schwendener, R., Ballmer-Hofer, 
K. (2003) Antennapedia and HIV transactivator of transcription (TAT) “protein 
transduction domains” promote endocytosis of high molecular weight cargo upon 
binding to cell surface glycosaminoglycans. J. Bio. Chem. 278, 35109-35114. 
 
 
[32] Ziegler, A., Blatter, X.L., Seelig, A. and Seelig J. (2003) Protein transduction 
domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding 




Subcellular localization and Co-localization of mRNAs in the cytoplasm of 




mRNA localization is a widespread post-transcriptional mechanism for targeting 
protein synthesis to specific subcellular locations ([1]).  It is believed that the specific 
localization of mRNAs plays a key role in the compartmentalization of protein synthesis 
in the cytoplasm, and facilitates protein-protein interactions ([2]).  Clearly, mRNA 
localization requires the formation of mRNA ribonucleoprotein particles (mRNPs) that 
can be targeted to specific regions of a cell ([3]), where polyribosomes (also referred to 
as polysomes) are assembled.  It has also been shown that both mRNP transport and 
polyribosome formation involves cytoskeletal structures ([4-6]).  However, many 
important questions remain open concerning mRNA localization.  For example, little is 
known about subcellular localization and organelle association of mRNAs.  Although it 
was suggested that 70-80% of mRNPs in a cell are co-localized with the cytoskeleton, 
such a co-localization has been confirmed for only a very small number of mRNAs ([4-
8]).  
Based on the review of literature (Chapter 1), there is very limited understanding of 
localization of mRNA in cells.  The few studies conducted using insitu hybridization, have 
shown localization of mRNA with cytoskeleton structure. There is very limited 
specification to which of the cytoskeleton elements are crucial for localization, the roles 
of each cytoskeleton elements (Microtubule, Actin and Intermediate Filaments). In 
addition, there is no discussion on role of cytoplasmic organelles e.g. ER, Mitochondria 
etc. for any possible involvement in translation of cytoplasmic soluble proteins. The 
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isolated view of cytoskeleton as the only system involved in mRNA localization is far 
from complete as it has been shown in various other studies that many of these 
organelles- especially mitochondria/ ER are closely associated with cytoskeleton ([9]). 
 In this study, we have made our first attempt to understand the organization of 
endogeneous mRNAs in the cytoplasm of living cells. In this chapter, we present the 
study on direct visualization of sub cellular localization of GAPDH mRNAs using 
molecular beacons, and reveal their co-localization with mitochondria ([10]). The 
motivation for this study has come from our earlier results (Chapter 2) of localized 
distribution of GAPDH mRNAs in the cytoplasm of living cells. Based on our earlier 
experiments, we discovered a particular filamentous localization of GAPDH mRNAs in 
the cytoplasm of living cells, with a clear tendency of surrounding the nucleus and 
following cell morphology. To address the question of mRNA localization and 
organization in the cytoplasm, we designed experiments to address following key 
questions: 
1) What intracellular organelles are involved in localization of GAPDH 
mRNA? 
2) What are the key cytoskeletal elements involved in localization of GAPDH 
mRNA? 
Material and Methods 
 
Design of Molecular Beacons 
 
 In this study we have used the same MB probe design for targeting GAPDH 
mRNA as used in Chapter (2). Further in this study, we have designed multiple controls 
to validate the localization of GAPDH mRNA observed using MB probes is specific and 
independent of Tat based delivery approach. For one of the positive control experiment 
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we designed a sequence targeting 28-s ribosomal RNA. Ribosomal RNA was chosen as 
a target RNA as its localization has been well studied ([18-19]). Further we have used 
random control beacon design to detect the background signal due to non specific 
interactions in living cells.  The sequences of MBs are shown in Table 3.1. In addition to 
these control MBs we also designed a fluoescently labeled poly A (24 mer) linear 
oligonucleotide to detect the signal after delivery of Tat-Poly A oligonucleotide complex 
in living cells. 
Cell culture 
 
 Normal human dermal fibroblasts (Cambrex, NJ) were grown in Clonetics 
fibroblast growth medium supplemented with 2% fetal bovine serum (Cambrex, NJ), 









Table 3.1: Design of molecular beacons 
GAPDH molecular beacon 
5’-Cy3-CGACGGAGTCCTTCCACGATACCACG/thiol-dT/CG-BHQ2-3' 
28S rRNA molecular beacon 
5’-Cy3-CGACTACCACCAAGATCTGCAGTCG/HQ-2/-3’ 
‘Random’ sequence molecular beacons 






Molecular beacon delivery via cell permeable peptide 
 
 The molecular beacon targeted to GAPDH (see Table 3.1) was linked via a 
disulfide bridge to the Tat peptide ((N terminus) TyrGlyArgLysLysArgArgGlnArgArgArg 
(C terminus)-Cys) (as discussed in Chapter 2). For delivery of molecular beacon, the 
peptide-linked molecular beacons were mixed with the regular media and incubated with 
the specific cells at 37oC for 30 minutes. When labeling mitochondria, cells were 
incubated with MitoFluor™ Green dye for half an hour in regular culture medium. After 
labeling, cells were washed and incubated with Tat linked GAPDH targeting beacon in a 
regular culture medium for 30 minutes. The cells were then washed twice with PBS to 
remove the incubation medium and placed in fresh medium for fluorescence imaging, 
which was carried out using a Zeiss Axiovert LSM-1000 confocal microscope. 
Nocodazole treatment 
 
For these experiments, cells were grown normally and plated in 4 well, Lab-tek II 
chambered coverslips.  Twenty-four hours after plating the MB probes were delivered to 
them. After 30 minutes of delivery, the cells were treated with   30µM concentration of 
nocodazole. The cells were imaged after 60 minutes after incubation with nocodazole. 
Fluorescence in-situ hybridization 
 
 
Normal human dermal fibroblasts were cultured in 8-well chambered coverslides 
for 24 hours in normal growth medium (FGM-2 Cambrex Co.) and then washed with 1x 
PBS (without Ca or Mg).  The slide was fixed in 100% methanol at –20oC for 10 minutes.  
After removing methanol, the slides were allowed to air dry and stored overnight at –
80oC.  In-situ hybridization assays were then performed by first washing the slides for 5 
minutes in 1x PBS and hybridizing them overnight at 37oC in 1x PBS (no Ca or Mg) 
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containing 400 nM of fluorescently labeled linear probes targeting GAPDH.  The cells 
were imaged, after removing the hybridization solution with washing and final incubation 
of cells in 1 x PBS. 
 
Fluorescence microscopy imaging 
 
 Fluorescence imaging of live cells was performed using a Zeiss Axiovert LSM-
100 confocal microscope.  For assays using the single beacon approach delivered via 
the Tat peptide, the Cy3 dye on the GAPDH targeted beacon was excited with 543 nm 
laser and detected using 565-625 nm filter.  For viewing MitoFlour™ Green on the 
confocal, excitation was achieved using the 488 nm emission from an Argon ion laser 
with detection using a band pass filter from 510-530 nm.   
Organelle labeling and fluorescence imaging 
 
 MitoFluor Green was used to label mitochondria as directed by Molecular 
Probes. Fluorescence imaging of live and fixed HDF cells was performed using a Zeiss 
Axiovert LSM-100 confocal microscope.  Imaging assays with peptide-linked, GAPDH-
targeting molecular beacons were performed using a Zeiss confocal microscope with a 
565-625 nm filter for emission detection under excitation at 543 nm.  The fluorescence 
signal of MitoFlour Green was detected using a bandpass filter of 510-530 nm under the 
excitation wavelength of 488 nm.  
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Results and Discussion 
 
To address the first question regarding the role of intracellular organelles in 
localization of GAPDH mRNA, we decided to simultaneously label certain key 
organelles- mitochondria and ER in addition to detecting GAPDH MB signal.  Since the 
pattern of fluorescent signal from MB probes targeting GAPDH mRNA was similar with 
the mitochondrial staining in HDF cells as reported by ([11], Molecular Probes website), 
so in our first experiment we decided to co-label mitochondria in addition to detecting MB 
signal. 
In this study, we decided to label mitochondria with a dye (MitoFlour 
green).Mitochondria in living cells are stained with 200 nanomolar concentrations of 
MitoFlour Green FM dye which exhibits bright green, fluorescein-like fluorescence. 
MitoFlour Green FM dye has an added advantage that it is essentially non fluorescent in 
aqueous solutions, only becoming fluorescent once it accumulates in the lipid 
environment of mitochondria. Hence, background fluorescence is negligible, enabling 
clear visualization of mitochondria in live cells immediately following addition of the stain. 
In addition this stain is more photostable as compared to conventional dye such as 
Rhodamine 123. The other reason we selected MitoFlour Green was to avoid any 
spectral overlap with Cy3 emission spectrum. This allowed us to simultaneously image 
the fluorescence signal from mitochondrial staining and MB probes using a standard 
confocal set up. The results of the co-localization of GAPDH and mitochondria are 
shown in Figure 3.1. Figure 3.1(A) detection of mitochondrial staining using mitofluor 
green dye, Figure 3.1(B) shows the fluorescent signal from MB probes hybridized to 
GAPDH mRNAs. The overlay of the two channels to determine the co-localization is 
shown in Figure 3.1(C). The results show a high degree of co-localization of GAPDH 
mRNAs with the mitochondria. The extent of co-localization improved with increase in 
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distance from the nucleus. In the peri-nuclear regions, we could also detect some 
GAPDH mRNA signal not highly co-localized with the mitochondria.  
The other organelle, we decided to label in this study was ER. The reason we 
selected ER as it has been indicated in literature that ER is closely associated with 
mitochondria, and ER is also a site of translation for various proteins, which are exported 
from cells or present on various membranes of cells. ER and mitochondria association is 
required for lipid transfer from ER to mitochondria and also for homeostasis of Ca2+ ions 
in cells. In this study, we decided to co-label mitochondria and ER using MitoFlour, ER 
Tracker respectively. This approach allowed us to simultaneously label both the 
organelles and validate the close relationship between mitochondria and ER. This 
approach will address our hypothesis of involvement of Mitochondria/ER in subcellular 
localization of GAPDH mRNA. The results of co-localizations of ER and the mitochondria 
are shown in Figure 3.2. The results show that mitochondria do overlap with the 
segments of ER, while ER extends through most of the cytoplasm. This result taken 
together with the result described in Figure 3.1, suggests that GAPDH mRNA could be 
co-localized with both ER and mitochondria, although its pattern of distribution in the 
cytoplasm is better correlated with mitochondrial distribution as compared with ER 
distribution. In this study, we could not directly label ER and detect signal from MB 



















Figure 3.1: Co-localization of GAPDH m RNA with Mitochondria 
(A) Mitochondria staining using Mitoflour green (Green color) 
(B) GAPDH m RNA detection using molecular beacons (Red Color) 
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Figure 3.2:  Human dermal fibroblast images: A,D) mitochondrial stain, 
MitoFluor™ Green (green), B,E) ER-Tracker™ (red), and C,F) merge of A and B, 
and merge of D and E. 
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 To address the next question, regarding the role of cytoskeletal structures in 
localization of GAPDH mRNA in living cells, we have studied the effect of microtubule 
depolymerization on the distribution of GAPDH MB probe signal in the cytoplasm. The 
major reason for selection of microtubules was their close association with mitochondria 
and ER.  For microtubule depolymerization, we have used nocodazole, which is an anti-
neoplastic agent and exerts its effect by de-polymerization of microtubules.   
The result of nocodazole treatment and its effect on the localization of GAPDH 
mRNAs is shown in Figure 3.3. Figure 3.3 (A) shows the distribution of GAPDH mRNAs 
in the cytoplasm of control cells. Figure 3.3 (B) shows the distribution of GAPDH 
mRNAs signal after nocodazole treatment as described in the Material and Methods 
section. The result clearly shows significant changes in the distribution of GAPDH 
mRNAs signal in the cytoplasm. This result clearly highlights the association of GAPDH 
mRNAs with microtubule network. This result in combination with previous results of co-
localization with mitochondria and ER clearly indicates the close relationship of various 
organelles and the cytoskeleton in mediating the localization of mRNAs. Studies in 
Chapter 5 will further address the role of microtubules in mediating the transport of 











Figure 3.3: (A)-GAPDH m RNA in HDF cells (Filamentous structure) 
(B)-Effect of nocodazole treatment on localization of GAPDH mRNA 




Control studies for mRNA localization 
 
To confirm that mRNA localization and co-localization patterns shown in Figure 
3.1 was a result of specific probe-target hybridization, control studies were performed by 
delivering negatively charged Cy3 or Cy5 dyes into HDF via SLO and detecting the 
corresponding fluorescence signal.  As shown in Figure 3.4 A and 3.4 B, although the 
signals of Cy3 and Cy5 shows some degree of localization due to non-specific binding to 
certain cellular structures, they did not give the filamentous localization pattern of 
mitochondria.  This suggested that the Cy3 and Cy5 reporter dyes were not attracted 
specifically to mitochondria, whose surfaces are also negatively charged.  Therefore, the 
fluorescence signal of Cy3- and Cy5-labeled molecular beacons in live HDF cells shown 
in Figure 3.1 was due to their specific hybridization to the mRNA targets, not an artifact 
of the reporter dyes.   
In our previous study (Chapter 2) we delivered, ‘random’-sequence molecular 
beacons using peptide-linked ‘random’-sequence molecular beacons into HDF cells, and 
detected the resulting fluorescence signal.  This provide a negative control in that, if the 
images in Figure 3.1 showing co-localization of the GAPDH mRNAs with mitochondria 
were resulted from non-specific opening of molecular beacons near mitochondria, the 
same would occur with ‘random’ beacons.  However, using the same excitation and 
emission detection optics, the ‘random’ beacons gave very low background signal as 
compared with the true signal ([12, 13]), indicating that the fluorescence signal from the 
GAPDH beacons was indeed a result of specific mRNA detection. As a further control, 
we delivered into HDF cells Cy3-labeled linear 24-mer poly-A oligonucleotide conjugated 
with Tat-1 peptide through a stable chemical linkage ([12, 13]).  As shown in Figure 3.4 
C, 30 min after delivery, this fluorescent oligonucleotide construct accumulated in the 
perinuclear region of the cell due to the very low affinity for a target in the cytoplasm. 
The signal level in the cytoplasm due to unquenched Poly A oligonucleotide was fairly 
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low as compared with MB signal due to hybridization with GAPDH mRNAs. To detect 
this signal we have to increase the pinhole and votage gain on photo multiplier tube 
during confocal imaging. This highlights an interesting aspect that if fluorophores are 
dispersed in the cytoplasm, the effective signal is much lower than the case of localized 
signal with same concentration of fluorophores.  This control experiment clearly 
demonstrates that, with Tat-1 peptide as the delivery vehicle, labeled oligonucleotide 
probes may localize differently depending on the target, further confirming that the 
filament-like localization GAPDH mRNAs shown in Figure 3.1 was a result of specific 
targeting of molecular beacons.  In addition to peptide-based delivery, we internalized 
GAPDH-targeting molecular beacons into HDF cells using Streptolysin O and imaged 
the resulting fluorescence using a confocal microscopy.  As can be seen from Figure 3.4 
D, GAPDH mRNAs shown a clear filamentous pattern, similar to the results obtained 
using peptide-linked, GAPDH-targeting molecular beacons.  The detection of GAPDH 
mRNAs using two different delivery methods (both peptide-based and SLO) served as a 











Figure 3.4: Control studies of mRNA localization. 
In A) and B), the fluorescence of Cy3 and Cy5 dyes alone inside HDF cells is shown 
respectively, indicating that free Cy3 and Cy5 dyes inside a living cell did not result in a 
filamentous mRNA localization pattern shown in Figure. 1C  
In C), the overlap of white-light image of an HDF cell and the fluorescence signal of Cy3-
labeled, Tat-peptide conjugated 24-mer poly-A oligonucleotides in an HDF cell is shown.  
Note that most of the labeled oligonucleotides accumulated in the perinuclear region due 
to the very low affinity of the probe for any target in the cytoplasm.   
In D), a confocal fluorescence image of the localization of GAPDH mRNA is shown as 
the result of SLO based delivery.  Clearly, SLO-based and peptide-based delivery gave 
very similar filamentous patterns of GAPDH mRNA localization. 
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 As a positive control, we performed fluorescence in situ hybridization (FISH) 
assays to see if the filamentous pattern of mRNA localization could be observed in 
fixed cells.  The epifluorescence images of GAPDH mRNA detection using FISH are 
displayed in Figure 3.5 A, indicating that their localization patterns in the cytoplasm 
are similar to that in living cells as shown in Figure 3.1 B.  In the FISH assays, 
methanol was employed for fixation which is often used to maintain the subcellular 
structure and retain molecules associated with microtubule ([14, 15]) together, these 
positive and negative control studies suggest that the mRNA localization patterns 
shown in Figure 3.1 C are true. We also performed fluorescence in situ hybridization 
(FISH) using 28S rRNA-targeting molecular beacons in methanol fixed cells.  As can 
be seen from the FISH image displayed in Figure 3.5 B, the fluorescence intensity is 
quite high in the rough ER (the “waffle-like” pattern in the cytoplasm), which is 
different from the localization pattern of the GAPDH mRNAs shown in Figure 3.1 












Figure 3.5: Fluorescence in situ hybridization studies 
In A), the FISH results of GAPDH mRNA detection are shown respectively as positive 
controls, further confirming the filamentous mRNA localization pattern displayed in 
Figure 3.1 (A). 
In B), the FISH image of the 28S rRNA beacon displaying significant localization with 
ER.  
A  B 
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Localization of 28S rRNA and its co-localization with rough ER 
 
It has been shown that 28s ribosomal RNA molecules accumulate to rough 
endoplasmic reticulum (ER), not co-localize with mitochondria nor have a filament-like 
localization patterns ([16-18]).  To demonstrate a different RNA localization pattern using 
molecular beacons, we designed a molecular beacon to target the human 28s ribosomal 
RNA (rRNA) with the same hybridization domain as used by ([18]) and ([16]) where living 
cell detection of 28s rRNA was performed and the accessibility of target sequence was 
demonstrated.  Detection of 28s rRNA provides an excellent control for subcellular RNA 
localization because most of the 28s rRNA molecules in the cytoplasm are known to be 
either localized to the rough ER or bound to free ribosomes ([17]).   
We delivered molecular beacons targeting 28s rRNA into live HDF cells using 
SLO ([13]) and performed fluorescence imaging of the resulting signal using a confocal 
microscope.  As shown in Figure 3.6 A, most of the fluorescence signal as a result of 
beacon-rRNA hybridization was near the cell nucleus.  Imaging the cell with white light 
(Figure 3.6 B) and then overlapping the two images demonstrates that the beacon-
induced signal in the cytoplasm was localized with the rough ER, as shown in Figure 3.6 
C.  This pattern of 28S rRNA co-localization with the rough ER is significantly different 
from those displayed in Figure 3.1 where the filamentous localization of GAPDH mRNAs 
seems to coincide with mitochondria.  We also performed a negative control study to 
deliver single ‘random’-sequence molecular beacons into HDF cells using SLO; the 
resulting fluorescence signal is shown in Figure 3.6 D, along with the white-light image 
of the same cells shown in Figure 3.6 E; the overlap of the images in Figure 3.6 D and 
6 E is given in Figure 3.6 F.  The very low background signal displayed in Figure 3.6 
after 1 h of incubation confirms that the image shown in Figure 3.6 A was indeed due to 
specific detection of 28S rRNA by molecular beacon.   
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Our results shown in Figure 3.6 A-C are consistent with what reported by 
Molenaar et al. ([18]) using a FISH (fluorescence in situ hybridization) assay to image 
28S rRNA.  Specifically, most of the signal in the cell cytoplasm was concentrated near 
the cell nucleus, suggesting a co-localization of 28S rRNA with rough ER.  However, in 
the same study, the live-cell imaging of 28S rRNA using microinjection failed to detect 
28S rRNA in the cytoplasm, largely due to the delivery method (microinjection) that has 
been shown to concentrate oligonucleotides rapidly into cell nucleus ([20]).  Positive 
detection of 28S rRNA in the cytoplasm of live HeLa cells has also been reported ([17]), 
although issues such as the signal-to-background ratio and the concentration of the 



















Figure 3.6: A control study for the localization of the molecular beacons in live cells. 
The fluorescence signal from 28s rRNA-targeting single molecular beacons in HDF cells.  
B) A white light image of the same cell using a confocal microscope.  C) The overlap of 
the images in A) and B) indicating 28S rRNA co-localization with the rough ER.   
The results of a negative control assay using Cy3-labeled “random” beacon are given in 
D), E) and F) showing respectively the fluorescence signal of “random” beacons, the 
white light image of the same cell and their overlap.  The very low background signal of 
“random” beacons confirms the specificity of 28S rRNA detection using molecular 
beacons.   
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  Summary 
 
Taken together, our observations strongly suggest that GAPDH mRNA 
molecules are co-localized with mitochondria, which in turn are associated with ER and 
microtubules.  GAPDH proteins, which are essential to glycolysis and the production of 
pyruvate, have been shown to be associated with mitochondria ([19], [10]).  Therefore, 
co-localization of GAPDH transcripts with mitochondria may facilitate the localization of 
their corresponding proteins to mitochondria.  Although the physical basis of the 
association of GAPDH mRNAs with the ER, mitochondria and microtubules needs to be 
further explored, our unexpected finding may stimulate further studies of the transport, 
localization and organelle association of mRNA.  For example, it will be important to 
study the localization of mRNAs corresponding to different classes of proteins, and to 
reveal the biological significance of mRNA-mitochondria association.   
Molecular beacon based RNA detection in living cells may provide a novel 
approach for studying the dynamics of subcellular localization of specific RNAs and 
revealing their biological functions.  Unlike FISH studies in which cells need to be fixed, 
living cell RNA detection using molecular beacons enables real-time dynamic 
measurements of RNA localization, including mRNA trafficking and transport to and from 
mitochondria as well as changes in mRNA localization patterns in response to drug 
molecules and external stimuli such as growth factors and applied shear stress.  For 
example, the structural dynamics of localized mRNA can be studied using molecular 
beacons in conjunction with FRAP (fluorescence recovery after photobleaching, Chapter 
5).  It should also be possible to visualize alterations in mRNA localization as a result of 
the deletion of specific sequences (e.g., ‘zipcode’) on a target mRNA, which may help 
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Imaging the effects of mTOR and PI-3 Kinase mediated inhibition of 





Imaging of RNA in living cells or tissue is important for various applications 
including diagnostics, drug development and for fundamental understanding of RNA cell 
biology. In this direction, we are interested in developing an exogenous oligonucleotide 
probe based approach to image RNA in living cells and potentially in-vivo. To achieve 
this aim, we have developed few methods in our previous studies ([1, 2], Chapters 2 
and 3)) to image endogenous mRNAs in living cells with high specificity and sensitivity. 
Combining the delivery approaches (Tat-peptide and Streptolysin O- (SLO) based) with 
molecular beacons, we have studied the intracellular distribution of endogenous RNAs in 
living cells ([1, 2]). In our previous studies, we have observed that both GAPDH and K-
Ras mRNAs were highly localized in the cytoplasm and co-localized with a mitochondrial 
structure (Santangelo et. al, JBO Accepted).  Further, we are interested in evaluating the 
characteristics of MB probes in living cells, evaluating the state of mRNAs (high 
accessibility) when these MB probes hybridize with a target sequence. This will help 
develop a better understanding of the relationship between fluorescent signal from MB 
probes and gene expression profile in cells. 
Having successfully imaged specific mRNAs in living cells, we are interested in 
further exploring the critical question regarding what population of RNP’s we are able to 
detect using a hybridization-based detection in living cells? Can we control the probe 
design, including its chemistry, to control or extend the fractions of RNPs it can hybridize 
with? These questions have significance in both diagnostic and fundamental RNA cell 
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biology applications. From a diagnostic prospective, if we are to relate the signal from 
the hybridized MB probes in living cells to the relative levels of gene expression in those 
samples, we need to establish what population of RNAs and what functional state of 
those RNAs we are able to hybridize with?  From a fundamental biological prospective, 
MB probes can provide information regarding the sub-cellular localization of RNAs in the 
cytoplasm. The fundamental question we can address in this direction is, “how 
localization and co-localization of RNA is effected by different stages of RNA life?” The 
answers to these questions can enhance our understanding of MB probes, provide us 
with a knowledge base, which can allow us to tailor MB probe design including chemistry 
to target various RNAs in living cells and also address key biological questions in above 
areas. 
In this study, we have made our first attempt to address these challenges by 
understanding the effect of translational inhibition on hybridization of MB probes and 
organization of specific RNA targets in living cells. The rationale for selection of this 
approach is based on a fundamental understanding that active translational state of 
mRNAs is related to functional gene expression in living cells.  As it is during this stage 
of mRNA life, the ribonucleotide sequence information is translated into polypeptides. 
Further we wanted to extend our understanding of the relationship between a specific 
organization of RNAs observed in our previous studies ([1, 2], (Chapter 2, 3) and the 
functional state of these RNAs. Furthermore, the repression of translation is an important 
approach for various therapeutic interventions ([20, 21]) especially in cancer treatment 
([22]). Thus, understanding the ability of MB probes to measure such effects can be a 
valuable tool for diagnostic applications. In addition there are defined and established 
approaches to inhibit translation processes in living cells within the time scale of our 
studies ([23-31]). The approaches selected for this study are based on a signaling 
mediated repression of translational states. This approach also allows understanding of 
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the role of intra-cellular signaling processes in the organization of RNPs. At preset there 
is a very limited understading of the role of signaling in sub-cellular organization of 
RNAs, although extensive knowledgebase has been developed to understand the 
changes in translation as well as transcriptional profiles with various signaling events in 
cells using array based approaches ([6, 21, 22]). Thus this study will complement the 
present understanding of global trends in levels of transcripts and polypeptides with 
specific sub cellular changes in mRNA distribution with signaling processes. 
  In this direction, we have designed a study where we have perturbed the 
translation processes in living cells using small molecule based approaches. Using this 
approach we have studied the response of MB probes and target RNAs to the 
repression of translation process in living cells. To achieve this aim, translation process 
is disrupted by targeting the mTOR pathway, which plays a central role in translation and 
cell growth ([24]) and also by indirect signaling through inhibition of PI-3 Kinase, which is 
a key signaling protein upstream of mTOR pathway ([31]). PI-3 Kinase is a critical 
signaling protein which links the extra- cellular events, including the serum response and 
the growth factor stimuli, with intracellular signaling in cells ([31, 32]).  Ability to link 
extra- cellular events with RNA biology in cytoplasm can provide new information 
regarding the regulation of RNA in the cytoplasm of living cells. In addition to these facts, 
deregulation of PI-3 Kinase mediated signaling due to mutations in PTEN gene have 
been established in various cancer models including prostate and glioblastoma ([31]). If 
the PI-3 Kinase signaling events are deregulated in those cancer models, it is likely that 
the mTOR signaling and its control on the translation events are also deregulated in 
such scenarios ([21, 31]). The ability to understand the molecular changes in RNA life 
cycles under such conditions can not only enhance our understanding of the 
pathological process but also provide a key insight into regulation of RNA. This study 
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provides a first example of our attempts to link MB based imaging of specific RNAs with 
functional cellular assays using small molecule based inhibition approaches.  
mTOR pathway is a central pathway responsible for sensing nutrient and cellular 
energy levels and it exercises control over cell growth and translational machinery in 
response to variety of these stimuli ([29, 33, 34]). It exerts its control over translation 
processes by direct signaling to multiple downstream effectors including ribosomal S6 
kinase 1(S6K1) and eukaryotic translational initiation factor 4E binding protein 1 (4E-
BP1) ([2, 24, 32]). It controls these effector molecules by inducing phosphorylation at 
multiple sites. Rapamycin (inhibitor of the mTOR pathway) is known to cause a rapid 
dephosphorylation of the 4E-BP1 and in turn inhibit the cap-dependent mRNA 
translation ([28, 31, 33]). This inhibition is caused by binding of dephosphorylated 4E-
BP1 with mRNA cap binding protein. (Eukaryotic initiation factor 4E (elf4E)).  This 
process is mediated by binding of Rapamycin with a widely expressed intracellular 
protein FKBP12 (FRAP), which then forms an active complex. This active complex then 
binds with mTOR protein with high affinity ([20]).  
PI-3 kinase pathway is a central regulator of mitogenic stimuli and growth factor 
based signaling events in cells ([31]). It has been demonstrated that PI-3 kinase directly 
signals to the mTOR pathway through downstream activation of AKT. ([32]).  Both 
mTOR and PI-3 kinase pathways converges on downstream effectors of the translation 
initiation machinery, i.e., 4E-BP-1 and the Ribosomal S6 kinase ([35]). In this study 
Wortamannin (at 1 µm concentration) was used to inhibit the activity of PI-3 kinase.  
Wortamannin has been shown to be a potent inhibitor of PI-3 kinase-based signaling 
events in various cellular studies ([36, 37]).  
Here we have inhibited the translational processes in living cells by using 
rapamycin-based (10 µM) direct inhibition of mTOR pathway and Wortamannin-based 
inhibition of PI-3 kinase (1 µM). Disruption of the mTOR pathway, which directly 
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influences the translation process in living cells, provides us a method to directly disrupt 
this process and study its influence on specific mRNA targets and the MB probes bound 
to those targets. Wortamannin-based (1 µm) inhibition of PI-3 kinase allows us to model 
the effects of extra-cellular conditions, specifically on the role of PI-3 kinase 
activation/inhibition, on organization of mRNA targets, and the corresponding MB probes 












Wortamannin, Phosphate buffered saline, DMSO, TCEP, Streptolysin O (SLO) 
were purchased from Sigma Aldrich, St. Louis, MO. Rapamycin was purchased from 
Calbiochem Corp, CA.  Mitoflour green dye for live cell staining of mitochondria was 
obtained from Molecular probes. 
Molecular Beacons 
 
  Molecular beacon probes as shown in Table 4.1 (same as used in our earlier 
studies (Chapter 2 and 3)) were synthesized by MWG Biotech, NC and Biosource Corp, 
CA. The Molecular beacon probes were designed with regular DNA chemistry (De-oxy 
ribonucleotide backbone) for each of the target RNA. In addition, MB probes for K-Ras 
mRNA studies were also designed with the same sequence but with 2’ o methyl 
chemistry.  The probes were purified using double HPLC. MB probes were designed 
with Cy3 fluorophore and BHQ-II quencher pair. In all cases quencher end was the 3’ 
end, while dye was conjugated to the 5’- end.   
Cell Culture 
 
All experiments in this study were carried out using primary human dermal 
fibroblast cells.  These primary cells were obtained from Cambrex Corp., NJ. These 
were the same cell type as used in our previous studies (Chapter 2 and 3).  HDF cells 
were cultured using standard media formulation provided by Cambrex Corp., NJ. A 
batch of HDF cells were cultured only for about 10 splitting cycles.  For imaging 
experiments, cells were plated on 4 well or 8 well Nalgene-Nunc chamber cover slides 





All imaging experiments for detection of MB signal in living cells were carried out 
using a confocal microscope (Zeiss Axiovert LSM-100) with an optical pin hole of 2.4 airy 
units with excitation @ 543 nm and detection using a band pass filter from 560-615 nm. 
These settings were chosen to provide a thick slice in a confocal image and in turn 
provide integration of the fluorescent signal over a significant depth. This was helpful in 
establishing that the signal from MB probes decreases throughout the cell with inhibition 
of translation process rather than a single thin slice.   For simultaneous imaging of 
mitochondria and MB signal, we have used laser excitations @ 488 nm and 543 nm. The 
detection was carried out using band-pass filter 510-530 nm and 560-615 nm.  
Cellular Studies with Molecular Beacons  
 
For cellular delivery of MB probes, experiments were carried out using HDF cells. 
For delivery, cells were treated with activated streptolysin O (SLO) for a period of 10 
minutes as described in (Chapter 3)  with a slight modification in the experimental 
procedure. Specifically the incubation with SLO+ MB probes was carried out in a regular 
serum rich medium as we have observed no noticeable difference in the efficiency of MB 
delivery in a regular media as compared with a serum free media used in previous study 
(3). This allowed us to maintain same extra-cellular conditions throughout the 
experiment.  After this incubation period of 10 minutes, the regular medium with SLO 
was changed to regular serum rich media. The cells were incubated for a period of 30 
minutes following this change of media. Following this period, we imaged the signal 
obtained by hybridization of MB probes. This was carried out to confirm the binding of 
MB probes in all samples of interest. The results of this study are similar to the ones 
reported in our previous study (Chapter 2 and 3). Following this, we added small 
molecules (Rapamycin or Wortamannin) of interest to the regular media for 40 minutes 
to perturb the translation process. For targeting mTOR pathway we have used 
rapamycin at a concentration level of 10 µm and for PI-3 mediated changes we have 
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used Wortamannin at 1 µm concentration.  After drug treatment, the cells were imaged 
live using the confocal microscopy set up as described above. 
 
Fixed cell studies 
 
Normal human dermal fibroblasts were cultured in 8-well chambered coverslides 
for 24 hours in normal growth medium (FGM-2 Cambrex Co.) and then washed with 1x 
PBS (without Ca or Mg).  The slide was fixed in 100% methanol at –20oC for 10 minutes.  
After removing the methanol, the slides were allowed to air dry and stored overnight at –
80oC.  In-situ hybridization assays were then performed by first washing the slides for 5 
minutes in 1x PBS and hybridizing them overnight at 37oC in 1x PBS (no Ca or Mg) 
containing 100 nM of MB probes targeting GAPDH and K-Ras.  After removing the 
hybridization solution with washing and adding 1x PBS, the cells were imaged. The in-
situ hybridization for wortamannin and rapamycin treated cells was carried under same 
conditions as the untreated cells. The experiments were repeated three times and 
images were taken from multiple cells (typically 20 cells per well). 
Studies with 2’ o methyl MB probes 
 
To understand the role of chemistry of MB probe, we designed the probes with 2’ 
o methyl chemistry in addition to regular DNA chemistry. These 2’ o methyl probes have 
the same sequence as regular MB probes, but have modified backbone chemistry that 
enhances the affinity of these probes and also increases the melting point of a 
hybridized structure. These probes were introduced in living cells using SLO as with 
unmodified MB probes. These probes were incubated for about 4 hours after removal of 
excess SLO. This time period was required to get sufficient hybridization with 
intracellular RNA target. This was primarily due to a higher melting point of these 
modified MB probes (approximately 80 °C), much higher than the regular MB probes 
with melting temperature (around 55 °C). Further these probes have a 2’ o methyl 
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backbone chemistry, which renders them resistant to nuclease activity, thus longer 
incubation periods were not considered a significant disadvantage in this study. 
 
RNA Isolation, RT-PCR, and qt-PCR 
 
RNA from treated and untreated cells was isolated using Qiagen’s RNeasy 
isolation kit. An absorbance reading was taken at 280nm and RT reactions were set-up 
with equal concentrations of total RNA from each sample. The RT reaction was 
performed with random hexamer primers. For the PCR reaction 2uls of RT product was 
used for each sample. For regular PCR the cycle parameters for GAPDH were 95 for 
45s, 60 for 45s, 72 for 1min 30s for 30 cycles and for K-ras 95 for 30s, 52 for 1min, 72 
for 1min for 40 cycles. The qt-PCR reactions were run on a Bio-Rad iCyler using Bio-
Rad’s iQ SYBR Green Supermix. It was a two-step reaction with 95 for 10s followed by 
the corresponding annealing temperature listed above for 45s and 40 cycles. The 
starting concentrations were determined with Bio-Rad’s MyiQ software. The primer 
sequences used are as follows; GAPDH forward (CGA CCC ATG GCA AAT TCC ATG 
GCA), GAPDH reverse (TCT AGA CGG CAG GTC AGG TCC ACC), K-ras forward 
(GAT TCC TAC AGG AAG CAA GT), and K-ras reverse (TAA TGG TGA ATA TCT TC). 
 
 113
Results and Discussions 
 
In this study our hypothesis was that the translation state of mRNAs favors the 
hybridization of MB probes with its target mRNAs. This hypothesis was based on current 
understanding that multiple ribosomes loaded on mRNAs during translation process 
favors the opening of local secondary structure ([3, 38]) and also favors the removal of  
bound proteins to allow for a effective read out of the mRNA sequence for translation 
into polypeptide. Further it has been shown that major structural changes take place at a 
global scale of mRNA secondary structure during the translation process ([39]). These 
changes involve the formation of a lariat structure, which brings together the 3’ and the 
5’ ends of a mRNA through an association of elf4G complex with a polyA binding 
proteins and elf4E ([39]). Additionally, the EM data of RNA molecules with multiple 
ribosomes loaded across its length suggests a high degree of accessibility (Wells et al, 
1998) for a short oligonucleotide probe (~ 18 bp) for hybridization with its target. With 
this understanding we have designed this study to address the above discussed 
questions related to MB probes, RNA organization and translational process. 
Effect of Rapamycin and Wortamannin treatment on the MB-based detection of 
mRNAs in living cells 
 
The aim of this first experiment was to understand the effect of translation 
repression on MB-based detection of mRNAs. We chose to study GAPDH and K-Ras 
mRNAs as we have demonstrated in our previous studies ([1, 2]) the specific and 
sensitive detection of these mRNAs using MB probes. Using the same design of MB 
probes as in our previous studies and the methods as described in the methods section 
here, the probes were introduced into living cells. Following an initial incubation of cells 
with MB probes for specific mRNA targets for 30 minutes, the cells were treated with 
either Rapamycin (10 µm conc.) or Wortamannin (1 µm conc.) for 40 minutes along with 
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an untreated control sample. The initial incubation was carried out to allow for the 
hybridization of MB probes with target mRNAs in unpertubed conditions. Following this 
initial incubation of MBs, the incubated cells were briefly imaged to detect the signal from 
the hybridized MB probes (data not shown). The results of these studies for both the 
GAPDH and the K-Ras are shown in Figure 4.1. Figure 4.1 A shows a localized signal 
of the GAPDH mRNA in living cells in agreement with our previous studies ([1, 2]). 
Figure 4.1 B shows the effect of rapamycin treatment on the distribution of GAPDH 
mRNAs. Prior to rapamycin or wortamannin treatment, the samples incubated with MBs 
had the same distribution as untreated cells shown in Figure 4.1 A. After 40 minutes of 
treatment, we observed a significant decrease in the MB fluorescence signal in the 
cytoplasm. The results suggests that MB probes, which were hybridized with the target 
mRNA before treatment, have come off the target mRNA after incubation of cells with 
rapamycin and formed a closed, nonfluorescent hairpin structure. In Figure 4.1 B we 
could only detect some signal in the peri-nuclear region of cytoplasm. This signal is an 
integrated signal for a thick optical slice of 2.5 airy units on a confocal system. This 
pinhole thickness was chosen to avoid the limitations of a smaller thickness of a typical 






Figure 4.1: Effect of the Rapamycin and the Wortamannin treatment (repression of 
translation) on MB-based detection of the GAPDH and K-Ras mRNAs in living cells. 
 (A) Image of the distribution of GAPDH mRNAs in living cells using MBs in untreated 
cells. (B)-(C) Images of the GAPDH distribution in living cells using MBs treated with 
Rapamycin (10 µM for 40 minutes) and Wortamannin (1 µM for 40 minutes) respectively. 
The MBs were hybridized for 30 minutes similar to the untreated cells, after 30 minutes 
of MB incubation cells were treated with Rapamycin and Wortamannin. The results show 
a reduction in signal intensity in the cytoplasm and also the residual signal intensity was 
observed in the peri-nuclear region only. These cells had similar signal intensity and 
distribution of GAPDH mRNAs as untreated cells shown in Figure 1(A) before treatment 
with Rapamycin and Wortamannin. 
(D) Image of the distribution of K-Ras mRNAs in living cells using MBs in untreated cells.  
(E)-(F) Images of the K-Ras distribution in living cells using MBs treated with Rapamycin 
(10 µM for 40 minutes) and Wortamannin (1 µM for 40 minutes) respectively. The MBs 
were hybridized for 30 minutes similar to the untreated cells, after 30 minutes of MB 
incubation cells were treated with Rapamycin and Wortamannin. The results show a 
reduction in signal intensity in the cytoplasm and also the residual signal intensity was 






Figure 4.1 C shows the result of wortamannin treatment using the same GAPDH 
MB probe and the same incubation time as in Figure 4.1 B. The result shows a similar 
decrease in the fluorescent signal from a MB probe in the cytoplasm as observed in 
case of Figure 4.1 B. The result of wortamannin treatment also shows some signal in 
the peri-nuclear region of the cytoplasm. The images of Figure 4.1 A-C were taken 
under the same imaging conditions including the optical pinhole, the voltage gain on 
PMT etc. The combined results of Figure 4.1 A-C clearly indicate that the MB probes 
are reversibly bound, i.e., the MB probes bound to mRNA target can come off the target 
with the repression of a translational process. Furthermore, this observation indicates 
that the MB probes can even fold back into a hairpin MB structure, which will bring the 
fluorophore in close approximation to the quencher and quench the resultant fluorescent 
signal, upon removal from the target mRNA. With this decrease in the fluorescent signal 
from MB probes, we still could not clearly deduce the fate of mRNA with this 
perturbation.  Further we cannot establish if this trend is more generic for the various 
other MB probes targeted to different mRNAs or is it specific to the GAPDH target with 
this particular MB probe 
 To answer this question, we carried out a study with a MB probe, which targets 
K-Ras mRNA in living cells. We have validated this probe in our previous studies ([1, 2]). 
The results of this study, shown in Figure 4.1 D-F, indicate a similar trend as observed 
for the GAPDH mRNAs with and without the repression of translation. Figure 4.1 D 
shows a similar localization of K-Ras mRNA in living cells as observed in our previous 
studies ([1, 2]). Upon treatment with rapamycin and wortamannin we observed a similar 
decrease in the MB fluorescent signal in the cytoplasm, and also detected some signal 
in the peri-nuclear region of cytoplasm similar to the case of GAPDH MB study (Figure 
4.1 (A-C)). Imaging of the K-Ras based MB detection was carried out using a same 
optical pinhole as in case of the GAPDH detection in Figure 4.1 but at a higher PMT 
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gain voltage. This was done because the fluorescent signal intensity obtained from 
hybridization of K-Ras MB probe was lower than the intensity obtained from hybridization 
of GAPDH MB probe at a same PMT gain value. This can be attributed to the lower level 
of K-Ras mRNAs as compared with GAPDH mRNAs. 
 The combined result of these studies clearly indicates that MB probes can come-
off the bound target and fold back to the hairpin state when translation processes are 
repressed in cells. Since we have observed these changes with two different mRNAs, 
targeted with two different MB probes, this trend appears to be more generic than the 
case of a specific MB probe and a specific mRNA. Further this study highlights that the 
translational states of mRNAs in the cells can have a direct effect on the hybridization of 
MB probes. Due to decrease in signal from MB probes, we could not establish 
information regarding the fate of these mRNAs or the subcellular organization of these 
mRNAs with other cellular structures with this experiment.  
 
Effect on the subcellular organization and MB based detection of mRNAs upon 
treatment with Wortamannin and Rapamycin 
 
In our previous study (Chapter 3), we have demonstrated the co-localization of 
GAPDH and K-Ras mRNAs with mitochondrial structure in living cells. The aim of this 
part of the study was to understand if the co-localization of mRNAs (based on our MB 
probes) with mitochondrial structure is affected by the repression of translational 
process. Although this part of the study will only provide us a relationship between the 
fluorescent signal from MB based probes and the intracellular organization of 
mitochondrial and may not represents the actual behavior of mRNAs, it will still help us 
understand the sub-cellular structural changes with the repression of translation. In 
combination with the next part of this study including FISH, PCR and other controls, this 
will help us complete this understanding.  
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Figure 4.2 and Figure 4.3 shows the data for MB probes targeting GAPDH and 
K-Ras mRNAs respectively in living cells with co-staining of mitochondria. Figure 4.2 A 
shows the co-localization of GAPDH mRNAs with mitochondrial staining in living cells. 
This result is in agreement with our previous study (Chapter 3). Figure 4.2 B and 4.2 C 
show the effect of rapamycin and wortamannin treatment on the co-localization of 





Figure 4.2: Colocalization of GAPDH mRNAs with Mitochondria in untreated and treated 
(translationally repressed) cells. 
(A) - Images show the distribution of Mitofluor green and the MB signal for GAPDH 
mRNAs in two confocal channels and their overlap to indicate the co-localization of 
GAPDH mRNAs with the mitochondria in untreated cells. Yellow color in the overlayed 
image indicates the high degree of co-localization of mRNAs with the mitochondria. 
 (B)-(C)- Images show the distribution of Mitofluor green and the MB signal for the 
GAPDH mRNAs in two confocal channels and their overlap to indicate the co-
localization of GAPDH mRNAs with the mitochondria in Rapamycin (10 µM for 40 






Figure 4.3: Colocalization of K-Ras mRNAs with Mitochondria in untreated and treated 
cells (repression of translation). 
(A)- Images show the distribution of Mitofluor green and the MB signal for the K-Ras 
mRNAs in two confocal channels and their overlap to indicate the co-localization of K-
Ras mRNAs with the mitochondria in untreated cells.  
(B)-(C)- Images show the distribution of Mitofluor green and the MB signal for the K-Ras 
mRNAs in two confocal channels and their overlap to indicate the co-localization of K-
Ras mRNAs with the mitochondria in Rapamycin (10 µM for 40 minutes) and 







Figure 4.2 B and C clearly indicates a lack of any significant co-localization of MB 
fluorescence signal with mitochondrial staining. The MB signal does not follow the 
pattern of mitochondrial staining in the cytoplasm of these cells including the peri-nuclear 
region after treatment with rapamycin and wortamannin. Mitochondrial staining after 
treatment has a similar extended filamentous distribution as in case of untreated control 
sample.  
Similar results were obtained for K-Ras mRNAs in living cells. Figure 4.3 A 
shows the co-localization of K-Ras mRNAs with mitochondria in an untreated control 
case. The results show a high degree of co-localized K-Ras mRNAs, especially away 
from the peri-nuclear region in the cytoplasm (indicated by yellow- overlap of green-
Mitostain and red colors-MB signal) in agreement with our previous study (Chapter 3). 
Upon treatment with rapamycin and wortamannin, we observed no co-localization of 
fluorescent MB signal with mitochondrial staining (Figure 4.3(B) and 4.3(C)). This trend 
is similar with the result obtained for GAPDH MB fluorescent signal after treatment with 
rapamycin or wortamannin (Figure 4.2 B-C). 
This study shows that the translational repression by incubation of samples with 
rapamycin or wortamannin does not significantly change the distribution and 
organization of mitochondria in cells. Further a reduced peri-nuclear signal from MB 
probes does not co-localize with mitochondria after the treatment. This raises an 
interesting aspect that the translation state favors the co-localization of MB signal and in 
effect the mRNAs (GAPDH and K-Ras) with mitochondrial structure in cells. At present 
we cannot resolve the fate of these mRNAs but the signal from MB probes does not 
show co-localization with mitochondria after treatment. 
Sub cellular fate of mRNAs after treatment with rapamycin and wortamannin 
 
 Until this stage in our study, we have only looked indirectly at specific mRNAs 
using the fluorescent signal from MB probes. With the decrease in the fluorescent signal 
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from MB probes upon repression of translational process, we could not clearly deduce 
the fate of mRNAs. At this stage of our study we had three plausible hypotheses that 
could explain the significant decrease in the signal from MB probes with the repression 
of translation machinery: 
1. Decay of mRNAs 
2. Secondary structure changes or RNA binding proteins etc –Significant changes 
in the secondary structure/ RNA binding protein complexes may be able to 
compete- off MB probes from its target mRNAs. Such changes may be induced 
when translation state of cells is repressed. If this observation is true, it will 
support our hypothesis that the hybridization of these specific MB probes is 
favored by active translational state. 
3. Dispersal of mRNAs in the cytoplasm- Disperal of RNAs in the cytoplasm can 
reduce the resultant fluorescent intensity from hybridization of MB probes as 
compared to a highly localized distribution in the cytoplasm. This can be 
potentially overcome by using imaging set-up with single molecule detection in 
living cells. 
To assess which of this plausible hypothesis truly represent the behavior of mRNAs 
upon treatment with rapamycin or wortamannin, we did the following studies. First, RT-
PCR was performed to determine the levels of K-RAS and GAPDH mRNAs pre- and 
post-treatment. The PCR results clearly show that with rapamycin treatment, we only 
observed about 10-20 % increases in the levels of K-Ras and GAPDH mRNAs as 
compared with untreated control samples (Figure 4.4 A-B). Upon treatment with 
wortamannin, we did not observe any significant changes in the levels of K-Ras and 
GAPDH mRNAs as compared with control samples (Figure 4.4 C-D). These results 
clearly suggest that mRNA level for GAPDH and K-Ras has not decreased upon 
treatment with either rapamycin or wortamannin.
 123
 









Figure 4.4: PCR results for the GAPDH and the K-Ras mRNAs in treated (Rapamycin or 
Wortamannin treatment for repression of translation) and untreated cells 
 (A)- (B): Comparison of the GAPDH and the K-Ras mRNAs in Rapamycin treated (10 
µM for 40 minutes) and untreated cells respectively. The result shows relative increase 
in the GAPDH and the K-Ras mRNA levels in Rapamycin treated cells. 
(C)- (D): Comparison of the GAPDH and the K -Ras mRNAs in Wortamannin treated (1 
µM for 40 minutes) and untreated cells. The result shows relative increase in the 
GAPDH and the K-Ras mRNA levels in Wortamannin treated cells. 
Control Treated 
(A) RT-PCR GAPDH 
Rapamycin and Conrol 
 
(B) RT-PCR K-Ras 
Contol and Rapamycin 
Regular Treated 
Treated Regular 
(C) RT-PCR GAPDH- 
Control and Wortamannin 
(D) RT-PCR K-Ras 
Control and Wortamannin 
Control Treated 
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 With this we have two other plausible explanations to understand the changes in 
MB signal, as they no longer correspond to the changes in mRNA levels. To resolve 
which of these processes is responsible for the changes in the fluorescent MB signal 
and what is the fate of the mRNAs with the repression of translation, we performed in-
situ hybridization. We realize that using our imaging methods it is not possible to probe 
the secondary structure of RNA in living cells/ fixed cells. Still in-situ hybridization in 
certain cases can increase the accessibility of the target for its probe due to the effect of 
fixative agents (Methanol/Acetone), some of which tends to disrupt RNA-protein 
complexes (precipitation of proteins etc.) and also dissolve some of the lipid 
components. Further we chose this as it will also help us to directly access the possibility 
related to dispersal of mRNAs in the cytoplasm. Thus, this assay would help us 
understand the changes and address both the plausible hypothesis. 
 The results of in-situ hybridization to detect GAPDH mRNAs in an untreated 
control sample and treated samples with rapamycin or wortamannin are shown in Figure 
4.5 A-C respectively. The results in Figure 4.5 A shows a similar distribution of the 
GAPDH mRNA in fixed cells (control case) as obtained with untreated live cells (Figure 
4.1 A). Figure 4.5 B and C show the distribution of GAPDH mRNAs in rapamycin and 
wortamannin treated fixed cells respectively. The results show a distinct change in the 
distribution of mRNAs in treated cells as compared with an untreated sample. The 
localization of GAPDH mRNAs does not have extended filamentous structure in the 
cytoplasm but instead, it has an aggregated distribution in the cytoplasm. The relative 
intensity levels in the translationally repressed cells are not significantly different than 
those obtained with an untreated fixed sample.  
Similar results were obtained when HDF cells were fixed for detection of K-Ras 
mRNAs in an untreated and treated sample. In untreated control cells (Figure 4.5 D) we 
can observe the extended cytoplasmic localization of K-Ras mRNAs, which agrees with 
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our live cells studies in the present and previous studies ([1, 2]). On treatment with 
rapamycin and wortamannin (Figure 4.5 D-E), we observe that the K-Ras mRNAs also 
have an aggregated peri-nuclear distribution in the cytoplasm. This distribution is similar 
to the one obtained for GAPDH mRNAs in a treated sample. (Figure 4.5 B-C) 
Based on these results, we have obtained an understanding that mRNAs upon 
treatment with rapamycin or wortamannin are distributed significantly differently than the 
untreated regular cells. It is clear that although the MB probes are not able to follow the 
changes in the RNA localization with translational repression, the same probes during in-
situ hybridization assay could hybridize with a target RNA. This clearly suggests that we 
have been able to increase the accessibility for MB probes using methanol as a fixative. 
These results suggest that the changes in structure of mRNA molecules with the 








Figure 4.5: Fluorescent in-situ hybridization (FISH) based detection of GAPDH and K-
Ras mRNAs in treated (Rapamycin or Wortamannin treatment for repression of 
translation) and untreated cells. 
 (A) and (D) FlSH based detection of GAPDH and K-Ras mRNAs in untreated cells. 
Cells were fixed in methanol (-20 C for 5 minutes) and hybridized overnight in 1X PBS 
with 100 nM MBs targeting the GAPDH and K-Ras mRNAs respectively. The result 
shows very similar filamentous distribution of the GAPDH and K-Ras mRNAs in the 
cytoplasm as observed for living cells. 
 (B)-(C) and (E)-(F) FISH based detection of GAPDH and K-Ras mRNAs in treated 
(Rapamycin or Wortamannin) cells respectively. The same fixation protocol was used as 
in Figure (A) and (D). Cells were treated for 40 minutes and with the same concentration 
of drugs as in live cell assays before fixation. The results show a distinctly different 
pattern of localization of both mRNAs in the treated cells as compared with untreated 
cells. In treated cells, most of the signal is observed in the peri-nuclear sites with mRNAs 
showing an aggregated distribution. No significant reduction in the intensity of the MB 





In our previous study (Chapter 3) and in this study, we have shown that the 
distribution of GAPDH and K-Ras mRNAs co-localizes with mitochondria in living cells. 
Similar distribution of these mRNAs was observed in fixed cell samples of untreated 
control cells (Figure 4.5 A and D). Upon treatment with rapamycin or wortamannin, 
neither mRNAs in fixed cells nor MB probes in living cells are co-localized with 
mitochondrial structure. This evidence taken together clearly highlights that upon 
repression of translation there is no significant co-localization of these mRNAs with 
mitochondria. Thus the translational state not only favors the binding of our probe to the 
target mRNAs but also favors the co-localization of mRNAs with mitochondria. This 
result highlights the functional information regarding the state of the mRNA and its 
localization with mitochondria. This extends our previous study, where we have earlier 
reported this observation with these two mRNAs. 
Further the results of in-situ hybridization study also disproves the third plausible 
explanation, in which a signal from the MB probe is reduced due to the dispersal of 
mRNAs upon treatment with rapamycin or wortamannin. With this we believe that the 
changes in the secondary structure of mRNAs upon treatment cause MB probes to 
come off a bound target. Although the direct evidence of such structural changes in a 
cell is not possible with current method, the evidence obtained from this study strongly 
suggest this as a well founded hypothesis for the changes observed in the MB 
fluorescent signal in living cells and localization in fixed cells. 
 To further prove that the above changes in a MB signal are co-related with the 
inhibition of translation of mRNAs, we decided to study the effect of wortamannin or 
rapamycin treatment on MB probes hybridized with a non-translated RNA in the 
cytoplasm of living cells. If our hypothesis is true, this study will serve as a positive 
control to prove that the MB probes targeted to non-translated RNAs are not affected by 
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treatment with either rapamycin or wortamannin. For this study, we chose 28-s rRNA as 
a candidate non-translated RNA in the cytoplasm of living cells. This RNA is a part of 
ribosomal complex and we have successfully targeted this RNA in our previous study 
(Chapter 3). The results of this experiment are shown in Figure 4.6. Figure 4.6 A 
shows the distribution of the 28-s rRNAs in untreated control cells. This distribution is 
similar to the results obtained in our previous study. Most of the fluorescence signal is 
distributed in a peri-nuclear section of the cytoplasm. Upon treatment with rapamycin 
(Figure 4.6 B), we did not observe any significant decrease in the fluorescent signal 
intensity of MB probes targeted to 28-s rRNA, further there are no significant changes in 
the localization of fluorescent signal with treatment. Similar results are obtained upon 
treatment of cells with wortamannin (Figure 4.6 C).  
These results provide us an understanding that MB probes targeted to non-
translated RNAs (non-mRNA) are not affected upon treatment with rapamycin or 
wortamannin. This clearly illustrates that the translation state of GAPDH and K-Ras 
mRNAs was responsible for the changes in MB signal upon treatment. These findings 
also suggest that it is possible to target a translationally inactive RNA only if the 
secondary structure has been well established and extensive studies have been 
performed to experimentally evaluate its structure and accessibility for a target probe.  
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Figure 4.6: (A): Distribution of 28-s Ribosomal RNA in living cells without any treatment 
using MB probes. MB probes designed to target 28-s rRNA were delivered to the cells 
using same protocol for delivery of MBs targeting GAPDH and K-Ras mRNAs. The 
image shows distribution of 28-s rRNA in the cytoplasm, which is distinctly different from 
the distribution of K-Ras and GAPDH mRNAs. 
(B)- (C): Distribution of 28-s Ribosomal RNA in Rapamycin (10 µM for 40 minutes) and 
Wortamannin (1 µM for 40 minutes) treated cells respectively. The treatment of 
Rapamycin or Wortamannin does not affect the signal intensity as well as the distribution 
of 28-s rRNA.  This observation validates that the MB probes does not change their 







In this case, the accessibility of this particular MB probe sequence for targeting 
28-s rRNA has been well established using both FISH and live cell studies  ([40-42]). For 
the case of mRNAs this is a harder problem, as their structure is highly dynamic and 
thus prediction of local static structure is difficult ([14]). Thus designing MB probes for a 
local static secondary structure of an RNA target, which has global changes in its 
conformations during its life in a cytoplasm, may not be possible without extensive 
studies. Nevertheless, the increased accessibility of mRNA during active translation 
processes may provide an alternative to such a challenge and may allow for an easy 
design of MB probe for specific targeting of mRNAs, although such designs may not be 
able to detect different states of target mRNA.  
 
Effect of MB probe chemistry on the stability of MB-RNA structure with the 
repression of translational processes 
 
In this study till this stage we have used regular deoxynucleotide chemistry in the 
design of MB probes. Using this probe chemistry we have established that the MB 
probes designed to target GAPDH and K-Ras mRNAs come off the hybridized target 
upon treatment with rapamycin or wortamannin. In this direction, we were interested in 
exploring if high affinity probe chemistries such as 2’ O methyl chemistry will show a 
similar trend as observed with regular DNA chemistry probes. With this motivation, we 
designed MB probe with 2’O methyl chemistry to target K-Ras mRNAs in living cells. 
With this chemistry we maintained the same sequence design as with a regular DNA 
chemistry.  
The results of the study are shown in Figure 4.7. Figure 4.7 A shows the 
fluorescence signal obtained from 2’ O methyl MB probe targeting K-Ras mRNA in living 
cells. The results show a similar distribution of the K-Ras mRNAs in the cytoplasm as 
obtained earlier with a regular DNA chemistry probes. Figure 4.7 B shows the 
fluorescence signal using the same MB probe in a rapamycin treated sample. The 
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results clearly shows that the MB signal does not significantly decrease upon treatment 
with rapamycin, contrary to the results obtained with the DNA chemistry probe. The 2’ O 
methyl probe not only remains bound to its target RNA but also follows the change in K-
Ras mRNA localization in the cytoplasm. The results of this study show an aggregated 
distribution of mRNAs in the cytoplasm upon treatment with rapamycin, which parallels 
the results obtained with in situ hybridization studies using a DNA MB probe (Figure 
4.5). This indicates that the high affinity 2’ O-methyl backbone can prevent the 
dissociation of MBs from their target RNA upon treatment, therefore following the 
changes in the localization of mRNAs. This approach, although great for following 
changes associated with mRNAs, still has several issues related to the functional 
characteristics of target mRNAs when such high affinity probes are bound to them. High 
affinity probes such as those used in this experiment could potentially prevent the 
ribosomes from translating the target mRNAs. It has recently been discovered that 
ribosome’s posses an inherent helicase activity ([3]), which allows them to unwind the 
local secondary structures with melting temperatures of approximately 70 ºC or less.  
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Figure 4.7: (A) - (B) Detection of K-Ras mRNAs using 2’ O Methyl MB probes in 
untreated and Rapamycin treated cells respectively. The result shows that 2’O Methyl 
MB probes shows similar localization and signal intensity as obtained with a regular DNA 
chemistry. Thus result suggests that both chemistries are comparable in detecting signal 
in living cells. On treatment with Rapamycin, the signal from the MB probes does not 
diminish as in case of regular DNA chemistry and further the MB probes follows the 
distribution of mRNAs as they are perturbed by the chemical treatment.  Thus 2’ O 
Methyl MB probes does not come-off the bound target and are able to follow the 





This has implications as these 2’ o methyl probes have melting temperatures close to 70 
ºC or higher ([43]), which may prevent the translocation of ribosomes through the target 
mRNA. This also has implications that regular chemistry DNA probes bound to the 
targets with melting points lower than 70 ºC will experience on and off rates depending 
on the speed of translocation of these ribosomes. This observation though cannot be 
imaged with our present set up for imaging given that the multiple mRNAs localized in a 
given area will have the probes bound to the target mRNA at any given moment of time. 
Thus such fluctuations may require us to carry out FCS based measurements to monitor 
the changes in very small focal volume.  
Summary 
 
 In summary, we have positively tested a hypothesis that the translational state of 
mRNAs favors the hybridization of MB probes with its target mRNAs. This study has also 
provided the evidence that the MB probes are reversibly bound with target mRNAs and 
the repression of translation processes can cause a removal of the MB probes from its 
target mRNAs. The study has resulted in an interesting observation that active 
translational processes in cytoplasm favor the co-localization of K-Ras and GAPDH 
mRNAs with mitochondria. Further the repression of translation processes induces a 
significant re-distribution of mRNAs in the cytoplasm of living cells.  The study also 
highlighted the significant differences in the regular DNA chemistry and 2’ O methyl 
backbone chemistry. MB probes with 2’ o methyl backbone chemistry were not removed 
from the target RNAs with the repression of translation in living cells. This backbone was 
able to follow the changes in the localization of RNAs with the repression of translation. 
Future studies will be designed to develop an integrated approach by combining 
interference based silencing and drug-based knock downs with MB-based imaging to 
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allow for a comprehensive understanding of various questions in RNA biology and also 
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Measurement of intracytoplasmic mobility of endogenous messenger 





There are several important questions related to transport of mRNAs in living 
cells. It has been proposed that mRNAs after their export from nucleus are directed to 
specific sites in the cytoplasm of living cells ([1-3]). This process of RNA localization is 
believed to play a critical role in gene expression and in certain cases the localization of 
specific proteins ([1, 2, 4, 5]). It has been proposed that internal zip-code sequences 
within RNA molecules, various RNA binding proteins, cytoskeletal elements and   
possibly molecular motors ([2, 3, 6]) control the transport rate and localization of RNA 
molecules in the cytoplasm.  It is not clear as to how this complex machinery is 
organized in the cytoplasm to carryout the transport of RNA molecules and how the 
specifics of transport process are determined for different RNA molecules. This limited 
understading in this fundamental process is partly due to limited direct observation of 
endogenous mRNAs ([7-10] ) and their transport in the cytoplasm of living cells. In this 
study, we have developed an approach, which allows for the measurement of 
intracytoplasmic mobility of endogenous RNAs in living cells. This study combines a 
modified molecular beacon (MB) probe design with a FRAP (Fluorescence Recovery 
After Photobleaching) based biophysical tool and biochemical perturbations in a cell 
culture set-up to quantify the mobility of RNA in the cytoplasm of living cells.  
 Messenger RNAs begin their journey in the nucleus, after their birth and 
processing in nucleus (transcription and post-transcription processing (splicing etc.), the 
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assembly of RNA and its bound proteins), they are transported to the cytoplasm. It was 
originally proposed ([11]) that the mRNAs are transported vectorially from nucleus to the 
cytoplasm. Studies by ([12-14]) have shown that mRNAs exhibit a random diffusion in 
the nucleus rather than a local vectorial transport. This trend has been observed using 
both FCS (Fluorescence Correlation Spectroscopy) and FRAP based measurement of 
mRNA transport in the nucleus.  
For tagging mRNAs in the nucleus, previous studies ([12-13]) have used 
fluorescently labeled oligonucleotide probes complementary with Poly A section of 
mRNAs. One of the major challenges in the above approach for imaging or studying the 
dynamics of mRNAs is the lack of ability to distinguish the hybridized oligonucleotide 
from a pool of free unbound oligonucleotides. Various approaches have been used to 
address this challenge, in one of the approaches used by ([13]), the oligonucleotide were 
labeled with caged fluorophores. These fluorophores were fluorescent only after 
photolysis by a UV wavelength in a small focused region. Using the photolysis 
technique, it may be feasible to study the dynamics of a macromolecule with a high 
concentration or a generic target (e.g., Poly A sequence can represent the entire pool of 
mRNAs in the nucleus) in a specific compartment of a cell, but may not be feasible for a 
low concentration and also a widely dispersed macromolecule. One of the limitations of 
this technique is that the site of photolysis must be defined or known a priori, without 
which it may not be possible to study the dynamics of a specific macromolecule. This 
limitation can be reduced by using a secondary label to define an area of interest. This 
secondary labeling approach can provide a reference point for the photolysis process. 
Even with this modification, it is still not possible to study the entire distribution of a 
particular macromolecule. 
The other approach for studying RNA mobility in a nucleus using oligonucleotide 
probes have been based on using high affinity oligonucleotides chemistries (2’ O Methyl) 
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to allow for stable and faster binding ([12, 15]). This approach in combination with a strict 
control of the concentration of an exogenous probe can potentially reduce the 
background levels due to unbound probe molecules. The other advantage of using a 
high affinity oligonucleotide chemistry especially for targeting a Poly A section of mRNAs 
can be the higher melting temperature of the hybridized structure as compared to regular 
DNA chemistry oligonucleotide probe of similar length. This consideration can be 
important for the design of oligonucleotide probes for live cell studies at 37 ºC.  Thus to 
increase the melting point and in turn increase the stability of hybridized probe, longer 
probe lengths (~43 bp) are required with regular DNA chemistry as compared with 2’ O 
methyl chemistry ([12]). Despite these advantages of high affinity chemistry, still it is 
challenging to distinguish true signal from the background if the target macromolecule is 
widely dispersed and further the lack of specificity (SNP etc) of linear oligonucleotide 
probes can lead to false positives. 
The other major limitation in using oligonucleotide probes for live cell studies has 
been the limited success with non-invasive delivery (transfection agents etc.) of these 
probes. The studies discussed above have mainly used microinjection based delivery of 
oligonucleotide probes into cells. Microinjection process is generally limited to few cells, 
and also the approach is invasive as it creates a micron- sized hole in the plasma 
membrane and also introduces an exogenous fluid in cells leading to increase in volume 
of cells. The other disadvantage of this method has been the lack of ability to target 
mRNAs in the cytoplasm of cells. It has been reported that short oligonucleotide probes 
delivered using microinjection are imported to the nucleus. ([10, 16, 17]). This limits the 
targeting of oligonucleotide probes only to mRNAs in the nucleus.  To overcome this 
limitation, recently various moieties (such as streptavidin etc.) have been attached to the 
oligonucleotide probes to slow down their import into nucleus ([9]). 
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The above studies have been mainly focused on understanding the dynamics of 
RNA in the nuclei of living cells. There is no reported study to our knowledge with a 
quantitative analysis of the mobility of endogenous mRNAs in the cytoplasm of living 
cells. In part it has been due to the lack of ability to target endogenous mRNAs in the 
cytoplasm of living cells using microinjection method. Further in the cytoplasm the 
targeting of Poly A section of mRNAs may be not be the best approach as present 
understanding suggests that mRNAs are segregated and targeted to different sections of 
cytoplasm. These mRNAs in turn may associate with variety of sub cellular structures 
including organelle membranes (ER, Mitochondria) and cytoskeleton etc, which may 
effect their dynamics. These mRNAs can be translated at these sites, maintained in 
inactive state and also metabolized in the cytoplasm. Thus mRNAs can be at multiple 
sites and also in multiple states in a cytoplasm. Thus generic targeting using Poly A as a 
target may not provide a complete understanding of the dynamics. In this direction, this 
study establishes an experimental approach, which allows for imaging of specific 
endogenous mRNAs with high specificity, low background noise. This approach in 
combination with a simple biophysical assays such as FRAP and biochemical/ chemical 
perturbation of cellular processes allows for a mechanistic and a quantitative 
understanding of the dynamics of specific mRNAs in living cells.  
 The oligonucleotide probe used in this study is a dual labeled probe with a stem-
loop structure. This stem-loop structure provides the specificity for targeting, while the 
dye- quencher pair provides a facile method to distinguish the hybridized probe from the 
unhybridized probe ([18]). Probes used in this study are modified version of classical 
molecular beacon design. In this design MB probes were modified in the stem domain to 
conjugate a delivery peptide.  The probes used in this study are described in previous 
Chapters 2 and 3, ([7, 8]).   
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 Our objective is to develop an approach, which provides a quantitative 
understanding of intra- cytoplasmic mobility of RNAs in living cells. To achieve this we 
have used a fluorescence recovery after photobleaching (FRAP) based approach to 
study the dynamics in combination with modified MB probes. FRAP has been used by 
various research groups to measure the mobility of protein molecules in cytoplasm and 
nucleus of living cells ([19-22]). In this study, we have extended this approach to 
measure the mobility of specific endogenous RNAs in the cytoplasm. Figure 5.1 shows 
the schematic representation of a FRAP process in a cell. The pre-selected region of 
interest is bleached with a laser pulse, followed by recording of the recovery process 
(recovery of the fluorescence intensity) in a bleach section due to mobility of 
fluorophores from surrounding unbleached areas. The schematic view of the process is 
shown in Figure 5.1 (A-C) and the resultant intensity curve is shown in Figure 5.1 (D). 
Further we have used various chemical perturbations to determine whether the mobility 
of RNAs in the cytoplasm is mediated by active or passive processes. In this study, we 
have also directly assessed the contribution of microtubule cytoskeletal elements in the 
transport of RNA molecules. 
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Figure 5.1: Schematic representation of a FRAP experiment in a 
cytoplasm of a cell 
A-C) Image based representation of a FRAP procedure i.e., pre-bleach, 
bleach and post bleach recovery 
D)Normalized fluorescence intensity plot obtained from a FRAP 
experiment 
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Material and Methods 
 
Chemicals 
 Taxol, De-oxyglucose and Nocodazole were obtained from Sigma-Aldrich, Corp 
and stored as recommended by the supplier.  
 
Design of Molecular Beacons 
 
 In this study we have used the same design of MB probes for targeting GAPDH 
mRNA and 28-s rRNA described in (Chapter (2 and 3)).  
Cell culture 
 
 Normal human dermal fibroblast cells (Cambrex, NJ) were grown in Clonetics 
fibroblast growth medium supplemented with 2% fetal bovine serum (Cambrex, NJ), 
insulin, fibroblast growth factor, Gentamicin Sulfate and Amphotericin-B.  The cells were 
cultured on a cover slip glass. The cover slip glass provided by Bioptech’s Inc. was pre-
treated for 2 hours with a cell culture medium to allow for adsorption of serum proteins 
on the surface. This treatment increased the adhesion of fibroblast cells on the surface. 
The cells on a surface of a cover slip glass were cultured in a petridish with 
approximately 2 ml of culture medium and were typically allowed to grow for 3-4 days 
after every plating. In this study, we have used primary HDF cells with split cycles 
between 3-9.  
FRAP Assay 
 
 For FRAP studies, cells cultured on a cover slip glass after all the biochemical 
treatments and incubation of MBs at 37 ºC were transferred to FSC-2 chamber 
(Bioptech’s, Inc.) This flow chamber was maintained under static conditions, during the 
experiment. The culture medium was introduced only during a transfer from a petri dish 
to a flow chamber. The temperature in the chamber was maintained using a Bioptech’s 
closed chamber controller with a heated micro-adduct slide and an objective heater. The 
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images were acquired with a Zeiss LSM 510 confocal microscope using a 40 X oil 
objective. The images were zoomed-in using a 2x digital zoom in the Zeiss software. 
The cells were scanned using a 543 nm laser at 0.5 mW laser power (50% of the 
maximum power) for imaging. For bleach sequence we used 488 nm and 514 nm lasers 
each at 40% of the maximum laser power. The bleach sequence was repeated for 100 
iterations to ensure irreversible bleaching of the sample. To confirm that the number of 
iterations has no significant effect on the recovery characteristics of a fluorescent signal, 
the number of iterations was varied from 50 to 100 during initial experiments. The results 
indicated no significant differences in the recovery trends evaluated using normalized 
fluorescence intensity versus time plots.  Further the area of a bleached region of 
interest was varied from 1 µm2 –2 µm2 to validate if changes in the bleached area have 
significant effects on the recovery trends. No significant differences were observed in the 
above case. 
Further in this study, we have selected an optical pinhole of 2.4 airy units for 
imaging and bleach sequence in all the experiments. This slice thickness of the confocal 
imaging allowed us to model the recovery of fluorescence intensity in a bleached area as 
a radial diffusion in a cylindrical slice.  
Molecular beacon delivery via cell permeable peptide 
 
 The molecular beacon targeted to GAPDH and 28-s rRNA (see Table 5.1) was 
linked via a disulfide bridge to the Tat peptide ((N terminus) 
TyrGlyArgLysLysArgArgGlnArgArgArg (C terminus)-Cys) (as discussed in Chapter 2).  
For the delivery of molecular beacon, peptide-linked molecular beacons were mixed with 






For these experiments, cells were grown normally on coverslips as described 
above.  After 30 minutes of delivery of MB probes, the cells were treated with 2µM 
concentration of nocodazole or 10 µM concentration of taxol for 30 minutes. After this 
incubation time, the coverslips were transferred to FSC-2 chamber and analyzed using a 
FRAP based assay as described above. 
ATP depletion 
 
Energy depletion was obtained by addition of 2-deoxy glucose and Na Azide at 5 
mM concentration respectively to a regular culture media for 15 minutes at 37 C after 
regular incubation of celss with MB probes. The cells after this incubation were 
transferred to FSC-2 chamber and analyzed using a FRAP based assay as described 
above. 
Fluorescence in-situ hybridization 
 
Normal human dermal fibroblasts were cultured in a 4-well chambered coverslides for 24 
hours in normal growth medium (FGM-2 Cambrex Co.) and then washed with 1x PBS 
(without Ca or Mg).  The slide was fixed in 100% methanol at –20oC for 10 minutes.  
After removing the methanol, the slides were allowed to air dry and stored overnight at –
80oC.  In-situ hybridization assays were then performed by first washing the slides for 5 
minutes in 1x PBS and hybridizing them overnight at 37oC in 1x PBS (no Ca or Mg) 
containing 200 nM of fluorescently labeled linear probes targeting GAPDH.  After 
hybridization, the cells were analyzed using FRAP assay as outlined above at room 
temperature. In this study, we did not remove the excess MB probes, thus no washing 
step was included in the FISH protocol. 
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Results and Discussion 
 
Design of MB probes 
 
The MB probes used in the study are shown in Table 5.1. In this study, we have 
used MB probes for targeting GAPDH mRNAs and 28-s ribosomal RNAs. The sequence 
design of the MB probe used for targeting the GAPDH mRNAs is same as established in 
our previous study ([7]), while the sequence of 28-s Ribosomal RNA probe was adapted 
from ([15, 23]). The discussion on the design criteria for these probes and other details 
has been presented in ([7]).  
 
Table 5.1: Design of molecular beacons 
GAPDH molecular beacon 
5’-Cy3-CGACGGAGTCCTTCCACGATACCACG/thiol-dT/CG-BHQ2-3' 




Mobility of GAPDH mRNAs at 37 ºC 
 
 After 30 minutes of incubation of peptide linked MBs with cells, the cells were 
imaged in a FSC-2 chamber maintained at 37 ºC. The result of FRAP based intra-
cytoplasmic mobility of GAPDH mRNAs in living cell at 37 ºC is shown in Figure 5.2. 
GAPDH mRNAs have a filamentous distribution in the pre-bleach section shown in 
Figure 5.2 A. This is in agreement with our earlier observations ([7]). Figure 5.2 A 
shows a representative time course of the pre- and post bleach distribution of a 
fluorescent signal from MB probes hybridized with GAPDH mRNAs. The bleach area in 
these images is highlighted using a white circle. After bleaching the fluorophores in a 
region of interest, we observed a recovery of the fluorescence signal in the defined 
region. The result also shows the recovery of the filamentous structure similar to the pre-
bleach distribution of GAPDH mRNA. During this experiment, we did not observe any 
significant changes in the distribution pattern of the fluorescent signal in areas other than 
the bleached region of interest. Fluorescence intensity data from a bleached region was 
normalized to changes in the fluorescence intensity in an unbleached control area. This 
normalization allowed us to account for any variation or overall bleaching of the 
fluorescence intensity due to repeated exposure of the sample. 
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Figure 5.2 A: FRAP analysis of the mobility of GAPDH mRNAs at 37ºC using MB 
probes 
A. Image based distribution of Fluorescence intensity in a pre-bleach, immediately after 
bleaching and post bleach recovery for a GAPDH mRNAs in HDF cells.  
12.0 s 15.5 s 
27.4 s 39.4 s 

































































Figure 5.2 (A) Continued 
Figure 5.2 (B) 
Figure 5.2: FRAP analysis of the mobility of GAPDH mRNAs at 37ºC using MB 
probes 
A. Image based distribution of Fluorescence intensity in a pre-bleach, 
immediately after bleaching and post bleach recovery for a GAPDH mRNAs 
in HDF cells. The results indicate a directed recovery of the fluorescence 
intensity in a region of interest marked with white circle.  
B. Average normalized fluorescence intensity in a ROI as a function of time. 
The result shows 80% recovery of the bleached fluorescence signal, 
indicating significant mobility of the GAPDH mRNAs 
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  The recovery of fluorescence intensity in a bleach area was not a random 
process but the signal recovered along the same filamentous distribution after 
photobleaching as in a pre-bleach image. Figure 5.1 B shows the variation of 
fluorescence intensity (normalized average of 9 readings collected over three 
independent experiments) in a bleach region of interest as a function of time. The results 
show a rapid bleach of the fluorescence sample followed by the recovery process, which 
shows increase in fluorescence in a bleached region followed by saturation of recovery 
at later time points. The plot in Figure 5.1 B shows recovery of approximately 80% of 
the pre-bleach fluorescence intensity after photo bleaching, thus indicating a significant 
mobility of GAPDH mRNAs under these experimental conditions.  
Mobility of GAPDH mRNAs in fixed sample 
 
 To assess the contribution of the dynamics of MB probes (transient hybridization 
of the probes with RNA target due to inherent “on-off” rates of MB probes) in the 
observed recovery of GAPDH mRNAs as shown in Figure 5.2, we decided to chemically 
fix the cells without MB probes in methanol. Methanol fixation process precipitates RNA 
bound proteins and in-turn can enhance the accessibility of MB probe to target mRNAs. 
We have used this fixation process in our earlier study ([7]) and have observed a similar 
filamentous distribution of GAPDH mRNAs in the cytoplasm. After fixation, the cells were 
hybridized overnight with target MB probes. In this study, fixed cells after hybridization 
were not washed to avoid removal of any unbound probes. These samples were 
analyzed using a FRAP based assay under same optical imaging conditions as in case 
of live cells (Figure 5.2). These experiments were carried out at room temperature. The 
results of the study are shown in Figure 5.3. Figure 5.3 A shows a representative time 
series of the fluorescence intensity during a FRAP assay. The results show a negligible 
recovery of the fluorescence intensity in a bleached region. This clearly indicates that we 
have irreversibly bleached a region of interest with the selected bleach sequence and 
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other imaging settings (laser power, pinhole, PMT gain etc.). Since we did not observe 
any significant recovery in the fluorescence after bleaching, it also indicates that the off 
rate of MB probes does not have significant contribution to the recovery process. Figure 
5.3 B shows the plot of fluorescence intensity versus time in a region of interest. The 
result clearly shows no significant recovery of the fluorescence intensity over the same 
time scale as used in a live cell experiment. It is still a challenge to determine the 
dynamics (on-off rate) of MB probes in a living cell sample. It is likely that the target 
mRNA dynamics, cytoplasmic local environment and the inherent probe dynamics 
contribute to true hybridization and off rates of MB probes in living cells. Using fixed cell 
samples, we have only studied the inherent probe dynamics in presence of an mRNA 
target in a cytoplasm, without any contribution from active cellular processes. Further in 
the discussion section we will highlight some of the approaches, which may allow us to 
study the true dynamics of MB probes in living cell samples. 
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Figure 5.3 A: Image based distribution of Fluorescence intensity in a pre-bleach, 
immediately after bleaching and post bleach recovery for a GAPDH mRNAs in fixed HDF 
cells.  
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Figure 5.3 B: FRAP analysis of the mobility of GAPDH mRNAs in a fixed cell samples 
using MB probes to estimate the contribution of the off-rate of MB probes in recovery of 
bleached areas.Average normalized fluorescence intensity in a ROI as a function of 
time. The result shows very limited recovery of the bleached fluorescence signal, 
indicating that the inherent-off rate of MB probes does not have significant contributions 
to the recovery of a fluorescence signal in a bleached section. 
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Effect of Temperature on the mobility of mRNAs in the cytoplasm 
 
 To determine whether temperature conditions have any effect on the mobility of 
mRNAs in the cytoplasm of living cells, MB probes hybridized with target GAPDH 
mRNAs for 30 minutues at 37 C were transferred to the FSC-2 chamber. The chamber 
was maintained at 25 ºC on a confocal microscope stage. FRAP based analysis was 
carried out under similar confocal settings as in Figure 5.2. At 25 ºC, the distribution of 
MB fluorescent signal was not significantly different than observed at 37 ºC, indicating 
there are no major structural changes in cells, and MB probe binding characteristics are 
similar at both temperature conditions. The results of the fluorescence signal in living 
cells at different time points of pre and post bleach sequence are shown in Figure 5.4 A. 
Results show that there is a partial recovery of the fluorescence signal in a bleached 
region of interest. This recovery process was observed to be along a directed directon 
determined by pre-bleach distribution of fluorescence in the bleached ROI. This is similar 
to the trend observed at 37 ºC even though only a partial recovery of the fluorescence 
intensity was observed at 25 ºC. The result of the fluorescence intensity versus time in a 
bleached region of interest is shown in Figure 5.4 B. Results show that the recovery is 
slower and partial (approximately 30 % of the original intensity (pre-bleach)) as 
compared with the results obtained at 37 ºC.  This result clearly indicates that the 
mobility of GAPDH mRNA is sensitive to temperature conditions. The temperature 
dependence of biological processes in general indicates that the mobility of a 
macromolecule is mediated by active cytoplasmic processes, as there is no significant 
difference in the true diffusivity of macromolecules at 37 ºC and 25 ºC conditions. Thus 
for true diffusion processes we do not expect to observe a significant change in the 
recovery characteristics at these temperature conditions. 
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31.1 s 50.8 s 
90.3 s 123.2 s 
Figure 5.4 A: FRAP analysis of the mobility of GAPDH mRNAs at 25 ºC using MB 
probes. Image based distribution of Fluorescence intensity in a pre-bleach, 
















































Figure 5.4 B: FRAP analysis of the mobility of GAPDH mRNAs at 25 ºC using MB 
probes.Average normalized fluorescence intensity in a ROI as a function of time. 
The result shows about 30% recovery of the bleached fluorescence signal, indicating 
significant reduction in mobility of the GAPDH mRNAs at 25 ºC as compared to the 
80% recovery observed in case of similar experiments at 37 ºC. The results also 
indicate that the recovery process is significantly slower at room temperature as 
compared to the control experiments at 37ºC. 
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Effect of ATP depletion on the mobility of GAPDH mRNAs in the cytoplasm 
 
 To further establish that the mobility of GAPDH mRNAs is mediated by active 
process, we decided to biochemically deplete the ATP production in living cells. The 
cells incubated with MB probes were treated with 2-de-oxyglucose and Na Azide at 5 
mM concentration respectively for 15 minutes. This concentration of de-oxyglucose has 
been used in other studies for depletion of ATP ([12, 14]). Depletion of ATP has some 
effect on the distribution of GAPDH mRNAs in the cytoplasm. These changes are more 
prominent as compared to the changes in distribution of fluorescent signal, when cells 
were incubated at room temperature. This is likely as depletion of ATP results in change 
of mitochondrial distribution, inhibits motor driven transport and effect wide range of 
other cytoplasmic cellular processes etc.  Thus both the concentration of above 
chemicals and the incubation time were optimized to control significant changes in the 
distribution of fluorescent signal. The treated cells were studied using FRAP under the 
same experimental conditions as in Figure 5.1. These experiments were carried out at 
37 ºC.  The results of the study are shown in Figure 5.5.  Figure 5.5 A shows a time 
course of the fluorescence signal in a defined region of interest during a FRAP 
experiment. The result shows a recovery trend very similar to the trend observed in case 
of 25 ºC (Figure 5.4). The bleached area shows a partial recovery of the fluorescence 
signal, similar to the study at 25 ºC.  The plot of the average integrated fluorescence 
intensity in a region of interest versus time is shown in Figure 5.5 B. The plot shows a 
partial recovery of about 25 % after bleaching. The recovery kinetics are slower as 
compared to 37 ºC case and are similar to the trend observed for the FRAP study at 25 
ºC. Thus the results in Figure 5.4 and Figure 5.5, together clearly indicate that active 
transport processes are responsible for the mobility of GAPDH mRNAs in the cytoplasm 




        
 
        
 









37.4 s 69.9 s 
116.6 s 151.1 s 
Figure 5.5 A: FRAP analysis of the mobility of GAPDH mRNAs at 37 ºC with 
depletion of ATP by treatment with 2-de-oxyglucose and Na Azide for 15 minutes 
A. Distribution of Fluorescence intensity in a pre-bleach, immediately after 
bleaching and post bleach recovery for a GAPDH mRNAs in HDF cells 

























































Figure 5.5 B: FRAP analysis of the mobility of GAPDH mRNAs at 37 ºC with 
depletion of ATP by treatment with 2-de-oxyglucose and Na Azide at 5 mM 
concentration for 15 minutes 
Average normalized fluorescence intensity in a ROI as a function of time. The result 
shows about 25% recovery of the bleached fluorescence signal, indicating significant 
reduction in mobility of the GAPDH mRNAs with ATP depletion as compared with the 
control experiments at 37 ºC. The results also indicates that the recovery process is 
significantly slower with ATP depletion as compared with the control experiments at 
37 ºC 
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Effect of Microtubule network on the mobility of GAPDH mRNAs 
 
  To further understand, if these active processes are related to cytoskeleton 
network, we next studied the role of microtubule in the mobility of GAPDH mRNAs. As a 
first approach, we have used nocodazole, which is an anti-neoplastic agent and exerts 
its effect by de-polymerizing microtubules.  For initial experiments we used nocodazole 
at a concentration of 30 µm and incubation time period of 60 minutes. This concentration 
range was selected based on several studies, which have used this drug to study the 
role of microtubule network in various cytoplasmic processes ([24, 25]). This 
concentration of nocodazole resulted in dramatic changes in the distribution of MB probe 
signal in the cytoplasm of living cells (discussed in Chapter 3). The resultant MB signal 
after treatment was peri-nuclear, thus suggesting that the disruption of a microtubule 
network has a significant effect on the distribution of GAPDH mRNAs in the cytoplasm. 
This resuly indicates the role of microtubule in the localization of mRNAs in the 
cytoplasm, even though this treatment was too invasive to study the effect of 
microtubules on the mobility of mRNAs.  
 To reduce the invasiveness of nocodazole treatment, we lowered the 
concentration of nocodazole to 2 µM for an incubation time of 30 minutes. The cells after 
treatment were studied using FRAP to measure the mobility of GAPDH mRNAs. The 
results of this study are shown in Figure 5.6. Figure 5.6 A shows the time series of a 
fluorescence signal in pre and post bleach sequence. The results indicate that the 
recovery process after bleaching is more random as compared to the directed recovery 
(i.e., without significant changes in the shape of a fluorescent signal after bleaching and 
recovery in a region of interest) observed in earlier FRAP conditions (Figure 5.2-5.5). 
Thus microtubule appears to play a role in a directed recovery process. The result of the 
integrated average fluorescence intensity in a region of interest versus time is shown in 
Figure 5.6 B. This result is also directly compared with a control result (Figure 5.2 B) 
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obtained under same experimental conditions without nocodazole. The plot clearly 
indicates a partial recovery (about 45 %) of the fluorescence intensity in a bleach area 
with a slower kinetics as compared with a control case at 37 ºC. This result provides a 
direct observation of changes in the mobility of GAPDH mRNAs in the cytoplasm upon 
treatment with a microtubule-depolymerizing drug.   
 Further to study the role of microtubules in the mobility of GAPDH mRNAs, we 
decided to perturb the microtubule network with taxol. Taxol causes a significant re-
organization of microtubule network by catalyzing the assembly of microtubules from the 
sites other than microtubule organization center.  This assembly leads to stabilization of 
microtubule network. It has been reported ([26]) that taxol reduces the transport 
frequency as well as the speed of transport of cargo along the microtubules. To test the 
effect of taxol on the mobility of GAPDH mRNAs, HDF cells with MBs were treated with 
10 µm of taxol for a time interval of 30 minutes.  
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Figure 5.6 A: FRAP analysis of the mobility of GAPDH mRNAs at 37 ºC with 
perturbation of microtubule network by treatment with Nocodazole  
Distribution of Fluorescence intensity in a pre-bleach, immediately after bleaching 
and post bleach recovery for a GAPDH mRNAs in HDF cells with depolymerization 
















































Figure 5.6 B: FRAP analysis of the mobility of GAPDH mRNAs at 37 ºC with 
perturbation of microtubule network by treatment with 2 µM concentration of 
Nocodazole for 30 minutes 
Average normalized fluorescence intensity in a ROI as a function of time. The result 
shows about 25% recovery of the bleached fluorescence signal, indicating significant 
reduction in mobility of the GAPDH mRNAs with nocodazole treatment as compared 
with the control experiments at 37 ºC. The results also indicates that the recovery 
process is significantly slower with nocodazole treatment as compared with the 
control experiments at 37 ºC 
Figure 5.6 B 
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The representative result of a FRAP analysis for the mobility of GAPDH mRNAs in taxol 
treated cells is shown in Figure 5.7. Figure 5.7 A shows the time course of the 
fluorescence signal in pre and post bleach images. The results show a partial recovery 
of the fluorescent signal in a bleach region of interest as compared with the pre-bleach 
signal. This trend is similar to the trend observed with nocodazole. Unlike nocodazole, 
the signal recovery is still along a directed path (reference with pre-bleach signal 
morphology) as compared to more diffuse recovery with nocodazole. This clearly 
suggests that by stabilizing microtubules, we have reduced the randomness in the 
recovery of a fluorescent signal in a region of interest, although only partial recovery was 
observed, similar to the case of a nocodazole treatment. The plot of the integrated 
fluorescence signal in a region of interest versus time is shown in Figure 5.7 B. The 
results indicate that in comparison with control cells, the taxol treatment reduces the rate 
and extent of recovery (~45% recovery of the initial level of fluorescence intensity) of the 
fluorescent intensity in a bleached area of interest. These results taken together clearly 
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Figure 5.7: FRAP analysis of the mobility of GAPDH mRNAs at 37 ºC with 
perturbation of microtubule network by treatment with 10 µM concentration of Taxol 
for 30 minutes 
A) Image based distribution of Fluorescence intensity in a pre-bleach, 
immediately after bleaching and post bleach recovery for a GAPDH mRNAs in 
HDF cells with taxol treatment. The results indicate a partial directed recovery 
of the fluorescence intensity in a region of interest marked with a white circle.  
B) Average normalized fluorescence intensity in a ROI as a function of time. The 
result shows about 25% recovery of the bleached fluorescence signal, 
indicating significant reduction in mobility of the GAPDH mRNAs with taxol 
treatment as compared with the control experiments at 37 ºC. The results also 
indicates that the recovery process is significantly slower with taxol treatment 
as compared with the control experiments at 37 ºC 
 170
Mobility of 28-s rRNA in the cytoplasm of living cells 
 
Further a question remains, if what we have observed for the case of GAPDH 
mRNAs is representative of various RNA molecules in the cytoplasm of living cells. To 
make the study more generic to various class of RNAs, we selected to study the mobility 
of 28-s rRNA. 28-s rRNA was selected as a candidate RNA for this study, as it has a 
known localization (associated with ER membrane) in the cytoplasm of living cells and is 
a part of most abundant class of RNAs (ribosomal RNAs) in the cytoplasm. Transport of 
ribosomal complex in the nucleus has been studied using oligonucleotide probes 
targeted to 28-s rRNA in combination with a FRAP based assay ([23]). In this study, we 
have targeted the 28-s rRNA in the cytoplasm of cells. The study was carried out to 
study the effect of temperature and ATP depletion on the mobility of 28-s rRNA in the 
cytoplasm. The MB probe signal for 28-s rRNA has a peri-nuclear distribution, co-
localized with the ER membrane in the cytoplasm (Chapter 3).  
The results of the FRAP study to measure the mobility of 28-s rRNA in a 
cytoplasm are shown in Figure 5.8. Figure 5.8 A shows a representative time series of 
a fluorescent signal in a bleached region of interest (pre and post bleach) in the 
cytoplasm of living cells at 37 ºC. The results show a significantly limited recovery of the 
fluorescence intensity in a bleached region of interest. This trend is significantly different 
from the recovery trend observed for GAPDH mRNAs. To further understand the 
differences in the mobility of 28-s rRNA, we decided to compare the recovery trend at 25 
°C with that observed at 37 ºC. Figure 5.8 B shows the time series of the pre and post 
bleach fluorescent signal intensity in a region of interest. The results indicate only a 
partial recovery as observed at 37 ºC in Figure 5.8 A. The normalized integrated 
fluorescence intensity for the 28-s rRNA at 37 ºC and 25 ºC are shown in Figure 5.8 C. 
The results show only a partial recovery (approximately 25 %) of the fluorescence 
intensity. The lack of effect of temperature on the mobility of 28-s rRNA suggests that 
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passive processes in living cells mediate the movement of 28-s rRNA.  The extent and 
rate of recovery observed in this case are significantly different from the trend observed 
for GAPDH mRNAs. These results in Figure 5.8 and Figure 5.2, strongly suggests that 
different RNA molecules in the cytoplasm can have large differences in their mobility. 
These differences could be due to differences in associations in the cytoplasm of living 
cells. It is likely that mRNAs associated with cytoskeleton elements/ motors through 
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45.8 s 87.6 s 
108.5 s 128.3 s 
Figure 5.8 A: FRAP analysis of the mobility of 28-s rRNA at 37ºC using MB probes 
Image based distribution of Fluorescence intensity in a pre-bleach, immediately after 





Figure 5.8 B: FRAP analysis of the mobility of 28-s rRNA at 25ºC using MB probes 
Image based distribution of Fluorescence intensity in a pre-bleach, immediately after 
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Figure 5.8 C: FRAP analysis of the mobility of 28-s rRNA at 37ºC and 25 ºC using 
MB probes. 
C. Average normalized fluorescence intensity in a ROI as a function of time. 
The result shows about 20% recovery of the bleached fluorescence signal at 
37 and 25 ºC, indicating a reduced mobility of 28-s rRNA in living cells. 
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Calculation of apparent diffusion coefficients 
 
 To quantitatively compare the above results, we calculated the apparent diffusion 
coefficients. These coefficients can provide us a quantitative measure of the differences 
in the mobility of mRNAs under different experimental conditions. The average data 
obtained under each experimental condition was fitted to the analytical solution of a 2-d 









Here I0, I1 are modified Bessel functions, B sets the fluorescence directly after the 
photobleaching and summation of A+B determines the saturation value of the recovery. 
From this equation we obtained the value of T, which is a characteristic recovery time for 
the diffusion equation. This characteristic time is analogous to half-life (T 1/2) time 
constant of a first order kinetics. The aim of this analysis is to provide a quantitative 
measure of the mobility of RNAs in living cells. We realize that there are multiple 
moieties (binding to multiple proteins, membranes, transport etc.) involved in the 
regulation of this process and this analysis is a first order approximation of this complex 
process.  Thus the overall aim is not to model the process but to simulate the dynamics 
using a simplified analysis as outlined above.  
From the fits, we obtained a characteristic time, which was further used to 





exp =  
The calculated apparent diffusion coefficients are shown in Table 5.2. We also 
calculated the ratio of the diffusion coefficients with various treatments as discussed in 
above sections. The results indicate that the diffusion coefficient for GAPDH mRNAs 
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ranged from 0.052-0.03 µm2/s. This range is in agreement with the range of diffusivity 
values obtained by ([12, 14]) in the nucleus by targeting poly A mRNAs or by studying an 
engineered RNA molecules with multiple fluorescent proteins attached to it. Further 
these results are in agreement with the single particle diffusion measurements for RNAs 
in the cytoplasm by ([28]). Ratio of the diffusion coefficients under different treatment is 
in the range of 1.6-1.8, indicating a significant role played by ATP and microtubule 
network in the mobility of GAPDH mRNAs. Further the ratios of change in the apparent 
diffusivity in the cytoplasm with a change in temperature or depletion of ATP are in 
agreement with the results obtained by ([12, 14]). 
 
 






GAPDH-37 ºC 10.69 0.0512  
GAPDH-25 ºC 18.1 0.0309 1.68 
GAPDH-ATP Depleted 18.43 0.0302 1.72 
GAPDH-Taxol 20.1 0.0278 1.87 










In this chapter, we have studied the mobility of RNA molecules in the cytoplasm 
of living cells. We have extended our MB based detection and imaging approaches to 
fundamental biophysical studies to address questions related to dynamics of RNAs in 
living cells. The results of this study highlighted that different RNAs can have 
significantly different dynamics in the cytoplasm. Using FRAP based method, we 
established that the mobility of GAPDH is mediated by active cellular processes which 
requires ATP and microtubule cytoskeleton.  The recovery process after bleaching was 
along a directed path, which provided a further evidence to support our claims for active 
transport process in a cytoplasm. Using a nocodazole-based depolymerization of 
microtubule network, we reduced the directed recovery process in the bleached area.  
On the contrary using Taxol, we only observed a reduction in the extent of recovery but 
no significant changes in the overall shape of recovered signal compared with pre-
bleach distribution. This trend clearly suggests significant role of the microtubules in 
mediating the mobility of RNAs.  
In contrast with GAPDH studies, 28-s rRNAs have a significantly different 
dynamics. These ribosomal RNAs are not highly mobile in the cytoplasm of living cells. 
These differences could be inherently due to different localization in the cytoplasm. We 
need to still resolve the relationship between these differences in dynamics and the 
functional aspects of RNAs in the cytoplasm. To achieve this we clearly need to develop 
and combine multiple strategies to understand these processes. We believe that this 
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In this study, we were interested in developing an imaging approach, which can 
allow for highly specific detection of RNA molecules and simultaneously imaging of 
multiple RNAs in nuclei of living cells.  In order to achieve this goal, we have developed 
a bi-functional oligonucleotide probe that combines peptide-based delivery to nuclear 
compartment with molecular beacon based detection of RNA in nuclei of living cells.  
Imaging of RNAs in the nuclei can provide essential information regarding their 
organization, dynamics and can address basic questions related to transcription, 
processing of pre-mRNA, splicing and transport of RNPs from the nucleus to the 
cytoplasm.  
Approaches to image RNA in living cells have provided new insights into 
localization and dynamics of RNA in context with sub-cellular organization of these 
macromolecules ([1],[2, 3],[4],[5]). These developments have transformed the world of 
static FISH based studies, and enabled the study of RNA dynamics and function in living 
cells. In this area of live cell imaging of RNA, there are two recently developed 
complementary technologies, which have advanced this area significantly.  
One of these technologies is based on using a transgenic system where the 
fusion protein, GFP-MS2, is used to track the localization and the dynamics of RNA in 
living cells ([1, 6]). For this approach, two engineered plasmids are transfected, one 
containing a cassette expressing GFP-MS2 (MS2 is a Phage protein) and a second 
plasmid with a cassette expressing a RNA with MS2 binding sequences, engineered to 
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bind multiple MS2-GFP proteins (i.e. 20-25 MS2-GFP proteins on single RNA). This 
technique though very powerful in tracking RNA molecules with single molecule 
sensitivity, still lacks the ability to image endogenous RNAs. Further this approach may 
not be optimal for imaging small RNAs as linking multiple MS2-GFP fusion sites may 
perturb the structure and hence the function of these RNA molecules.  
The other complementary approach is aimed at imaging endogenous RNA in live 
cells. This approach has a clear advantage as it can allow for the study of basic RNA 
biology in living cells. In this approach, exogenous probes with sequences 
complementary to RNA targets are introduced into living cells. Among this class of 
probes, molecular beacons (MB) are among the most promising probe technology.  
These probes are described in Chapter 1 and 2. 
In our previous studies [2, 3] we have shown that using these probes we can 
image and detect endogenous RNA in the cytoplasm of living cells. Similarly, studies by 
[4, 7]., have used MB probes for imaging of RNA localization in embryos during 
development and in living cells. In addition to MB approach, studies have been done by 
introducing labeled RNA in living cells ([8]) or by using linear probes to study RNA in the 
nuclei and the cytoplasm of living cells respectively ([8-10]). One of the major challenges 
in using linear probes is distinguishing a background signal from a true signal.  By 
controlling probe affinity, concentration, and by utilizing FRET between two linear probes 
targeted to the same RNA, and studying highly localized RNAs, some of those 
challenges may be resolved. Further, in using exogenous probes, one of the major 
challenges is in the delivery of probes to the specific compartments of living cells. In 
previous studies ([7, 9-12]) probes are introduced into living cells by microinjection. 
Following microinjection of oligonucleotide probes into cytoplasm, it has been reported 
that most probes (including molecular beacons) are sequestered in the nucleus of living 
cells and often results in non-specific signal ([7]). Further, microinjection process is a 
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highly invasive and is typically limited to few cells. In this study we have developed an 
alternative approach, in which we utilize the active transport of MB probes from the 
cytoplasm to the nucleus. To achieve this, we have developed a peptide-linked 
molecular beacon approach in which, a single NLS (Nuclear Localization Sequence) 
peptide is chemically linked to the molecular beacon to form a bifunctional nanoprobe. 
Since NLS sequence does not have a membrane translocation function, the probes are 
introduced into cytoplasm by using a reversible membrane permeablizing agent SLO 
(Streptolysin O). SLO makes approximately 20-25 nm reversible pores in the cholesterol 
rich regions of plasma membrane. Using the combined approaches of NLS and SLO 
mediated delivery we have demonstrated that probes delivered to the nucleus retain 
high signal-to-noise ratio and specificity. The major motivation for this study is to develop 
a multifunctional MB based toolbox to study RNA biology in the nuclear compartment of 
cell, to allow for detection and study of viral replication in the nucleus and in combination 
with our previous work ([2]), this method can provide an integrated picture of RNA 
distribution in both nucleus and cytoplasm of living cells.  
In this study, we have chosen to study small nuclear RNP’s (U1 and U2 snRNPs) 
and small nucleolar RNP (U3 snoRNP) as target RNAs for imaging using this bi-
functional MB probes. U1 and U2 snRNPs are the key members of the splicing complex 
called spliceosome, a complex composed of multiple small RNAs and proteins. This 
complex is responsible for the splicing of nuclear pre-mRNA [13, 14]. Most of the 
information regarding function and organization of the splicing complexes has been 
developed using biochemical studies based on in vitro assembly of proteins and snRNPs 
in nuclear extracts and using in situ hybridization in fixed cells. To understand the 
function of this splicing process in vivo, there is a clear need to detect and image these 
small RNAs in living cells. U3 snoRNP is one of the best characterized small nucleolar 
RNP involved in biogenesis of ribosomes [15, 16]. This RNP is involved in 
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endonucleolytic cleave events of various pre-rRNA that leads to generation of 18-s pre-
RNA. Since these small nuclear RNAs have been previously studied  ([13, 14, 16-21]) 
using in situ hybridization technique in fixed cells, the results in our study are directly 
compared with the fixed cell studies to validate our observations in living cells. 
For delivery of MBs in nuclei of living cells, we have used a combination of SLO 
based passive delivery of probes to cytoplasm along with NLS mediated transport of 
probes from the cytoplasm to the nucleus of cells. NLS sequence selected in this study 
is based on the SV40 NLS domain [22, 23] . The sequence and design of peptide-linked 
MB are shown in Figure 6.1. After SLO based delivery of probes to the cytoplasm, the 
single NLS peptide-linked with MB probe was effective in delivering the probes to nuclei 
of living cells.  
Material and Methods 
 
Molecular beacon probes (as shown in Table 6.1) with modification in the stem region 
(dT- NH2 on the quencher side) were synthesized by MWG Biotech, NC and Biosearch 
Corp, CA. Molecular beacons were designed with regular DNA chemistry (De-oxy 
ribonucleotide backbone). The probes were purified using double HPLC. Probes for U1, 
U2 snRNPs and U3 snoRNPs were designed with Cy3 fluorophore and BHQ-II quencher 
pair. U1 snRNP probe was also designed with Cy5 fluorophore and BHQ-III quencher. In 
all MB designs, quencher end was the 3’ end, while a fluorescent dye was conjugated to 
the 5- end of MB.   
Peptides 
 
 SynPep Inc synthesized the NLS peptide (99% purity) as shown in Table 6.1. 
The peptide sequence was modified at its carboxy terminus to introduce cysteine 
residue. The spacer (Ahx) equivalent to length of 1 amino acid was introduced between 




 All experiments in this study were carried out using HeLa cells. This cell line has 
been used in several nuclear transport studies ([22]) and also in study of various 
snRNPs in fixed cells [13, 14]. HeLa cells were cultured using Dulbecco’s modified 
Eagle's medium + fetal calf serum (10%) + horse serum (2.5 %). HeLa cells were plated 
in T-25 (cell culture flask) using 1:10 dilution after each splitting cycle. A batch of HeLa 
cells was cultured only for about 10 splitting cycles.  For imaging experiments, cells were 




All chemicals (1X and 10 X PBS, TCEP, Streptolysin O (SLO), DMSO) except 
bio-conjugation reagents (bi-functional crosslinker) used in this study were bought from 
Sigma Aldrich Corp. The bio-conjugation reagent sulfo-SMCC was purchased from 
Pierce Biotech Corp.  
Peptide Conjugation  
 
In the direct linkage approach shown in Figures 6.1, a molecular beacon was 
modified at the same nucleotide position on the quencher-arm using modified nucleotide 
dT-amine group with a 6-carbon spacer.  To generate stable linkages using a chemical 
bridge between a peptide and a molecular beacon, the NLS peptide was modified with a 
cysteine group at its C terminus. Amine modified molecular beacon on the beacon was 
reacted with a heterofunctional crosslinker sulfo-SMCC (Pierce Biotech) for a period of 3 
hours at room temperature with intermediate shaking. The reaction was carried out with 
1x (2 um) molecular beacon and 20x (40 um) sulfo-SMCC in PBS buffer. After 3 hours, 
the excess of sulfo-SMCC was removed from the reaction mixture using centrifugal filter 
(YM-10) with a cut off of 10 kDa. The resultant solution was brought to same initial 
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volume by adding PBS and reacted with 2x (4 um) concentration of Cys modified NLS 
peptide for overnight at room temperature. Following this reaction, peptide linked 
molecular beacon complex was dialyzed overnight using Slide-A-Lyzer Dialysis Unit, 
10K MWCO (Pierce Biotech Inc., Rockford, IL) to remove unconjugated peptide.  To 
significantly reduce the probability of forming beacon-beacon conjugates, a higher (2x) 
concentration of peptides was used compared with that of beacons.  Further, the positive 
charged peptides helped prevent the formation of a disulfide bridge between two 
peptides.  
Solution assay to measure the signal-to-background ratio of modified and 
unmodified Molecular Beacons 
  Measurement of signal-to-background ratio of peptide linked molecular beacons 
and unmodified beacons were carried out using a SAFIRE microplate monochromator 
reader (TECAN, Austria).  To determine the signal-to-background ratios, 200 nM 
conventional and peptide-linked molecular beacons were mixed with 200 nM of 
complementary target respectively in the microplate reader, and the fluorescence 
intensity at equilibrium (10 minute incubation time) was recorded.  The fluorescence 
signal of each molecular beacon type (conventional and peptide-linked) in the absence 
of target was recorded as background signal.  
 
 
Cellular delivery of peptide-linked Molecular Beacons 
  
For cellular delivery of peptide-linked molecular beacons, experiments were 
carried out using HeLa cells (ATCC, VA). For imaging experiments cells were cultured in 
a 4 or 8-well Nalge Nunc culture plate with a glass coverslip bottom in their respective 
cell culture media (as described above) for 24 hours before the experiment.  For 
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delivery, cells were treated with activated streptolysin O (SLO) for a period of 10 minutes 
as described in [3], peptide-linked molecular beacons were mixed (1 µm concentration) 
with activated solution of streptolysin O in serum free media and incubated with the 
specific cells at 37oC for 10 minute period. After this incubation period, the medium was 
changed to regular serum rich media. The cells were incubated for a period of 1 hour 
following this change in medium. Following 1 hour of incubation, cells were imaged live 
using confocal microscope (Axiovert LSM-100, Zeiss). For detection and imaging of 
localization of U1, U2 snRNPs and U3 snoRNP we used laser excitation at 543 nm with 
emission detection using a band pass filter from 560-610 nm. For imaging co-localization 
of U1 and U2 snRNPs we used both 543 nm and 640 nm laser excitation. The signal 
was detected using band pass filter from 560-610 nm for Cy3 signal detection and long 
pass filter from 660 nm for Cy5 signal detection. 
Fixed cell studies 
 
 HeLa cells were cultured in 8-well chambered coverslides for 24 hours in normal 
growth medium (FGM-2 Cambrex Co.) and then washed with 1x PBS (without Ca or 
Mg).  The slide was fixed in 4% paraformaldehyde buffer with 10% acetic acid for 10 
minutes.  After removing the fixative, the slides were incubated overnight with 70% 
ethanol at 4 °C to improve the permeability of fixed cells.  In-situ hybridization assays 
were then performed by first washing the slides for 5 minutes in 1x PBS and hybridizing 
them overnight at 37oC in 1x PBS (no Ca or Mg) containing 100 nM of MB probes 
targeting U1, U2 snRNAs and U3 snoRNAs along with RNAse free BSA as 
recommended in protocol by Singer lab.  After removing the hybridization solution with 
washing and adding 1x PBS, the cells were imaged. 
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Results and Discussion 
 
Design of peptide linked MB 
   
In this study we have designed and synthesized the peptide-linked molecular 
beacons for targeting U1, U2 snRNPs and U3 snoRNPs, as well as a molecular beacons 
with a ‘random’ probe sequence.  The specific oligonucleotide sequences of these MBs 
and the sequence of NLS peptide are shown in Table 6.1. The design of these probes to 
target the segments of RNPs in nuclei of living cells are based on previous in-situ 
studies in fixed cells with linear oligonucleotide targets [13, 14, 17, 19]. Since linear 
oligonucleotide probes used in previous FISH studies were able to access the target in 
fixed cells, the same target sequences were used to generate loop domains for design of 
MBs. To achieve a stable hairpin structure (MBs structure) and appropriate melting 
temperature (based on Mfold predictions), the stem domains (complementary base 
paired regions at 3’ and 5’ ends of the probe) were added to the linear oligonucleotide 
sequences. These regions are underlined in Table 6.1. The ‘random’ beacon was 
designed as a negative control, with a 17-base probe sequence that does not have any 
match in the mammalian genome [2]. The probes used in this study are of DNA 
chemistry (Deoxy-nucleotide backbone).  The dye and quencher pairs (Cy3-BHQ-II and 
Cy5-BHQ-III) were selected to ensure effective quenching of the probes in their 
unhybridized state (hairpin shape).  
The conjugation approach was developed to link MBs with an NLS sequence as 
shown in Figure 6.1. The MBs were modified in the stem domain on the quencher arm, 
to introduce a functional group, a dT-(c6)-NH2. The details of the conjugation chemistry 
and the purification are discussed in the material and methods section. This design is 
similar to the approach developed in our previous study ([2]).  
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Table 6.1: The design of NLS peptide-linked molecular beacons
U3 snoRNA Molecular Beacon (5’-3’) 
Cy3-CGACCGGCTTCACGCTCAGGGG(dT-C6-NH2)CG-BHQ2 
U1 snRNA Molecular Beacon (5’-3’) 
Cy3-GCAGCCTGCCAGGTAAGTATGC(dT-C6-NH2)GC-BHQ2 
U2 snRNA Molecular Beacon (5’-3’) 
Cy3-CGAGCACAGATACTACACTTGGC(dT-C6-NH2)CG-BHQ2 














Figure 6.1: Shows a schematic design of a peptide linked Molecular beacon and its 
delivery into the nucleus of living cells. The NLS peptide is covalently linked to the MB 
using a modified (dT- C6-NH2 ) at the third base from the 3’ end on its quencher arm. 
The NLS linked MBs are delivered into cytoplasm of living cells using a reversible 
membrane permeablization agent Streptolysin O (SLO). Following the delivery of probe 
into the cytoplasm, the NLS peptide actively transport the MB-peptide complex to the 





Signal-to-Noise ratio of peptide-linked molecular beacons  
  
To determine the possible effect of peptide conjugation on the function of MB 
probes, in-solution hybridization assays were carried out to compare the S/N ratio 
(signal-noise ratio) of the peptide-linked molecular beacons with unmodified beacons. 
When the positively-charged NLS peptide is conjugated to a molecular beacon, the 
electrostatic interactions of the peptide with the negatively-charged hairpin, 
oligonucleotide backbone may interfere with the probe-target (RNA) binding. As shown 
in (Figure 6.2) there is no significant change in the S/N ratio for each MB probe design 
after modification with an NLS peptide. This result is in agreement with our earlier results 
with Tat peptide-linked MBs for cytoplasmic delivery ([2].) 
 
Imaging of U3 snoRNP, U1 and U2 snRNPs in the nucleus of living cells using 
multifunctional probes  
 
To demonstrate the delivery of peptide linked MBs, specific detection and 
imaging of an endogenous RNA in the nuclei of living cells, we have targeted the small 
nucleolar RNA (U3 snoRNA) and small nuclear RNAs (U1 and U2 snRNAs) in nucleus of 
living cells. NLS- linked MB probes targeted to respective RNAs were introduced into 
cytoplasm by using Streptolysin O (SLO) based reversible permeablization. The result 
for the detection of U3 snoRNP in the nucleus of a living cell is shown in Figure 6.3 A.  
The result shows a very discrete localization of signal in the nucleus of living cell with no 
detectable signal in the cytoplasm. The localized signal was detected in the nucleolus 
and discrete peri-nucleolar foci. The results obtained for U3 snoRNA imaging are in 








Figure 6.2: Signal –to-noise ratio of the NLS linked Molecular Beacons and the 
unmodified molecular beacons. The NLS linked MBs and the unmodified MBs were 
hybridized with complementary oligonucleotide targets (2 x concentration) at room 
temperature for 5 minutes. In addition the control wells had MB probes without any 
oligonucleotide target. MBs hybridized with the complementary target provided the 
numerical value of the signal intensity and the MBs without ant target provided the 
background noise from these probes. The ratio of the signal to noise for the three MB 
probes with and without modification are shown in the plot. The plot shows no significant 
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Figure 6.3: Imaging of U3 snoRNA, U1 and U2 snRNAs in the nucleus of living cells 
using NLS linked MB probes respectively. 
(A): Imaging of U3 snoRNA in the nucleus of a living cell using the NLS –linked MB’s. 
Most of the MB signal was obtained in the nucleolar and discrete peri-nucleolar region in 
the nucleus, with no signal in the cytoplasm. 
 (B): Imaging of U1 snRNAs in the nucleus of a living cell using NLS-linked MB’s. The 
result shows MB signal in the nucleoplasm of a living cell excluding the nucleolus. The 
localized foci of U1 snRNPs are widely distributed in the nucleoplasm, with few foci at 
discrete peri-nucleolar regions.  
 (C): Imaging of U2 snRNAs in the nucleus of a living cell using NLS-linked MB’s. The 
result shows MB signal at discrete foci in the nucleoplasm of living cells. The overall 
signal of U2 snRNAs is significantly lower than the signal obtained from U1 snRNAs. In 
addition few discrete foci were also observed in the peri-nuclear region of the cytoplasm, 





These studies have shown U3 snoRNA to be localized in the nucleolus and in certain 
cases associated with cajal bodies. U3 snoRNA is processed in cajal bodies prior to its 
transport and localization to nucleolus. Furthermore, we have observed a heterogeneous 
localization (punctate pattern) of U3 snoRNA in some nucleoli and a uniform 
fluorescence pattern in others. This observation is in agreement with the results obtained 
by ([18]).   
The result of detection and imaging of U1 snRNPs using NLS peptide-linked MBs 
is shown in Figure 6.3 B. The result shows a discrete localization of U1 snRNPs in the 
nucleoplasm of HeLa cells clearly excluding the nucleolus. The localized foci of U1 
snRNPs are widely distributed in the nucleoplasm, with few foci at discrete peri-nucleolar 
regions. This widespread localization of U1 snRNPs in the nucleoplasm is in agreement 
with previous studies. ([13, 14, 17, 20]). These studies have shown U1 snRNPs to be 
associated with both cajal bodies (processing of U1 snRNP after its import from 
cytoplasm) and speckles (site of assembly of splicing complex) sites in fixed cells. In 
addition to widespread nucleoplasmic localization, we also observed a localized signal at 
discrete spots in the cytoplasmic, peri-nuclear region. This signal indicates the fraction of 
U1 snRNPs in the cytoplasm. In the case of U1 and other snRNPs (excluding U6), they 
are exported from nucleus to the cytoplasm for assembly of snRNP complexes and 
processing of their 5’ cap.  After which, they are imported back into the nucleus, and are 
believed to be further processed in cajal bodies before being transported to speckle sites 
([25]). Detection of both populations (nuclear and cytoplasmic) of U1 snRNPs suggests 
high sensitivity of this approach. 
The result of detection and imaging of U2 snRNPs is shown in Figure 6.3C. The 
result shows localization at discrete foci in the nucleoplasm, excluding the nucleoli. In 
contrast to widespread localization of U1 snRNP’s in the nucleoplasm, U2 snRNP has a 
few discrete foci in the nucleus. This observation validates the result that the U2 snRNAs 
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are less abundant than the U1 snRNAs (Dreyfus et al, 2002). Further the localization 
pattern in this result is in agreement with previous studies ([13, 14, 19, 21]). In addition, 
a discrete signal was also observed in the peri-nuclear region of the cytoplasm. The U2 
snRNPs, similar to the U1 snRNPs, are also exported to the cytoplasm for processing.  
These results demonstrate that single NLS peptide-linked MB probes are 
transported from cytoplasm to the nucleus. To highlight high specificity of these probes 
in nuclei of living cells, we have shown the detection of snoRNAs and snRNAs with 
different distributions (nucleoplasm vs nucleolus) in the nucleus and the difference in 
transcription levels (U1 snRNA > U2 snRNA) of these RNPs.  Furthermore, based on 
single-probe based approach, we cannot absolutely conclude whether U2 snRNP/ U1 
snRNPs are restricted to cajal bodies, or the pattern observed represents both cajal 
bodies and speckle sites. In live cell imaging studies, this will require us to 
simultaneously label some of the proteins in the speckle domains such as SF2/ASF 
([26]). The combination of fusion proteins with an exogenous probe can provide valuable 
insight into dynamics and function of RNAs in living cells. Future studies will be designed 
to address some of the issues in this direction. 
In-situ hybridization in fixed cells  
 
To validate observations in live cell studies (Figure 6.3), we carried out in-situ 
hybridization in fixed cells. The cells were fixed and permeablized according to the 
protocol described in the Material and Methods section. The results for the detection of 
the U3 snoRNAs in fixed samples are shown in Figure 6.4 A. The results clearly show 
localization of U3 snoRNAs in the nucleoli, similar to the results in live cells. The results 
for the detection of U1 snRNAs and U2 snRNAs are shown in Figure 6.4 B and 6.4 C 
respectively. The results clearly show localization of both these snRNAs in the 
nucleoplasm excluding the nucleolus. Further U1 snRNAs are more wide spread in the 
nucleoplasm as compared to few discrete foci in the case of U2 snRNAs. These 
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observations are in agreement with the results obtained in live cell studies. Further in 
fixed cells, we could not detect any localized signal of these snRNAs in the cytoplasm as 
was observed for live cells studies. This could be due to loss of RNAs during fixation and 
washing processes or due to lack of accessibility of target sequences. In conclusion, the 









Figure 6.4: Fluorescent in situ hybridization (FISH) to image the U3 snoRNA, U1 and U2 
snRNAs in the nucleus of fixed cells. Cells were fixed using the protocol from Singer’s 
lab for a detection of RNAs in the nucleus.  
(A) In situ hybridization for U3 snoRNA 
(B) In situ hybridization for U1 snRNA 









Co-localization of U1 and U2 snRNAs in living cells 
 U1, U2 and other family members of snRNP family and other non-snRNP 
proteins form a splicing complex responsible for trans-splicing of pre-mRNA transcripts 
[17]. The assembly of this complex requires various snRNPs to come together and form 
a complex with defined structure and composition.  The assembly and working of this 
complex is till date only characterized by in vitro assembly of snRNPs and proteins [17, 
20]. There are several unknown steps involved in the assembly and working of 
spliceosome complex, e.g., it is not clear at what stage U1 and U2 snRNPs form a 
complex in living cells? To address this issue we will need a probe, which can non-
invasively detect complex formation in living cells, have an ability to multiplex, provide 
high S/N ratio and specificity in detection. As an initial step in this direction, we have 
studied the co-localization of U1-U2 snRNAs in living cells to demonstrate the ability to 
simultaneously detect multiple RNAs in the nuclei of living cells. The results of this study 
are shown in Figure 6.5 A-C. The results show clear co-localization of snRNAs at 
discrete foci in the nucleoplasm of living cells. Further the results also show a more 
widespread distribution of U1 snRNP in addition to the co-localized foci of U1-U2 
snRNAs. This result is in agreement with the earlier results (Figure 6.3 B-C). As 
mentioned earlier, we could not absolutely conclude whether the detected co-localization 
of U1-U2 snRNAs is in cajal bodies or speckles exclusively. This co-localized pattern 




Figure 6.5: Imaging of Co-localized U1 and U2 snRNAs in the nucleoplasm of living 
cells using peptide linked Molecular Beacons. 
 (A): Image shows the fluorescent signal from the U1 snRNA targeted by NLS linked MB 
in living cells.  
 (B): Image shows the fluorescent signal from the U2 snRNAs targeted by NLS linked 
MB in living cells 
 (C): The image shows the overlay of the two channels to show the co-localization of U1 
and U2 snRNAs in the nucleus of living cells. The result shows co-localization of U1 and 
U2 snRNAs at discrete foci in nucleoplasm. In addition to co-localized foci, U1 snRNAs 





To our knowledge this is the first observation of co-localization of U1-U2 snRNAs in 
living cells. The results shown in this study are in agreement with the in- situ results 
obtained in fixed cells (17).  
The question that remains to be resolved with regard to use of probes is what 
percentage of RNA population is detected with this method? This limitation can be due 
to limited accessibility of our probe to a given target in certain states, and an increased 
off-rate in certain conditions, such as when the probe is targeted to a protein-binding 
site. In this study we have observed widespread localization of U1 snRNPs and 
restricted localization of U2 snRNP in the nucleoplasm. This can potentially be true 
localization of these snRNPs or it may reflect only a fraction, which is accessible with the 
given probe. Given that we have seen similar patterns of localization in fixed and live 
cells, it is likely that we are able to access a large proportion of the population. This 
issue is a crucial factor in developing a comprehensive understanding of their 
organization and function. 
In- situ Hybridization of co-localization in fixed cells 
 To validate our observations of co-localization of U1-U2 snRNAs in living cells, 
we have performed in situ hybridization in fixed cells using probes targeted to U1 and U2 
snRNAs. The results of in situ hybridization are shown in Figure 6.6 A-C. The results 
clearly show discrete foci of co- localized U1 and U2 snRNAs. In addition to this, we also 
observed more widespread localization of U1 snRNAs in the nucleoplasm of fixed cells. 
The results obtained by in situ hybridization in fixed cells are in agreement with the 





Figure 6.6: Fluorescent in situ hybridization to validate the co-localization of U1 and U2 
snRNAs in fixed cells. The cells were fixed using the same protocol as in Figure 4.  
 (A): Detection of U1 snRNAs in fixed cells using the same MB probes as in Figure 6.5 
(A) using the same imaging conditions as in Figure 6.5(A) 
 (B): Detection of U2 snRNAs in fixed cells using the same MB probe as in Figure 6.5(B) 
using the same imaging conditions as in Figure 6.5(B) 
(C): Overlay of two channels to show the co-localization of U1 and U2 snRNAs  in the 







Control Studies in living cells 
 
 In order to determine the level of non-specific interactions of MB probes in living 
cells, we designed control studies with ‘random’ molecular beacons. These molecular 
beacons have sequences with no target in the human genome. Figures 6.7 A, shows a 
result of non-specific signal from the delivery of NLS peptide-linked ‘random’ beacon. 
The results show no detectable signal under the same imaging conditions as in case of 
Figure 6.3. This result clearly indicates that these probes delivered to cells using the 
combination of SLO and NLS peptide maintain their specificity and are stable during the 
timeframe of these studies.  
Further to prove that active transport from cytoplasm to the nucleus is necessary 
to transport significant amount of probes to the nuclei of living cells, we did a control 
study in which the probes targeted to U1 snRNAs and U3 snoRNA were delivered into 
cytoplasm using SLO without any NLS peptide conjugated to them. These snRNAs were 
selected for the control study as their expression level is higher as compared with U2 
snRNAs. Figure 6.7 B shows the result of U1 snRNAs detection using SLO delivered 
MB probe. The result shows discrete foci in the peri-nuclear region of the cytoplasm 
without any detectable signal in the nucleus.  Similarly Figure 6.7 C shows the results of 
U3 snoRNAs using the same approach as above. In this case we were not able to detect 
any significant signal either in the cytoplasm or in the nucleus of cells. This clearly 
indicates that without an NLS sequence attached to the MB probes, they are not actively 
transported to the nuclei of living cells. Since U1 snRNAs are exported from nucleus for 
their processing before being re-imported back to the nucleus, their detection in 
cytoplasm is in agreement with our earlier results, which also showed discrete foci in the 
peri-nuclear region. In case of U3 snoRNAs, which are only present in the nucleus, we 
are not able to detect any signal without attaching NLS sequence to the MB probe.  
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Figure 6.7: Negative Controls to validate the measurements made in this study. 
(A) The background signal from the delivery of a ‘random’ sequenced probe to the 
nucleus of living cells. This was designed to test the possibility of non-specific opening of 
MB beacons during the delivery to the nucleus. Result shows no significant background 
with the ‘random’ probe, which has no target in the mammalian genome. 
(B-C) The signal obtained from the delivery of the MBs with SLO without an NLS peptide 
for its active transport to the nucleus. This study was designed to demonstrate that the 
active transport is essential for delivery of MB probes to the nucleus and detection of 
target RNAs. (B): Shows the signal obtained by delivery of the MB probe without NLS 
peptide targeting U3 snoRNA in living cells. (C): Shows the signal obtained by delivery of 







 In this study, we have developed a method, which allows for direct imaging of 
endogenous RNAs in the nuclei of living cells. This approach combines a molecular 
beacon with NLS peptide, for efficient delivery of oligonucleotide probes to the nucleus. 
Using this approach, we have imaged with high specificity and sensitivity the distribution 
of small nuclear and small nucleolar RNAs. This method in combination with our 
previous study to detect RNA in the cytoplasm of living cells, allows for direct imaging of 
distribution and organization of RNA from the birth site in nucleus to its journey in the 
cytoplasm. In combination, with biophysical approaches such as FRAP/ FCS, this 
approach can allow for study of transport of RNAs from the nucleus to the cytoplasm. 
Further, in combination with labeled proteins, this approach can be used to study the 
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Development of magnetic nanoparticles based MR contrast agents  
Introduction 
 
 The integration of nanotechnology and biology is expected to produce major 
breakthroughs in medical diagnostics, therapeutics, molecular biology, and 
bioengineering ([1]; [87]). Recent advances include the development of functional 
nanoparticles (electronic, optical, or magnetic) that are covalently linked to biological 
molecules such as peptides, proteins, and nucleic acids ([88];  [89]; [90]). Due to their 
size-dependent properties and dimensional similarities to biomolecules ([91])  these 
bioconjugates are well suited as contrast agents for in-vivo magnetic resonance imaging 
(MRI) ([92]; [93]) , as luminescent dyes for cellular imaging, and as molecular beacons 
for ultrasensitive optical imaging and detection ([12];[94]; [40]). 
 In this study, we plan to develop a probe with a potential for deep tissue imaging. 
For detection in deep tissue, optical/ luminescence probes have limited applications. The 
limit is due to the inability for us to detect signal non-invasively from deep tissue sections 
using optical/ luminescence detectors. This provides a fundamental limitation of optical 
probes for studying biological processes non-invasively in deep tissue. For deep tissue 
imaging, PET, CT and MRI are leading technologies, which have been used both for 
research and clinical diagnosis.  
 With the aim, to develop a probe for imaging in deep tissue, we decided to 
develop a contrast agent for MRI application. Although contrast agents are often used in 
MRI to enhance lesion detection, typically they are not specifically targeted. For clinical 
diagnostic imaging, the most widely used contrast agent is that derived from chelates of 
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Gadolinium, a paramagnetic substance. In the presence of a paramagnetic substance, 
the relaxation properties, namely T1, T2 and T2* (1/ T2* = 1/T2 + 1/T2’, with T2’ being a 
time constant arising from magnetic field inhomogeneity) of proton nuclear spins are 
shortened to some extent. In clinical practice, the shortening of T1 is usually used as a 
basis for diagnosing disease. Another type of contrast agent is based on 
superparamagnetic iron oxides (SPIO) or superparamagnetic nanoparticles, which affect 
the relaxation times in a more significant way. Shortening of T2 relaxation times using 
magnetic nanoparticles is a used as a basis of clinical diagnostics. The currently 
approved SPIO particles for diagnostic are bulkier (larger than 50 nm), with limited ability 
to target intracellular targets. With a long term goal of developing a intracellular contrast 
agent, which can allow not only cell labeling in tissues etc but also provide disease 
specific contrast in deep tissue, we decided to develop this approach. 
 To meet the above requirement for intracellular targeting of biomolecules, for 
potential disease detection, our first major challenge was to develop functionalized 
magnetic nanoparticles with smaller coatings such that the entire complex could be of 
10-15 nm or smaller than that. After successful development of this construct our next 
goal was to achieve high efficiency intracellular delivery of these functionalized 
nanoparticles and its validation. Following the success of this, the next step has focused 
on optimization of coating design to enhance the contrast developed by this magnetic 
contrast agent. 
Specific Aims 
• Development of water soluble magnetic nanoparticles with functionalized 
surface 
• Delivery of functionalized nanoparticles in living cells 
• Optimization of the coatings design for contrast enhancement and stability 
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Super-paramagnetic iron oxide nanoparticles have a wide range of applications 
including high-density magnetic storage, catalytic and separation processes [1], 
magnetic resonance imaging [2], in vivo tracking of stem cells and tumor progression [3, 
4], cell and DNA sorting [5], drug delivery [6], and cell mechanics studies [7]. Most of 
these applications require the magnetic nanoparticles to be water-soluble, stable, and 
monodispersed. Recently, there has been a growing interest in developing 
multifunctional magnetic nanoparticle probes for intracellular molecular imaging.  One 
challenge of this application is to develop magnetic nanoparticle probes with sizes highly 
uniform and comparable to the target proteins and nuclei acids (~2-15 nm).  To facilitate 
cellular delivery and specific intracellular targeting, a probe domain and 
delivery/targeting ligands must be conjugated to the nanoparticle surface.  These 
sophisticated nanoparticle probes can be multifunctional, including self-delivery into 
deep tissue, targeting specific cell types, and generating contrast based on target-
specific clustering or other molecular switch mechanisms [8].  A critical step in 
developing such molecular probes for intracellular gene detection is to functionalize the 
nanoparticles with a biocompatible coating. 
 A variety of in situ and post-synthesis coating strategies have been developed for 
stabilization and functionalization of magnetic nanoparticles.  Post-synthesis coating 
processes include the use of monolayer ligands[9, 10], polymers [11, 12]  and silica 
coatings [13-15]. The monolayer ligand coatings rely on effective adsorption or 
chemisorption of the ligand on the surface of the nanoparticle.  These coatings tend to 
have low colloidal stability, limited flexibility for functionalization, and the tendency to 
form incomplete coatings due to residual surfactant on the surface. The polymer- and 
silica-based coating processes are difficult to control, often resulting in multilayered 
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coatings and multiple nanoparticles in the same encapsulation [14].  In situ coating 
approaches such as that with dextran [16] often lead to multilayered coatings which can 
result in a heterogeneous size distribution.  In situ synthesis conditions also limit the 
variety of functionalization that can be achieved.  
 Here we report the development of functionalized magnetic nanoparticles for 
intracellular delivery that are water-soluble, monodispersed, biocompatible, and easily 
adaptable for multifunctional bioconjugation of probes and ligands.  This is a part of our 
effort to develop an MRI contrast agent for intracellular measurements of gene 
expression in deep tissue.  In this approach, superparamagnetic iron oxide nanoparticles 
(MIONs) are encapsulated in a PEG-modified phospholipid micelle structure [17-19] 
(Figure 7.1).  A similar encapsulation strategy has been used for various hydrophobic 
drug molecules [18, 20] and more recently, quantum dots [21].  This approach exploits 
the hydrophobic nature of the nanoparticle surface by utilizing an amphiphilic PEG-
phospholipid, whose hydrophobic portion interacts with the nanoparticle surface to 
create micelles, resulting in a self-assembled monolayer coating.  The PEG portion of 
the coating confers solubility and biocompatibility while the use of modified PEG allows 
for bioconjugation [22] of proteins, multiple ligands, and nucleic acid probes.    
 
Materials and Methods 
 
Coating of Magnetic Nanoparticles 
The magnetic iron oxide (Fe3O4) nanoparticles (MIONs) (kindly provided by Dr. 
Charles O’Connor, University of New Orleans) were dispersed in toluene and insoluble 
in water prior to modification.  Mixtures of 1,2-distearoyl-sn-glycero-3-
phosphoethanolamine polyethylene glycol 2000 (DSPE-PEG 2000) and 1,2-distearoyl-
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sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol) 2000] (DSPE-PEG 
2000 amine) were dissolved in chloroform (1:8 ratio of DSPE-PEG 2000:DSPE-PEG 
2000 amine), and iron oxide nanoparticles was added to the solution at a concentration 
of 0.33 mg/ml.  This mixture was then dried under argon gas and left in a vacuum 
dessicator for 48 hours to remove all traces of organic solvents.  The dried film was 
easily resuspended in deionized water with agitation.  The solution obtained was filtered 




 To determine the size of the micelle-coated MIONs, we employed dynamic light 
scattering (DLS) using a DynaPro-LSR instrument (Protein Solutions, England), which 
allows specific measurement of the hydrodynamic radius of macromolecules in the size 
range of 1 nm-1 µm.  Micelle-coated MIONs were filtered first using Anotop 0.2 µm 
inorganic membrane syringe filters (Whatman International); dynamic light scattering 
experiments were then conducted at room temperature.  The size of the micelle-coated 
MIONs was calculated by fitting the data to a polydispersed model [23] using the 
Dynamics software (version 5.26) provided with the instrument.   
 To further determine the size of the coated nanoparticles, transmission electron 
microscopy (TEM) was performed on micelle-coated MIONs.  MIONs were spun in a 
microfuge at 14000 rpm for 6 minutes to obtain a concentrated solution.  The 
supernatant was decanted and 5 µL of this concentrate was placed on a carbon grid.  5 
µL of 1% phosphotungstic acid was added and allowed to sit for 30 seconds for negative 
staining.  Liquid was then removed from carbon grid, and the grid was imaged on a 
Hitachi H-7500 transmission electron microscope (TEM). 
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Bioconjugation and Functionalization 
 To functionalize magnetic nanoparticles for bioconjugation and subsequent 
delivery and imaging studies, we incorporated phospholipid-PEG molecules with primary 
amines (DSPE-PEG-amine) into the micelle structure.  For fluorescence imaging of the 
nanoparticles delivered into cells, we used Texas Red STP ester (1 µM) and the 
heterobifunctional cross-linking reagent, N-succinimidyl 3-(2-pyridyldithio)propionate 
(SPDP) (10 µM) to react with amine groups on the micelle-coated MIONs (mMIONs).  
These were allowed to react for 2 hours in 1X Dulbecco’s phosphate buffered saline 
without Ca or Mg (PBS; from ICN, Ohio).  To reduce the thiol group on SPDP, 20 mM of 
the reductant tris(2-carboxyethyl) phosphine hydrochloride (TCEP) was added and the 
mixture was incubated for 1 hour.  A Microcon YM10 filter unit was used to remove 
unreacted Texas Red and TCEP.  For cellular delivery, we used the cell penetrating 
peptide (CCP) Tat.  The Tat peptide-6-aminohexonic acid-Cys construct was reacted 
overnight with the fluorescently labeled mMIONs via the SPDP crosslinker at a 
concentration of 1 M.  Unreacted peptide was removed by dialysis into 2L of PBS 
buffer using a Slide-A-Lyzer Dialysis Cassette with a molecular weight cutoff of 10000 
Da (Pierce Biotechnology, Rockford, IL) for 24 hours. 
 
Iron Concentration Determination 
 Iron concentration of the mMION solution was determined colorimetrically using 
o-phenanthroline with a procedure modified from [24].  Iron solutions for a standard 
curve with concentrations ranging from 0.5 mg/L to 5 mg/L were diluted from a stock 
solution of FeSO4 (with 1:1000 dilution of concentrated H2SO4) with a Fe2+ concentration 
of 40 mg/L.  Samples and standards both contained 0.2% hydroxylamine HCl to 
maintain iron in the 2+ state and sodium citrate (150 µl per mL of iron solution) to 
maintain an acidic pH for Fe-phenanthroline complex formation.  To dissolve the iron 
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oxide nanoparticles and release Fe2+ for analysis, 0.15% v/v mercaptoacetic acid was 
added to each mMION solution and incubated overnight prior to analysis. O-
phenanthroline was added from a 0.25% w/v stock in water to a final concentration of 
0.0075% w/v for each of the standards and samples.  Absorbance was read at 510 nm. 
 
Cell Culture 
 Primary human dermal fibroblast (HDF) cells (Cambrex, NJ) and kidney-derived 
MDBK cells (ATCC, VA) were used in this study.  Primary HDF cells were cultured using 
FGM-2® Fibroblast Growth Medium 2 with 2% serum (Clonetics ® Media Systems, NJ), 
while MDBK cells were cultured using Dulbecco’s-modified Eagle's medium with fetal 
calf serum (10%) and horse serum (2.5%).  Primary HDF and MDBK cells were plated in 
T-25 cell culture flask using 1:10 dilution after each splitting cycle.  A batch of primary 
HDF cells was cultured for no more than 12 splitting cycles, while the MDBK cell line 
was cultured for 15-18 splitting cycles. 
 
Fluorescent Imaging 
 For fluorescence imaging studies, both HDF and MDBK cells were plated on 8-
well Nalgene Nunc cell culture plates and allowed to grow for 48 hours. The cells were 
incubated for an hour with TxRed-Tat peptide conjugated mMIONs (final Fe 
concentration of 42 µg/mL) in suitable cell culture medium (FGM-2 for HDF’s and 
DMEM+FCS (10%) + HS (2.5%) for MDBKs).  After incubation, cells were washed in 
PBS twice to remove unbound and extracellular mMIONs. Fresh media was added to 
cells after washing, and the cells were imaged using a Zeiss confocal microscope (40 X 
magnification, using a 543 nm laser). 
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Magnetic Contrast Measurements 
 A 0.47 T Bruker Minispec Analyzer MQ20 was used for T2 measurements.  
MDBK cells were grown in a T25 culture plate (approximately 106 cells) and then 
incubated with a 1:4 dilution of mMIONs and media as in fluorescent imaging 
preparation.  After 1 hour of incubation, cells were washed twice with PBS to remove 
extracellular and unbound mMIONs.  Following washing, cells were trypsinized, removed 
from the culture plate, and resuspended in a final volume of 1.5 mL of media.  500 µL of 
this cell suspension were placed in a 10 mm sample tube to determine the T2 value, 
using the CPMG pulse sequence.  The same cell samples were collected in media in 
200 µl microfuge tubes and imaged by a 3T Siemens TRIO MRI system using a T2-
weighted Turbo Spin Echo sequence.  
Results and Discussion 
 The magnetic nanoparticles were successfully coated with a PEG-phospholipid 
micelle coating using the process described in the Materials and Methods section.  The 
magnetic iron oxide (Fe3O4) nanoparticles (MIONs) used in our studies had an average 
size of 6.6 nm with size variation of 11%, as determined by transmission electron 
microscopy (Charles O’Connor, personal communication).  These nanoparticles were 
synthesized using the reverse micelle technique, which allows efficient control of the size 
of nanoparticles [25, 26].  Due to the synthesis process, the nanoparticles had a residual 
capping of surfactant molecules such as cetyltrimethylammonium bromide (CTAB) that 
rendered them soluble only in organic solvents.  To make the particles water-soluble and 
biocompatible, we employed a phospholipid-PEG micelle coating approach, which takes 
the advantage of the interaction between the residual hydrophobic capping ligands on 
the magnetic nanoparticles and the amphiphilic PEG-phospholipids.  The surface-
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exposed hydrophilic PEG chains provide high solubility of the coated magnetic 
nanoparticles. 
 Using the coating process schematically represented in Figure 7.1, we found 
that the nanoparticles were water-soluble (free from cloudiness) and stable in water or 
1X PBS for a period of weeks when kept at 4˚C.  As described in the Materials and 
Methods section, we characterized the mMIONs by measuring the size and Fe 
concentration.  Using dynamic light scattering (DLS) measurements, the average 
hydrodynamic radius of the mMIONs was 7.34 nm ± 0.71 nm (93.9% of mass).  The size 
distribution as a function of percent mass is shown in Figure 7.2 A.  The size range of 
the coated MIONs obtained with DLS is similar to that reported by [21] for micelle-
encapsulated quantum dots.  The DLS results also indicated a very narrow range of 
polydispersity in mMIONs, which may provide a crucial advantage for molecular imaging 
applications based on clustering of magnetic nanoparticles, as discussed later.   
 Electron microscopy was also performed to verify the presence of coating and to 
determine the coating thickness.  As shown in Figure 7.2 B, negative staining allowed a 
contrast between the background and the dark iron core, revealing an unstained micelle 
coating around the MIONs.  The size of mMIONs as determined by the TEM image is 
between 12 to 14 nm, similar to the results obtained by DLS.  This indicates that the 
coating thickness is around 3 nm.  Note that a fraction of micelles without iron cores 
were also observed in the TEM image shown in Figure 7.2 B.  Ultracentrifugation may 
be used in the future to separate empty micelles from mMIONs.  The Fe concentration of 
the coated magnetic nanoparticles (mMIONs) was colorimetrically determined to be 168 
















Figure 7.1: The scheme for the development of micelle-encapsulated 
superparamagnetic iron oxide magnetic nanoparticles (mMIONs).  In the first step, a 
mixture of phospholipid-PEG and phospholipid-PEG-amine (1:10) is dissolved in 
chloroform and then MIONs are added (final concentration of 0.33 mg/mL iron oxide).  
The mixture is dried under argon and left in vacuum desiccator for 48 hours.  Particles 




Figure 7.2: The size of mMIONs. 
A. Particle size distribution [% mass vs. hydrodynamic radius, Rh, (nm) of particles] of 
mMIONs measured using dynamic light scattering.  93.9% of the sample mass has a 
hydrodynamic radius of 7.34 nm.   
B.  Electron micrograph of negatively stained mMIONs at a magnification of 60 kx.  Dark 
iron cores can be seen encircled by unstained micellar coating against the stained 
carbon grid background, indicating a coating thickness of ~ 3-4 nm. 
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The use of phospholipids-PEG to coat MIONs provides a flexible framework for 
nanoparticle functionalization since PEGs modified with a variety of functional groups, 
including amines and sulfhydryls, are commercially available and can be easily 
incorporated into micelles.  Therefore, various moieties including proteins, nucleic acids 
and delivery/targeting ligands can be readily conjugated to the mMIONs.  In this study, to 
demonstrate the ability of mMIONs to generate intracellular contrast, we used Tat 
peptide for nanoparticle delivery into living cells.  Specifically, fluorescent dye molecules 
and delivery peptides were simultaneously attached to the surface of the mMIONs 
through a reactive amine group.  As a member of the cell penetrating peptide (CPPs) 
family, Tat peptide has been shown to deliver proteins, macromolecules, nanoparticles, 
and liposomes of sizes 2 nm to 200 nm across the cell membrane both in cell culture 
and in vivo applications [27, 28], making them very attractive for various intracellular 
delivery applications.  To validate the intracellular delivery of mMIONs, we used two 
reporting modalities: fluorescence imaging and magnetic contrast.  To obtain 
fluorescence imaging capability, the mMIONs were conjugated with TxRed dye (Figure 
















Figure 7.3: Steps for conjugating Tat peptide and fluorescent label (TxRed) to mMIONs 
for cellular delivery and imaging (microscopy, MRI).  The first step involves the 
simultaneous reaction of TxRed STP-ester and crosslinker SPDP with amines on the 
surface of mMIONs.  TCEP is added after the reaction to generate free thiols on surface-
bound SPDP.  The second step is the reaction of the Cys-modified Tat peptide with the 
free thiols of SPDP. 
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 For fluorescence imaging studies, both HDF and MDBK cells were incubated 
with TxRed-Tat conjugated mMIONs for an hour.  Cells were washed to remove 
unbound and extracellular mMIONs. Following washing, cells were incubated with fresh 
media and were imaged using a confocal microscope.  Figures 7.4 A and 7.4 B show 
the fluorescence images as a result of intracellular delivery of mMIONs in both cell lines.  
Note that in images of MDBK cells (Figure 7.4 A), the background signal is slightly 
higher than that in HDF cells.  We believe that this is due to the close clustering of 
MDBK cells in culture, which may contribute to signal increase due to out-of-focus cells.  
HDF cells have a more extended structure and are less densely packed.    
 To further validate the delivery of the mMIONs into live MDBK cells, we 
measured T2 (transverse) relaxation times and obtained MRI contrast images.  These 
measurements are based on the induced changes in water relaxation caused by 
magnetic nanoparticles.  In the presence of a paramagnetic substance such as 
mMIONs, water relaxation properties, namely T1, T2 and T2* (1/ T2* = 1/T2 + 1/T2’, with 
T2’ being a time constant arising from magnetic field inhomogeneity) of proton nuclear 
spins are shortened [29].  For T2 measurements, a Bruker Minispec Analyzer MQ20 was 
used.  MDBK cells were incubated with TxRed-Tat mMIONs for 1 hour and then washed 
to remove extracellular and unbound mMIONs. A suspension of this preparation was 
then used for T2 measurements.  The T2 relaxation time determined for cells with 
mMIONs was 623 ± 2 ms. In contrast, for control cells without mMIONS, the T2 time was 
1503 ± 20 ms (see Figure 7.5 A).  Therefore, in the mMION-treated cells, the T2 time is 
at least a factor of two shorter than control cells, indicating significant internalization of 
magnetic nanoparticles.  We further performed MR imaging using a 3T Siemens TRIO 
MRI system, and a shortened T2 time resulted in a darker image.  As can be seen in 
Figure 7.5 B, when the same cell sample as used for T2 measurements was imaged 
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using an MRI system, cells containing incubated with mMIONs gave a darker image than 

























Figure 7. 4: Fluorescent images of Tat-linked, TxRd-labeled mMIONs in living cells.   
(A) Images of TxRd-labeled mMIONs in MDBK cells.   
(B) Images of TxRd-labeled mMIONs in HDF cells. Images were obtained using a Zeiss 



































Figure 7.5: The effect of mMIONs on water relaxation inside living cells. 
A. T2 relaxation time (ms) measurements obtained using Bruker mq20 Minispec.  
MDBK cells with mMIONs gave a T2 relaxation time of 623 ms while cells without 
mMIONs had a T2 time of 1503 ms.   
B. B. MRI images of four different samples: (1) culture media only, (2) cells without 
mMION, (3) cells with mMION, (4) culture media only.  Images were obtained 
using a 3T Siemens TRIO, turbo spin echo, TR 4000, TE 310, in-plane voxel size 
0.5 x 0.5 mm. 
1 2 3 4





In this work we have developed a micelle-based coating strategy for 
functionalizing superparamagnetic iron oxide nanoparticles.  The coating of small, 
uniformly-sized iron oxide nanoparticles resulted in an MRI contrast agent with a narrow 
size distribution that is biocompatible, water soluble, stable, and has a functionalized 
surface to which multiple ligands can be attached.  Using the Tat peptide, we have 
demonstrated rapid (within 1 hour) delivery of mMIONs into living cells.  Intracellular 
delivery was validated using both fluorescence imaging and MRI contrast measurement.  
The surface of these mMIONS provides a flexible platform to which proteins, nucleic acid 
probes and a variety of ligands for cell delivery and targeting can be attached.  Because 
of the small sizes (10-15 nm), functionalized mMIONs are well suited as a contrast agent 
for probing intracellular events with less perturbation than other currently used iron 
oxide-based molecular probes.  The small and uniform size may also confer an 
advantage in clustering-based molecular switching techniques for specific detection of 
gene expression in deep tissue using MRI.  Therefore, the development of functionalized 
mMIONs in this study is a crucial step towards developing novel intracellular molecular 
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First introduced as MRI contrast agents in the mid-1980s ([1-3]), iron oxide 
nanoparticles display a property defined as superparamagnetism.  They are most often 
magnetite (Fe2O3/Fe3O4), and have crystal-containing regions of unpaired spins (Figure 
8.1), ([4]).  These magnetic domains are disordered in the absence of a magnetic field, 
but when a field is applied, the magnetic domains align to create a magnetic moment 
much greater than the sum of the individual unpaired electrons.  This does not, however, 
result in residual magnetization of the particles.   
Compared with micrometer-sized magnetic particles and chelates of 
paramagnetic ions such as gadolinium diethylenetriaminopentaacetic acid (Gd-DTPA), 
magnetic nanoparticles are much more efficient as relaxation promoters and their effect 
on the relaxivities of water is measurable even at nanomolar concentrations, as 
demonstrated theoretically [5] and experimentally [6-9]. Specifically, the use of 
ferromagnetic and superparamagnetic nanoparticles as contrast agents can induce a 
more than 10-fold increase in proton relaxivities [10].  In the presence of a paramagnetic 
or superparamagnetic substance, the relaxation properties, namely T1, T2 and T2* (1/ T2* 
= 1/T2 + 1/T2’, with T2’ being a time constant arising from magnetic field inhomogeneity) 
of proton nuclear spins are shortened to some extent. Superparamagnetic iron oxides 
(SPIO) or superparamagnetic nanoparticles affect the T2 relaxation time more 








Figure 8.1: (A) SPIO crystal in the absence of an external magnetic field (Bo); the 
orientation of the magnetic domains is random.  
(B) Application of an external magnetic field aligns the magnetic domains with Bo. 
(adapted from Wang et al, 2001[4]) 
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This shortening of T2 results in a darkening of the image where the SPIOs are 
located referred to as negative contrast. Due to better relaxation characteristics of the 
SPIO’s, these superparamagnetic particles are used in various applications. For several 
medical applications, the size of the SPIO’s and their coating are adjusted to target them 
to specific organs of the body ([4]). Particles ranging in size from 60 nm to 150 nm are 
quickly sequestered by the body’s reticuloendothelial system (RES) upon injection, 
rapidly appearing in the liver and spleen.  Even smaller particles under clinical 
investigation (referred to as ultrasmall SPIOs) are typically between 10 and 40 nm; these 
particles circulate in the blood stream much longer than the larger particles, can cross 
capillary walls and often are taken up extensively by lymph nodes and bone marrow.  
Even without specific targeting ligands conjugated on the surface of particles, a variety 
of different organ systems can be specifically imaged.  Further, differential cell uptake in 
cancerous tissue leads to contrast enhancement between normal and tumor tissues, 
which can be used clinically for cancer detection.  There are a number of SPIO 
compounds already FDA-approved for use in the clinic (see Table 8.1), as well as others 
undergoing clinical trials.  In this study, our focus is on ultrasmall SPIOs as described in 
previous Chapter (7). 
Although magnetic nanoparticles or SPIO’s have been extensively studied and 
used for various applications related to MR imaging in clinical and research settings, the 
processes which contribute to the relaxation characteristics of MIONs have not been well 







Table 8.1:  Properties and applications of some SPIO agents (modified from 




Target Organs FDA 
Approval 
AMI-121[14] 300 nm GI lumen Approved 
OMP[15] 3.5 m GI lumen Approved 
AMI-25[16, 
17] 
80-150 nm Liver/spleen Approved 
SHU 555A[16, 
18, 19] 
















30 nm Blood pool Phase II 
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It is not clear whether the relaxation processes are mediated by the diffusion of 
protons or chemical exchange of protons. It is likely that the processes involved in 
magnetic relaxation events not only depend on the magnetic core but also on the coating 
layer, which usually renders these nanosize particles water-soluble and stable in 
physiological buffers. Thus to fully understand the relaxation characteristic of MIONs, we 
have to understand not only the behavior of protons in the vicinity of iron oxide core but 
also their interactions with the coating material. Depending on their thickness and 
chemical characteristics, coating materials can influence the diffusion of protons and 
chemical exchange processes.  
In most of the studies involving magnetic nanoparticles ([8, 26-29]), it is typically 
not possible to independently change the coating size without a significant change in the 
chemistry of a surface coating. With a number of existing coating methods, it is very 
difficult to obtain a narrow size distribution of coated particles ([26-30]). This size 
variation can limit an independent analysis of the role of size and chemistry of coatings 
on relaxivity characteristics of MIONs.  These factors have limited the experimental 
approaches needed to gain a fundamental understanding of the magnetic relaxation 
processes. To provide an insight into the role of coating thickness in magnetic relaxation 
processes, we have varied the size of the surface coatings in this study, with constant 
magnetic core and fixed chemical composition of the coating material. This approach will 
allow us to independently probe the contributions from coating thickness in determining 
the effective magnetic relaxivities of mMIONs.   
In Chapter 7, we developed a coating approach, which allows for modular 
coating of magnetic nanoparticles using amphiphilic phospholipid-PEG micelles. One of 
the advantages of the micelle-based coating was the monodispersity in the size of the 
coated magnetic nanoparticles in contrast with the other coatings such as silanes or 
dextran coating. The results were shown in Figure 7.2 of Chapter 7. The other 
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significant advantage was the ability to tailor the surface of the coated particles with 
variety of ligands using mixture of modified phospholipids-PEG molecules. Using this 
approach we have conjugated multiple biomolecules on the surface of the coated MIONs 
(Figure 7.4 in Chapter 7). In this study, we exploit another significant advantage in 
which we can change the coating size by changing the size of the PEG chain, while 
keeping the same core size and the chemistry of the coating. By employing a series of 
phospholipid-PEG conjugates with increasing molecular weights (PEG 550, PEG 750, 
PEG 1000, PEG 2000, and PEG 5000) and demonstrating a corresponding increase in 
coating layer thickness with dynamic light scattering (DLS), we have studied the impact 
that coating layer thickness has on both T1 and T2 relaxation properties. To gain a more 
complete understanding of these effects on relaxation, we have done computer 
simulations (in collaboration with Dr Hu’s lab) to predict how changes in coating 
thickness will affect relaxivity, using a model that assumes that water is excluded by the 
coating. Thus a thicker coating will have a larger exclusion volume for water protons. 
 
Material and Methods 
 
Coating of Magnetic Nanoparticles 
 
The magnetic iron oxide (Fe3O4) nanoparticles (MIONs) (kindly provided by Dr. 
Charles O’Connor, University of New Orleans) were dispersed in toluene and insoluble 
in water prior to modification.  These nanoparticles were coated with different size of 
DSPE-PEG polymers similar to the approach developed in Chapter 7. The chemistry of 
the lipid chain and the PEG backbone was maintained constant in this study. In a typical 
coating procedure, we added an excess of DSPE-PEG at a concentration of 1 mg/ml 
(e.g. we added 100 µl of DSPE-PEG 2000,1,2-distearoyl-sn-glycero-3-
phosphoethanolamine polyethylene glycol 2000 at 10 mg/ml concentration) to a iron 
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solution at 0.33 mg/ml dissolved in chloroform.  This mixture was then dried using a 
rotary evaporator at water bath temperature of 60°C. This step was a slight modification 
to the procedure described in Chapter 7. The use of the rotary evaporator with a 
vacuum pump allowed us to better remove the toluene and chloroform from the mixture 
as compared with argon evaporation and vacuum dessicator used in previous chapter. 
The dried film was easily resuspended in deionized water with agitation.  The solution 
obtained was filtered using 0.2 µm Anotop inorganic membrane syringe filters (Whatman 
International Ltd., England).   
Size Determination 
 
 To determine the size of the micelle-coated MIONs, we employed dynamic light 
scattering (DLS) using a PSS-Nicomp ZLS 380 (PSS, Corp.), which allows specific 
measurement of the hydrodynamic radius of macromolecules in the size range of 1 nm-1 
µm.  Micelle-coated MIONs were filtered first using Anotop 0.2 µm inorganic membrane 
syringe filters (Whatman International); dynamic light scattering experiments were then 
conducted at room temperature.  The size of the micelle-coated MIONs was calculated 
by fitting the data to a NICOMP algorithm proided by PSS Corp. The number wieghted 
average of three readings was used as representative size measurements of these 
particles. 
  
Iron Concentration Determination 
 
 Iron concentration of the mMION solution was determined colorimetrically using 
o-phenanthroline with a procedure modified from [31].  Iron solutions for a standard 
curve with concentrations ranging from 0.5 mg/L to 5 mg/L were diluted from a stock 
solution of FeSO4 (with 1:1000 dilution of concentrated H2SO4) with a Fe2+ concentration 
of 40 mg/L.  Samples and standards both contained 0.2% hydroxylamine HCl to 
maintain iron in the 2+ state and sodium citrate (150 µl per mL of iron solution) to 
 236
maintain an acidic pH for Fe-phenanthroline complex formation.  To dissolve the iron 
oxide nanoparticles and release Fe2+ for analysis, 0.15% v/v mercaptoacetic acid was 
added to each mMION solution and incubated overnight prior to analysis.  O-
phenanthroline was added from a 0.25% w/v stock in water to a final concentration of 
0.0075% w/v for each of the standards and samples.  Absorbance was read at 510 nm. 
For each O-phenanthroline reading, we made three independent samples at two 
different dilutions. Three repeats of this process were carried out for each of the DSPE-
PEG coated particles. 
 
Magnetic Contrast Measurements 
 
 A 0.47 T Bruker Minispec Analyzer MQ20 was used for T2 and T1 measurements.  
The samples for the T2 and T1 were prepared by 1:10 dilutions of the coated stock 
solutions in 1X PBS.  500 µL of this sample was placed in a 10 mm sample tube to 
determine the T2 and T1 measurement, using the CPMG and the inversion recovery 
pulse sequences respectively.  All the measurements were made at 20Cْ using a 
temperature-controlled probe cavity with an external water bath. Each measurement was 
repeated three times to measure variations within the readings, and each coating 









Results and Discussion 
 
The mMIONs coated with DSPE-PEG (550, 750, 1000, 2000, and 5000) were 
prepared as described in the Materials and Methods section. To measure a change in 
the size of mMIONs coated with different sized polymers, the coated particles were 
analyzed using dynamic light scattering (DLS). Results of the size variation of mMIONs 
coated with PEG chains of different lengths using amphiphilic polymers of the type 
DSPE-PEG (DSPE-PEG 550, 750, 1000, 2000 and 5000) are shown in Table 8.2. The 
result shows an increase in the particle diameter with an increase in polymer coating 
size. The DLS results show no significant difference in the size of DSPE-PEG 550 and 
750. The DSPE-PEG 5000 particles had a diameter of 17 nm. This data is in agreement 





Table 8.2: Variation of diameter of coated mMIONs with changes in coating size 
Serial Number Coating Type Size (Diameter (nm)) 
1 DSPE-PEG-550 8.0 nm 
2 DSPE-PEG-750 9.1±1.7 nm 
3 DSPE-PEG-1000 11.9±1.7 nm 
4 DSPE-PEG-2000 14.2±1.4 nm 
5 DSPE-PEG-5000 16.8±3 nm 
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For the measurement of T2 and T1 relaxation times, the sample was prepared by 
dilution (1:10 in 1x PBS) of the stock solution of coated magnetic nanoparticles.    The 
measured T2 and T1 relaxation times (ms) were converted to R2 and R1 values (1/mM*s) 
by normalizing the relaxation times with the concentration of samples.  The 
concentration of the samples was measured using the o-phenanthroline method as 
outlined in the Methods section.  The results for R2 as a function of DSPE-PEG size 
(PEG 550, 750, 1000, 2000 and 5000) are shown in Figure 8.2. The results show that 
the R2 value increases as the size of the DSPE-PEG polymer is reduced. The relaxivity 
curve as a function of DSPE-PEG size indicates a sharp drop (nearly exponential) in the 
relaxivity as the polymer size is increased from PEG 550 to PEG 2000. The curve also 
indicates that there is a significant (ratio of about 2.5 fold) increase in the magnetic 
relaxivity with the decrease in coating size from DSPE-PEG 550 to DSPE-PEG 5000.  
Upon increasing polymer size from PEG 2000 to PEG 5000, we did not observe any 
significant changes in the relaxivity value, suggesting an asymptotic trend in the R2 
values. These results clearly indicate the role of coating size in determining the net 
magnetic relaxivity of MIONs. The highest R2 value is obtained for the MIONs coated 
with DSPE-PEG 550. This indicates that by reducing the coating size, we can increase 
the contrast produced by MIONs. This is important for medical applications, as higher 
contrast translates into a reduced amount of MIONs required for imaging.   
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Figure 8.2: Variation of R2   for mMIONs coated with micelle coating of 
various sized phospholipid-PEG chains (DSPE-PEG 550, 750, 1000, 2000 
and 5000) 
 241
  The results for the variation of R1 as a function of polymer size is shown in Figure 
8.3. The results show  that the R1 values changes with the changes in polymer coatings. 
The mMIONs coated with DSPE-PEG 550 and 750 had a lower value of R1 as 
compared with rest of the mMION samples. This result shows that the size variation of 
the DSPE-PEG coatings does have significant effect on the R1 relaxivity values of the 
mMIONs. The magnetic nanoparticles have been predominantly used as negative 
contrast agent (R2 relaxivity) for most clinical applications, but there has been recent 
interest in decreasing the R2/R1 ratio, which may allow these particles to be used as 
blood pool agents ([12, 33]). Typically Gd3+, Gd3+-linked albumin and other such R1 
contrast agents have dominated the blood pool agent field.  Due to the need for higher 
concentrations, shorter circulation times, and toxic side effects associated with Gd3+ 
and its conjugates, there has been increasing interest in exploring the use of magnetic 
nanoparticles as alternative blood pool agents ([12, 33]). In this study we were interested 
in determining how polymer coating size can play a role in affecting the R2/R1 ratio ([12, 
33]. The results of Figure 8.2 and 8.3 taken together suggest that by decreasing the 
polymer coating size, we can increase the ratio of R2/R1. Thus for this coating 
chemistry, the use of larger polymer coatings may be desirable to achieve a decreased 
R2/R1 ratio, thus making these particles more suitable for blood pool applications.  
Using modified chemistries, we may be able to further affect the ratio of R2/R1 to 



































Figure 8.3: Variation of R1   for mMIONs coated with micelle coating of 
various sized phospholipid-PEG chains (DSPE-PEG 550, 750, 1000, 2000 
and 5000) 
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  Results in Figure 8.2 and Table 8.2 taken together indicate that with size 
changes of magnetic nanoparticles from an average diameter of 9 nm to 17 nm, there is 
a considerable decrease in the R2 relaxivity of magnetic nanoparticles (factor of 3). This 
is important for various biological applications, especially when using bimolecular 
conjugates such as antibodies (antibodies with average diameter around 10 nm).  It is 
likely that the attachment of these biomolecules can have a considerable effect on the R2 
characteristics of these MIONs by changing the overall apparent thickness of the 
coating.  Attachment of multiple moieties on a single nanoparticle’s surface can cause a 
considerable increase in the overall size of nanoparticles, potentially resulting in a 
decrease in the relaxivity of a contrast agent.  
 To further gain a mechanistic understanding of the change in magnetic relaxivity 
with changes in the size of a polymer coating, our collaborators (Omar Zurkiya, Dr Hu’s 
lab) have developed a numerical approach using a Monte- Carlo simulation to 
understand the proton movement in a sample with magnetic nanoparticles. The 
approach uses a first-order approximation in which coatings are considered as an 
exclusion layer for protons, thus effectively controlling the minimal distance of approach 
for protons in solution (Figure 8.4 A).  
Using the above assumptions, Monte Carlo simulations were performed as 
previously described [11, 34] to model movement of protons in a field with nanosize 
magnetic inhomogeneities . Briefly, protons take random walks through the particle 
fields. At each time step, the sum of Bz due to the particle dipolar fields is computed and 
the proton accumulates a phase according to Φ=γ·Bz·∆t (where γ is the gyromagnetic 
ratio and ∆t, time step, 0.5µs). Simulations were performed using 2000 protons, and 
magnetic parameters used were representative of nanoparticles with a 6.6 nm core 
diameter (6070 Fe atoms per particle). Phase changes were accumulated in 10 µs 
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intervals and R2 and R2* were calculated as previously described [3]. An additional 
parameter, exclusion radius, was introduced as a spherically-shaped, excluded space 
into which protons were not allowed to diffuse. Simulations were performed varying 
exclusion radius to mimic variation in the size of polymer coatings.  
The results of the simulation are shown in Figure 8.4 B. The trend observed in 
the numerical simulation is in agreement with the results of the experimental studies 
shown in Figure 8.2. The simulation data (Figure 8.4 B) show R2 decreasing with 
increasing exclusion volume. This drop indicates that changes in the size, on the scale 
of nanometers, can have a significant effect on R2. In solution, it is likely that many 
processes occur at the interface of the particle coating and the surrounding water, 
making it difficult to directly compare coating size to excluded volume. However, the 
similarity of the results indicates that at least some of the decrease in R2 observed with 
increasing coating thickness in the PEG-modified nanoparticles is due to physical 
exclusion of protons from the immediate neighborhood of the magnetic core. In all 
simulations, values for R2 and R2* were the same as expected for the motion averaging 

















Figure 8.4: (A) Schematic picture of the exclusion volume concept used for monte-carlo 
simulation for calculation of relaxivity values for coated magnetic nanoparticles  
B) Predicted variation of R 2 values as a function coating thickness obtained from 





In this study, we have demonstrated that the coating thickness of magnetic 
nanoparticles can play a significant role in the relaxivity characteristics of these 
nanoscale particles. The coating size has a significant effect on the R2 value of the 
MIONs, with little influence on the R1 relaxivity values. The results of this study have 
considerable impact on the design of magnetic nanoparticles-based contrast agents 
and their applications in medical diagnostics. The numerical simulation results 
indicate that we can mimic the effect of the coating size on magnetic relaxivity values 
with a very basic model, which relies solely on physical exclusion of protons from the 
coated shell of MIONs. Future studies will be designed to vary the chemistry of the 
coatings and environmental factors such as pH and solvent to gain a more 
comprehensive mechanistic understanding of the processes determining the proton 
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In the first part of this dissertation, we have focused on the development of a 
technology platform which can allow for optical imaging of endogenous RNAs in living 
cells. To achieve this aim, we have developed a bi-functional probe, which allows for 
imaging of endogenous RNA in living cells by simple addition of the probes to a regular 
cell culture media. This bi-functional probe design combines a specific optical switch 
(molecular beacon) for detection of RNA with the peptide-based delivery approach for 
the transport of probes across plasma membrane of living cells. This study has adapted 
existing molecular beacon probes from conventional homogeneous assays typically in a 
PCR setting to intracellular measurement/imaging of RNA expression in living cells. The 
early stage studies have focused on the development of bio-conjugation approaches to 
allow for specific conjugation of peptides to molecular beacons. The major challenge in 
this process was the non-specific (electrostatic mediated) coupling of peptides with 
nucleic acid probes. To overcome this challenge we have altered the salt conditions in 
the reaction buffer used for conjugation to reduced non-specific interactions. 
Using peptide linked molecular beacons, we have developed an approach to 
image endogenous RNAs in living cells (Chapter 2). To prove that our delivery approach 
is highly efficient and effective in delivering MBs into the cytoplasm and also maintaining 
their specificity, we have carried out a comparison of the TAT-peptide linked MBs with 
both dendrimer and liposome based approaches for delivering oligonucleotide probes 
into living cells. The results of these studies demonstrate that the traditional delivery 
methods (using liposomes/dendrimers) are significantly slower as compared to the 
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peptide-linked delivery of MBs and these traditional delivery approaches also lead to 
non-specific opening of MB probes. Further for various transfection agents, cells have to 
be maintained in a serum-free media or a reduced-serum media, which can potentially 
change the gene expression profiles of cells due to major roles played by serum proteins 
and other ligands in various intracellular signaling events related to both transcription 
and translation processes. Thus using traditional transfection methods, we not only have 
a higher probability of imaging false positive events due to probe degradation but also 
more likely change the RNA levels and functional state that we aim to observe.  To 
validate the specificity of targeting mRNAs with peptide linked MB probes, we have 
carried out various positive and negative control experiments (random sequenced 
probes, organic dyes, In-situ hybridization, other target RNAs with known localization 
patterns) to validate our observations.  In this study, we have chosen GAPDH and K-Ras 
mRNAs as target RNAs for demonstration of the ability to image endogenous gene 
expression in living cells using MBs. To further demonstrate the ability of this technology 
to detect differential levels of gene expression which is crucial for its applications in 
disease diagnostics, we have selected survivin as a target RNA for this purpose and 
shown successfully such an ability of molecular beacons. Survivin expression levels 
have been shown to be higher in pancreatic cancer cells and other forms of cancers 
including breast cancer.  
After successful demonstration of the technology, we have applied these tools to 
study basic biological questions related to localization and co-localization of mRNAs in 
living cells.  This is an area that has not been extensively explored due to the lack of 
tools to image endogenous RNAs in living cells. At present, we have a relatively good 
understanding of the localization patterns of proteins, but there has not been much 
success in mapping of RNA localization and its related processes in living cells. With this 
tool, we have made initial attempts to address various aspects of RNA localization in 
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living cells. In this direction, our first study (Chapter 3) provided key information 
regarding the co-localization of GAPDH and K-Ras mRNAs with mitochondria in living 
cells. This localization pattern was significantly different from the RNA localization 
pattern observed with MB probes targeting 28-s RNA (a positive control in this study). 
This to our knowledge was one of the first successful studies aimed at imaging 
endogenous RNAs in living cells with high specificity and sensitivity. Experiments were 
also designed to study the role of cytoskeleton structure in the organization of mRNAs in 
the cytoplasm of living cells. The results of these studies clearly indicate microtubules 
are essential in the localization of GAPDH mRNAs in living cells.  
Further in this thesis work, we were interested in developing a connection 
between the functional state of mRNAs and the fluorescent signal observed in our 
imaging experiments. To acheive this goal, we treated cells with Rapamycin and 
Wortamannin which alters the translational state of mRNAs in living cells. The results of 
these studies (Chapter 4) indicate that the translational state of mRNAs favors the 
hybridization of MB with its target sequence. This study has also provided the evidence 
that MB probes are reversibly bound with target mRNAs and the repression of the 
translation process can prevent MBs from binding to its target RNAs once coming off. 
The study has also provided an interesting observation that the active translational 
processes in cytoplasm favor the co-localization of K-Ras and GAPDH mRNAs with 
mitochondria. Further, we found that the repression of translation induces a significant 
re-distribution of mRNAs in the cytoplasm of living cells.  The study also revealed the 
significant differences in the regular DNA backbone chemistry and 2’-O-methyl 
backbone chemistry of MBs. Speficically, MB probes with 2’-O-methyl backbone were 
not removed from the target RNAs with the repression of translation in living cells. This 
backbone was able to follow the changes in the localization of RNAs with the repression 
of translation. 
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To expand the static studies, we were interested in understanding the dynamics 
of RNA molecules in the cytoplasm of living cells and their relationship with cytoskeleton 
and other biochemical processes in living cells. In this effort (Chapter 5), we have 
studied the mobility of RNA molecules in the cytoplasm of living cells. The results of this 
study highlighted that different RNAs can have significantly different dynamics in the 
cytoplasm. Using a FRAP based method, we established that the mobility of GAPDH 
mRNAs is mediated by an active cellular process which requires ATP and intact 
microtubule cytoskeleton.  The recovery process after bleaching was always along a 
directed path, which provided a further evidence to support our claims for active 
transport processes in the cytoplasm. Using a nocodazole-based depolymerization of 
microtubule network, we reduced the directed recovery process in the bleached area.  In 
contrast, using Taxol, we only observed a reduction in the extent of recovery but there 
was no significant change in the overall shape of recovered signal compared with the 
pre-bleach distribution. This trend clearly suggests a significant role of the microtubules 
in mediating the mobility of mRNAs.  
In contrast with GAPDH mRNA studies, the 28-S rRNAs have a significantly 
different dynamics. These ribosomal RNAs are not highly mobile in the cytoplasm of 
living cells. These differences could be inherently due to different localization in the 
cytoplasm. We still need to resolve the relationship between these differences in 
dynamics and the functional aspects of RNAs in the cytoplasm. To achieve this we 
clearly need to develop and combine multiple strategies. We believe that the present 
study provides an initial step in this direction. 
So far we have focused our efforts on studying RNA molecules in the cytoplasm 
of living cells.  However, most RNA molecules begin their journey from the nucleus of a 
cell. After being synthesized and processed by macromolecular machineries in cell 
nucleus mRNAs are exported to the cytoplasm for various functions. To expand our 
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technology we have developed a method (Chapter 6), which allows for direct imaging of 
endogenous RNAs in the nucleus of living cells. This approach combines a molecular 
beacon with a NLS peptide, for efficient delivery of oligonucleotide probes to the 
nucleus. Using this approach, we have imaged with high specificity and sensitivity the 
distribution of small nuclear and small nucleolar RNAs. This method in combination with 
our previous study to detect RNA in the cytoplasm of living cells, allows for direct 
imaging of distribution and organization of RNA from its birth site in the nucleus to its 
journey in the cytoplasm. In combination with biophysical approaches such as FRAP/ 
FCS, this approach can allow for the studies of transport of RNAs from the nucleus to 
the cytoplasm. Further, in combination with labeled proteins, this approach can be used 
to study the dynamics and function of RNP complexes in the nuclei of living cells. 
 
Future Work 
 There are several areas where we need to extend this thesis work to realize the 
full potential of this technology.  
 
Future work in technology development 
 
Development of design rules for MBs to target various RNAs 
 
 A significant challenge to the future success of the molecular beacons 
technology for living cell gene detection is to establish design rules that can provide a 
better accessibility for MBs to bind with the target RNA molecules in different stages of 
the RNA life.  Meeting this challenge requires not only an extensive study of the behavior 
of MB probes but also a detailed understanding of RNA biology in living cells. This 
challenge is similar to that faced by antisense and RNAi research. To make design rules, 
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we can either take an empirical approach in which we study each target RNA as a 
unique problem and optimize the design for each target by iterative efforts, or a 
fundamental approach in which we classify the target RNAs in various groups and 
develop approaches to predict the secondary structure of RNP’s as well as the 
sequences that are occupied by RNA-binding proteins, and then design MBs based on 
those classifications.  Although we have been using only the first approach, in the future, 
studies should be designed to bridge the gap between an empirical approach and a 
fundamental RNA biology approach. Along this direction, we may perform initial 
experiments using an in-vitro reconstituted system and develop a fundamental 
understanding of various issues with well controlled experimental conditions. 
Detection of point mutations 
 
To detect point mutations of RNA with high specificity, we need to optimize the 
design of MBs by developing a better understanding of the thermodynamics and kinetics 
of probes in the intracellular environment. This will require a better design of probes with 
the optimal melting temperature under physiological (intracellular) conditions. This ability 
will extend this technique to the diagnosis of several diseases including cancers. 
Delivery in tissue samples 
 
 Using a peptide based delivery approach, we have developed a method to allow 
for effective delivery of molecular beacons in to living cells. This method was selected as 
it has the potential for delivery in vivo, including tissue samples, animal models or even 
human studies. Establishing this capability, in combination with near-IR dyes will allow 
us to image the molecular processes including disease markers in intact tissues and 
animal models in the near future. 
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Development of biophysical tools to understand probe and RNA dynamics 
 
 In this study, we have made initial attempts to combine molecular beacon based 
detection of RNA with biophysical approaches such as FRAP to understand the 
dynamics of RNA molecules in living cells.  As a future direction, FRAP studies may be 
complemented with FCS based molecular analysis of the dynamics of probe and RNA 
molecules. Further, we may expand the biophysical studies with advanced optical 
imaging to improve the optical resolution (STED microscopy) which can allow for better 
understanding of the organization and dynamics of RNA. These techniques may also be 
combined with biophysical approaches of single molecule imaging to have highly 
sensitive imaging of RNA molecules in living cells.  For example, the use of quantum 
dots could lead to single molecule sensitivity in detecting RNA molecules in living cells. 
 
Future Work in areas of fundamental biological studies 
 
 We have several unresolved questions related to the biology of RNA, for which 
novel probes and related imaging methods can provide cutting edge tools to address 
those questions. 
Interactions of RNA with RNA-binding proteins in living cells 
 
 Proteins are the essential partners of various RNA molecules and they play a 
critical role in the functions and life of RNA. There are various crucial protein-RNA 
interactions at different stages of the RNA life cycle, which can be of potential interest for 
future studies. Some of these interactions can be related to the export and transport of 
RNPs from cell nucleus to the cytoplasm of living cells. There are other interactions, 
which control the metabolism of RNAs. Future studies can be potentially designed to 
address various fundamental biological questions related to different aspects of RNA 
journey in living cells. In this area, we need to combine molecular beacons with various 
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approaches to label partner proteins using fluorescent labels such as GFP, FlAsH etc. 
These approaches may provide a functional understanding of RNA-protein interactions. 
Development of these tools will not only address the fundamental biological issues but 
also provide a crucial tool set to address questions related to molecular processes 
leading to disease states. It has been suggested that certain RNA-protein interactions 
can stabilize the RNA molecules associated with oncogenes in cancer cells.  
 
 
 
 
 
  
 
 
